Jackson Financial Inc. - Quarter Report: 2022 June (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☑ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2022
or
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from _____ to _____
Commission File Number: 001-40274
Jackson Financial Inc.
(Exact name of registrant as specified in its charter)
Delaware | 98-0486152 | |||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
1 Corporate Way, Lansing, Michigan | 48951 | |||||||
(Address of principal executive offices) | (Zip Code) |
(517) 381-5500
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of exchange on which registered | ||||||
Class A Common Stock, Par Value $0.01 Per Share | JXN | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ | ||||||||
Non-accelerated filer | ☑ | Smaller reporting company | ☐ | ||||||||
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
As of August 5, 2022, there were 84,864,727 shares of the registrant’s Class A Common Stock, $0.01 par value, outstanding.
TABLE OF CONTENTS
PART I—FINANCIAL INFORMATION | |||||
Item 1. Financial Statements | |||||
Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021 | |||||
Condensed Consolidated Income Statements for the three and six months ended June 30, 2022 and 2021 | |||||
Condensed Consolidated Statements of Comprehensive Income (Loss) for the three and six months ended June 30, 2022 and 2021 | |||||
Condensed Consolidated Statements of Equity for the three and six months ended June 30, 2022 and 2021 | |||||
Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2022 and 2021 | |||||
1
.
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
Jackson Financial Inc.
Condensed Consolidated Balance Sheets
(in millions, except per share data)
June 30, | December 31, | |||||||||||||
2022 | 2021 | |||||||||||||
(Unaudited) | ||||||||||||||
Assets | ||||||||||||||
Investments: | ||||||||||||||
Debt Securities, available-for-sale, net of allowance for credit losses of $43 and $9 at June 30, 2022 and December 31, 2021, respectively (amortized cost: 2022 $48,223; 2021 $49,378) | $ | 43,478 | $ | 51,547 | ||||||||||
Debt Securities, at fair value under fair value option | 2,005 | 1,711 | ||||||||||||
Debt Securities, trading, at fair value | 103 | 117 | ||||||||||||
Equity securities, at fair value | 260 | 279 | ||||||||||||
Mortgage loans, net of allowance for credit losses of $80 and $94 at June 30, 2022 and December 31, 2021, respectively | 11,574 | 11,482 | ||||||||||||
Mortgage loans, at fair value under fair value option | 357 | — | ||||||||||||
Policy loans (including $3,485 and $3,467 at fair value under the fair value option at June 30, 2022 and December 31, 2021, respectively) | 4,459 | 4,475 | ||||||||||||
Freestanding derivative instruments | 1,243 | 1,417 | ||||||||||||
Other invested assets | 3,648 | 3,199 | ||||||||||||
Total investments | 67,127 | 74,227 | ||||||||||||
Cash and cash equivalents | 5,258 | 2,623 | ||||||||||||
Accrued investment income | 504 | 503 | ||||||||||||
Deferred acquisition costs | 13,115 | 14,249 | ||||||||||||
Reinsurance recoverable, net of allowance for credit losses of $11 and $12 at June 30, 2022 and December 31, 2021, respectively | 31,667 | 33,126 | ||||||||||||
Deferred income taxes, net | 981 | 954 | ||||||||||||
Other assets | 1,369 | 853 | ||||||||||||
Separate account assets | 196,184 | 248,949 | ||||||||||||
Total assets | $ | 316,205 | $ | 375,484 | ||||||||||
Liabilities and Equity | ||||||||||||||
Liabilities | ||||||||||||||
Reserves for future policy benefits and claims payable | $ | 16,053 | $ | 17,629 | ||||||||||
Other contract holder funds | 59,576 | 59,689 | ||||||||||||
Funds withheld payable under reinsurance treaties (including $3,649 and $3,639 at fair value under the fair value option at June 30, 2022 and December 31, 2021, respectively) | 25,506 | 29,007 | ||||||||||||
Long-term debt | 2,634 | 2,649 | ||||||||||||
Repurchase agreements and securities lending payable | 32 | 1,589 | ||||||||||||
Collateral payable for derivative instruments | 621 | 913 | ||||||||||||
Freestanding derivative instruments | 1,217 | 41 | ||||||||||||
Other liabilities | 4,072 | 3,944 | ||||||||||||
Separate account liabilities | 196,184 | 248,949 | ||||||||||||
Total liabilities | 305,895 | 364,410 | ||||||||||||
Commitments, Contingencies, and Guarantees (Note 14) | ||||||||||||||
Equity | ||||||||||||||
Common stock, (i) Class A Common Stock 900,000,000 shares authorized, $0.01 par value per share and 84,864,727 and 88,046,833 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively and (ii) No authorized Class B Common Stock at June 30, 2022 and 100,000,000 shares authorized, $0.01 par value per share and 638,861 shares issued and outstanding at December 31, 2021 (See Note 18) | 1 | 1 | ||||||||||||
Additional paid-in capital | 6,020 | 6,051 | ||||||||||||
Treasury stock, at cost; 9,608,399 and 5,778,649 shares at June 30, 2022 and December 31, 2021, respectively | (371) | (211) | ||||||||||||
Accumulated other comprehensive income (loss), net of tax expense (benefit) of $(907) and $194 at June 30, 2022 and December 31, 2021, respectively | (3,722) | 1,744 | ||||||||||||
Retained earnings | 7,635 | 2,809 | ||||||||||||
Total shareholders' equity | 9,563 | 10,394 | ||||||||||||
Noncontrolling interests | 747 | 680 | ||||||||||||
Total equity | 10,310 | 11,074 | ||||||||||||
Total liabilities and equity | $ | 316,205 | $ | 375,484 |
See Notes to Condensed Consolidated Financial Statements.
2
Jackson Financial Inc.
Condensed Consolidated Income Statements
(Unaudited, in millions, except per share data)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||
Fee income | $ | 1,852 | $ | 1,896 | $ | 3,774 | $ | 3,712 | ||||||||||||||||||
Premiums | 32 | 31 | 66 | 65 | ||||||||||||||||||||||
Net investment income | 747 | 796 | 1,467 | 1,724 | ||||||||||||||||||||||
Net gains (losses) on derivatives and investments | 3,867 | (2,521) | 5,472 | 185 | ||||||||||||||||||||||
Other income | 21 | 30 | 41 | 53 | ||||||||||||||||||||||
Total revenues | 6,519 | 232 | 10,820 | 5,739 | ||||||||||||||||||||||
Benefits and Expenses | ||||||||||||||||||||||||||
Death, other policy benefits and change in policy reserves, net of deferrals | 912 | 210 | 1,479 | 493 | ||||||||||||||||||||||
Interest credited on other contract holder funds, net of deferrals | 217 | 217 | 423 | 440 | ||||||||||||||||||||||
Interest expense | 24 | 7 | 44 | 13 | ||||||||||||||||||||||
Operating costs and other expenses, net of deferrals | 517 | 600 | 1,124 | 1,198 | ||||||||||||||||||||||
Amortization of deferred acquisition and sales inducement costs | 1,198 | (264) | 1,713 | 548 | ||||||||||||||||||||||
Total benefits and expenses | 2,868 | 770 | 4,783 | 2,692 | ||||||||||||||||||||||
Pretax income (loss) | 3,651 | (538) | 6,037 | 3,047 | ||||||||||||||||||||||
Income tax expense (benefit) | 717 | (54) | 1,047 | 531 | ||||||||||||||||||||||
Net income (loss) | 2,934 | (484) | 4,990 | 2,516 | ||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 31 | 56 | 62 | 124 | ||||||||||||||||||||||
Net income (loss) attributable to Jackson Financial Inc. | $ | 2,903 | $ | (540) | $ | 4,928 | $ | 2,392 | ||||||||||||||||||
Earnings per share | ||||||||||||||||||||||||||
Basic | $ | 33.77 | $ | (5.72) | $ | 56.87 | $ | 25.32 | ||||||||||||||||||
Diluted | $ | 32.56 | $ | (5.72) | $ | 54.72 | $ | 25.32 |
See Notes to Condensed Consolidated Financial Statements.
3
Jackson Financial Inc.
Condensed Consolidated Statements of Comprehensive Income (Loss)
(Unaudited, in millions)
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Net income (loss) | $ | 2,934 | $ | (484) | $ | 4,990 | $ | 2,516 | ||||||||||||||||||
Other comprehensive income (loss), net of tax: | ||||||||||||||||||||||||||
Securities with no credit impairment net of tax expense (benefit) of: $(363) and $260, for the three months ended June 30, 2022 and 2021, respectively, and $(1,108) and $(397), for the six months ended June 30, 2022 and 2021, respectively | (2,791) | 948 | (5,488) | (1,432) | ||||||||||||||||||||||
Securities with credit impairment, net of tax expense (benefit) of: $2 and nil for the three months ended June 30, 2022 and 2021, respectively, and $6 and $1, for the six months ended June 30, 2022 and 2021, respectively | 8 | — | 22 | 2 | ||||||||||||||||||||||
Total other comprehensive income (loss) | (2,783) | 948 | (5,466) | (1,430) | ||||||||||||||||||||||
Comprehensive income (loss) | 151 | 464 | (476) | 1,086 | ||||||||||||||||||||||
Less: Comprehensive income (loss) attributable to noncontrolling interests | 31 | 56 | 62 | 124 | ||||||||||||||||||||||
Comprehensive income (loss) attributable to Jackson Financial Inc. | $ | 120 | $ | 408 | $ | (538) | $ | 962 |
See Notes to Condensed Consolidated Financial Statements.
4
Jackson Financial Inc.
Condensed Consolidated Statements of Equity
(Unaudited, in millions)
Accumulated | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional | Treasury | Shares | Equity | Other | Total | Non- | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Common | Paid-In | Stock | Held | Compensation | Comprehensive | Retained | Shareholders' | Controlling | Total | ||||||||||||||||||||||||||||||||||||||||||||||||||
Stock | Capital | at Cost | In Trust | Reserve | Income | Earnings | Equity | Interests | Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balances as of March 31, 2022 | $ | 1 | $ | 6,081 | $ | (351) | $ | — | $ | — | $ | (939) | $ | 4,782 | $ | 9,574 | $ | 715 | $ | 10,289 | |||||||||||||||||||||||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | 2,903 | 2,903 | 31 | 2,934 | |||||||||||||||||||||||||||||||||||||||||||||||||
Change in unrealized investment gains and losses, net of tax | — | — | — | — | — | (2,783) | — | (2,783) | — | (2,783) | |||||||||||||||||||||||||||||||||||||||||||||||||
Change in equity of noncontrolling interests | — | — | — | — | — | — | — | — | 1 | 1 | |||||||||||||||||||||||||||||||||||||||||||||||||
Treasury stock acquired in connection with share repurchases | — | — | (100) | — | — | — | — | (100) | — | (100) | |||||||||||||||||||||||||||||||||||||||||||||||||
Dividends on common stock | — | — | — | — | — | — | (50) | (50) | — | (50) | |||||||||||||||||||||||||||||||||||||||||||||||||
Share based compensation | — | (61) | 80 | — | — | — | — | 19 | — | 19 | |||||||||||||||||||||||||||||||||||||||||||||||||
Balances as of June 30, 2022 | $ | 1 | $ | 6,020 | $ | (371) | $ | — | $ | — | $ | (3,722) | $ | 7,635 | $ | 9,563 | $ | 747 | $ | 10,310 | |||||||||||||||||||||||||||||||||||||||
Accumulated | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional | Treasury | Shares | Equity | Other | Total | Non- | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Common | Paid-In | Stock | Held | Compensation | Comprehensive | Retained | Shareholders' | Controlling | Total | ||||||||||||||||||||||||||||||||||||||||||||||||||
Stock | Capital | at Cost | In Trust | Reserve | Income | Earnings | Equity | Interests | Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balances as of March 31, 2021 | $ | 1 | $ | 5,927 | $ | — | $ | (4) | $ | 10 | $ | 1,443 | $ | 2,608 | $ | 9,985 | $ | 585 | $ | 10,570 | |||||||||||||||||||||||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | (540) | (540) | 56 | (484) | |||||||||||||||||||||||||||||||||||||||||||||||||
Change in unrealized investment gains and losses, net of tax | — | — | — | — | — | 948 | — | 948 | — | 948 | |||||||||||||||||||||||||||||||||||||||||||||||||
Change in equity of noncontrolling interests | — | — | — | — | — | — | — | — | (42) | (42) | |||||||||||||||||||||||||||||||||||||||||||||||||
Reserve for equity compensation plans | — | — | — | — | $ | (1) | — | — | (1) | — | (1) | ||||||||||||||||||||||||||||||||||||||||||||||||
Balances as of June 30, 2021 | $ | 1 | $ | 5,927 | $ | — | $ | (4) | $ | 9 | $ | 2,391 | $ | 2,068 | $ | 10,392 | $ | 599 | $ | 10,991 | |||||||||||||||||||||||||||||||||||||||
Accumulated | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional | Treasury | Shares | Equity | Other | Total | Non- | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Common | Paid-In | Stock | Held | Compensation | Comprehensive | Retained | Shareholders' | Controlling | Total | ||||||||||||||||||||||||||||||||||||||||||||||||||
Stock | Capital | at Cost | In Trust | Reserve | Income | Earnings | Equity | Interests | Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balances as of December 31, 2021 | $ | 1 | $ | 6,051 | $ | (211) | $ | — | $ | — | $ | 1,744 | $ | 2,809 | $ | 10,394 | $ | 680 | $ | 11,074 | |||||||||||||||||||||||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | 4,928 | 4,928 | 62 | 4,990 | |||||||||||||||||||||||||||||||||||||||||||||||||
Change in unrealized investment gains and losses, net of tax | — | — | — | — | — | (5,466) | — | (5,466) | — | (5,466) | |||||||||||||||||||||||||||||||||||||||||||||||||
Change in equity of noncontrolling interests | — | — | — | — | — | — | — | — | 5 | 5 | |||||||||||||||||||||||||||||||||||||||||||||||||
Treasury stock acquired in connection with share repurchases | — | — | (240) | — | — | — | — | (240) | — | (240) | |||||||||||||||||||||||||||||||||||||||||||||||||
Dividends on common stock | — | — | — | — | — | — | (102) | (102) | — | (102) | |||||||||||||||||||||||||||||||||||||||||||||||||
Share based compensation | — | (31) | 80 | — | — | — | — | 49 | — | 49 | |||||||||||||||||||||||||||||||||||||||||||||||||
Balances as of June 30, 2022 | $ | 1 | $ | 6,020 | $ | (371) | $ | — | $ | — | $ | (3,722) | $ | 7,635 | $ | 9,563 | $ | 747 | $ | 10,310 | |||||||||||||||||||||||||||||||||||||||
Accumulated | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional | Treasury | Shares | Equity | Other | Total | Non- | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Common | Paid-In | Stock | Held | Compensation | Comprehensive | Retained | Shareholders' | Controlling | Total | ||||||||||||||||||||||||||||||||||||||||||||||||||
Stock | Capital | at Cost | In Trust | Reserve | Income | Earnings | Equity | Interests | Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
Balances as of December 31, 2020 | $ | 1 | $ | 5,927 | $ | — | $ | (4) | $ | 8 | $ | 3,821 | $ | (324) | $ | 9,429 | $ | 494 | $ | 9,923 | |||||||||||||||||||||||||||||||||||||||
Net income (loss) | — | — | — | — | — | — | 2,392 | 2,392 | 124 | 2,516 | |||||||||||||||||||||||||||||||||||||||||||||||||
Change in unrealized investment gains and losses, net of tax | — | — | — | — | — | (1,430) | — | (1,430) | — | (1,430) | |||||||||||||||||||||||||||||||||||||||||||||||||
Change in equity of noncontrolling interests | — | — | — | — | — | — | — | — | (19) | (19) | |||||||||||||||||||||||||||||||||||||||||||||||||
Reserve for equity compensation plans | — | — | — | — | 1 | — | — | 1 | — | 1 | |||||||||||||||||||||||||||||||||||||||||||||||||
Balances as of June 30, 2021 | $ | 1 | $ | 5,927 | $ | — | $ | (4) | $ | 9 | $ | 2,391 | $ | 2,068 | $ | 10,392 | $ | 599 | $ | 10,991 | |||||||||||||||||||||||||||||||||||||||
See Notes to Condensed Consolidated Financial Statements.
5
Jackson Financial Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited, in millions)
Six Months Ended June 30, | ||||||||||||||
2022 | 2021 | |||||||||||||
Cash flows from operating activities: | ||||||||||||||
Net income (loss) | $ | 4,990 | $ | 2,516 | ||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||
Net realized losses (gains) on investments | 125 | (168) | ||||||||||||
Net losses (gains) on derivatives | (3,492) | 113 | ||||||||||||
Net losses (gains) on funds withheld reinsurance | (2,105) | (130) | ||||||||||||
Interest credited on other contract holder funds, gross | 423 | 440 | ||||||||||||
Mortality, expense and surrender charges | (269) | (280) | ||||||||||||
Amortization of discount and premium on investments | 13 | 27 | ||||||||||||
Deferred income tax expense (benefit) | 1,075 | 563 | ||||||||||||
Share-based compensation | 69 | 46 | ||||||||||||
Change in: | ||||||||||||||
Accrued investment income | (2) | 39 | ||||||||||||
Deferred acquisition costs and sales inducements | 1,364 | 148 | ||||||||||||
Funds withheld, net of reinsurance | (90) | (398) | ||||||||||||
Other assets and liabilities, net | (5) | (768) | ||||||||||||
Net cash provided by (used in) operating activities | 2,096 | 2,148 | ||||||||||||
Cash flows from investing activities: | ||||||||||||||
Sales, maturities and repayments of: | ||||||||||||||
Debt securities | 6,942 | 10,325 | ||||||||||||
Equity securities | 43 | 25 | ||||||||||||
Mortgage loans | 551 | 682 | ||||||||||||
Purchases of: | ||||||||||||||
Debt securities | (5,981) | (5,502) | ||||||||||||
Equity securities | (25) | (51) | ||||||||||||
Mortgage loans | (1,039) | (1,557) | ||||||||||||
Settlements related to derivatives and collateral on investments | 2,570 | (2,948) | ||||||||||||
Other investing activities | (446) | (394) | ||||||||||||
Net cash provided by (used in) investing activities | 2,615 | 580 | ||||||||||||
See Notes to Condensed Consolidated Financial Statements.
6
Jackson Financial Inc.
Condensed Consolidated Statements of Cash Flows (continued)
(Unaudited, in millions)
Six Months Ended June 30, | ||||||||||||||
2022 | 2021 | |||||||||||||
Cash flows from financing activities: | ||||||||||||||
Policyholders' account balances: | ||||||||||||||
Deposits | $ | 10,285 | $ | 9,759 | ||||||||||
Withdrawals | (12,983) | (15,184) | ||||||||||||
Net transfers from (to) separate accounts | 2,554 | 1,191 | ||||||||||||
Proceeds from (payments on) repurchase agreements and securities lending | (1,557) | 1,157 | ||||||||||||
Net proceeds from (payments on) Federal Home Loan Bank notes | — | (130) | ||||||||||||
Net proceeds from (payments on) debt | (783) | (4) | ||||||||||||
Net proceeds from issuance of senior notes | 750 | — | ||||||||||||
Debt issuance costs | (7) | — | ||||||||||||
Dividends on common stock | (102) | — | ||||||||||||
Purchase of treasury stock | (240) | — | ||||||||||||
Other financing activities | 7 | — | ||||||||||||
Net cash provided by (used in) financing activities | (2,076) | (3,211) | ||||||||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash | 2,635 | (483) | ||||||||||||
Cash, cash equivalents, and restricted cash at beginning of period | 2,631 | 2,019 | ||||||||||||
Total cash, cash equivalents, and restricted cash at end of period | $ | 5,266 | $ | 1,536 | ||||||||||
Supplemental cash flow information | ||||||||||||||
Income taxes paid (received) | $ | (2) | $ | 34 | ||||||||||
Interest paid | $ | 40 | $ | 10 | ||||||||||
Non-cash investing activities | ||||||||||||||
Debt securities acquired from exchanges, payments-in-kind, and similar transactions | $ | 214 | $ | 117 | ||||||||||
Other invested assets acquired from stock splits and stock distributions | $ | 42 | $ | 99 | ||||||||||
Reconciliation to Statement of Financial Position | ||||||||||||||
Cash and cash equivalents | $ | 5,258 | $ | 1,536 | ||||||||||
Restricted cash (included in Other assets) | 8 | — | ||||||||||||
Total cash, cash equivalents, and restricted cash | $ | 5,266 | $ | 1,536 | ||||||||||
See Notes to Condensed Consolidated Financial Statements.
7
Jackson Financial Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)
1. Business and Basis of Presentation
Jackson Financial Inc. (“Jackson Financial”) along with its subsidiaries (collectively, the “Company,” which also may be referred to as “we,” “our” or “us”), is a financial services company focused on helping Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Jackson Financial, domiciled in the United States (“U.S.”), was a majority-owned subsidiary of Prudential plc (“Prudential”), London, England and was the holding company for Prudential’s U.S. operations. As described below under "Other," the Company's demerger from Prudential was completed on September 13, 2021 ("Demerger"), and the Company is no longer a majority-owned subsidiary of Prudential.
Jackson Financial’s primary life insurance subsidiary, Jackson National Life Insurance Company and its insurance subsidiaries (“Jackson”), is licensed to sell group and individual annuity products (including immediate, registered index-linked, deferred fixed, fixed index and variable annuities), and individual life insurance products, including variable universal life, in all 50 states and the District of Columbia. Jackson also participates in the institutional products market through the issuance of guaranteed investment contracts (“GICs”), funding agreements and medium-term note funding agreements. In addition to Jackson, Jackson Financial’s primary operating subsidiaries are as follows:
•PPM America, Inc. (“PPM”), is the Company’s investment management operation that manages the life insurance companies’ general account investment funds. PPM also provides investment services to other former affiliated and unaffiliated institutional clients.
•Brooke Life Insurance Company (“Brooke Life”), Jackson’s direct parent, is a life insurance company licensed to sell life insurance and annuity products in the state of Michigan.
Other subsidiaries, which are wholly owned by Jackson, consist of the following:
•Life insurers: Jackson National Life Insurance Company of New York (“JNY”); Squire Reassurance Company LLC (“Squire Re”); Squire Reassurance Company II, Inc. (“Squire Re II”) and VFL International Life Company SPC, LTD;
•Broker-dealer, investment management and investment advisor subsidiaries: Jackson National Life Distributors, LLC ("JNLD"); Jackson National Asset Management, LLC ("JNAM");
•PGDS (US One) LLC (“PGDS”), which provides certain services to the Company and certain former affiliates; and
•Other insignificant wholly owned subsidiaries.
The Condensed Consolidated Financial Statements also include other insignificant partnerships, limited liability companies (“LLCs”) and other variable interest entities (“VIEs”) in which the Company is deemed the primary beneficiary.
Other
On August 6, 2021, the registration statement on Form 10 of the Company's Class A Common Stock filed with the U.S. Securities and Exchange Commission (the "SEC"), became effective under the Securities Exchange Act of 1934, as amended. We refer to that effective Form 10 registration as the "Form 10." The Demerger transaction described in the Form 10 was consummated on September 13, 2021. As of June 30, 2022, Prudential retained a 14.3% remaining interest in the Company. Prudential sold additional shares of the Company’s Class A Common Stock during the third quarter of 2022 and as of August 5, 2022 Prudential retained a 9.0% remaining interest in the Company.
On September 9, 2021, the Company effected a 104,960.3836276-for-1 stock split of its Class A Common Stock and Class B Common Stock by way of a reclassification of its Class A Common Stock and Class B Common Stock (the “stock split”). The incremental par value of the newly issued shares was recorded with the offset to additional paid-in capital. All share and earnings per share information presented herein have been retroactively adjusted to reflect the stock split.
8
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 1. Business and Basis of Presentation
On June 18, 2020, the Company’s subsidiary, Jackson, announced that it had entered into a funds withheld coinsurance agreement with Athene Life Re Ltd. (“Athene”) effective June 1, 2020 to reinsure on 100% quota share basis, a block of Jackson’s in-force fixed and fixed-index annuity product liabilities in exchange for a $1.2 billion ceding commission ("Athene Reinsurance Agreement").
In addition, we entered into an investment agreement with Athene Life Re Ltd., pursuant to which Athene invested $500 million of capital in return for a 9.9% voting interest corresponding to a 11.1% economic interest in the Company. That investment was completed on July 17, 2020. In August 2020, the Company made a $500 million capital contribution to its subsidiary, Jackson. As of June 30, 2022, Athene retained a 8.9% voting interest and 8.9% economic interest.
We continue to closely monitor developments related to the COVID-19 pandemic. The COVID-19 pandemic has caused significant economic and financial turmoil both in the United States and around the world. While there has been a gradual resumption of activity, COVID-19 and its variants continue to affect activity, and those effects could continue and could worsen in the future. The extent to which the COVID-19 pandemic impacts our business, results of operations, financial condition and cash flows will depend on future developments that are highly uncertain and cannot be predicted. The Company implemented business continuity plans that were already in place to ensure the availability of services for our customers, work at home capabilities for our employees, where appropriate, and other ongoing risk management activities. The Company has had employees, as needed or voluntarily, in our offices during this time, as permitted by local and state restrictions. The Company rolled out a broader “return to office plan” for all employees, with many associates in 2022 now working on an “office-centric” hybrid schedule between in-office and remote working arrangements.
Basis of Presentation
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Accordingly, certain financial information that is normally included in annual financial statements prepared in accordance with GAAP, but not required for interim reporting purposes, has been condensed or omitted. These Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and the related notes included in our Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC on March 7, 2022, (the "2021 Annual Report"). The condensed consolidated financial information as of December 31, 2021 included herein has been derived from the audited Consolidated Financial Statements in the 2021 Annual Report, although certain amounts have been reclassified to conform to the 2022 presentation.
Certain accounting policies, which significantly affect the determination of financial condition, results of operations and cash flows, are summarized in the Company’s Notes to Consolidated Financial Statements for the year ended December 31, 2021 in the Company’s 2021 Annual Report.
In the opinion of management, these financial statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results. Operating results for the three and six months ended June 30, 2022, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2022. All material intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires the use of estimates and assumptions about future events that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. Significant estimates or assumptions, as further discussed in the notes, include:
•Valuation of investments and derivative instruments, including fair values of securities deemed to be in an illiquid market and the determination of when an impairment is necessary;
•Assessments as to whether certain entities are variable interest entities, the existence of reconsideration events and the determination of which party, if any, should consolidate the entity;
•Assumptions impacting estimated future gross profits, including policyholder behavior, mortality rates, expenses, projected hedging costs, investment returns and policy crediting rates, used in the calculation of amortization of deferred acquisition costs;
9
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 1. Business and Basis of Presentation
•Assumptions used in calculating policy reserves and liabilities, including policyholder behavior, mortality rates, expenses, investment returns and policy crediting rates;
•Assumptions as to future earnings levels being sufficient to realize deferred tax benefits;
•Estimates related to expectations of credit losses on certain financial assets and off balance sheet exposures;
•Assumptions and estimates associated with the Company’s tax positions, including an estimate of the dividends received deduction, which impact the amount of recognized tax benefits recorded by the Company; and
•Assumptions used in calculating the value of guaranteed benefits.
These estimates and assumptions are based on management’s best estimates and judgments. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors deemed appropriate. As facts and circumstances dictate, these estimates and assumptions may be adjusted. Since future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates. Changes in estimates, including those resulting from continuing changes in the economic environment, will be reflected in the consolidated financial statements in the periods the estimates are changed.
2. New Accounting Standards
Changes in Accounting Principles – Adopted in Current Year
In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The new guidance provides optional expedients for applying GAAP to contracts and other transactions affected by reference rate reform and is effective for contract modifications made between March 12, 2020 and December 31, 2022. If certain criteria are met, an entity will not be required to remeasure or reassess contracts impacted by reference rate reform. The practical expedient allowed by this standard was elected and will be applied prospectively by the Company as reference rate reform unfolds. The contracts modified to date met the criteria for the practical expedient and therefore had no material impact on the Company’s consolidated financial statements. The Company will continue to evaluate the impacts of reference rate reform on contract modifications and other transactions through December 31, 2022.
Changes in Accounting Principles – Issued but Not Yet Adopted
In August 2018, the FASB issued ASU 2018-12, “Targeted Improvements to the Accounting for Long-Duration Contracts,” which includes changes to the existing recognition, measurement, presentation and disclosure requirements for long-duration contracts issued by an insurance entity. ASU No. 2018-12 is effective for fiscal years beginning after December 15, 2022.
The amendments in ASU 2018-12 contain four significant changes:
1.Market risk benefits: market risk benefits, a new term for certain contracts or features that provide for potential benefits in addition to the account balance which expose us to other than nominal market risk (for example, certain guaranteed benefits on annuity contracts, including guaranteed minimum withdrawal benefits and guaranteed minimum death benefits on variable annuities), will be measured at fair value. Changes in fair value will be recorded and presented separately within the income statement, with the exception of changes in fair value due to instrument-specific credit risk, which will be recognized in other comprehensive income (loss) (“OCI”). See Note 10 for more information regarding guaranteed benefits;
2.Deferred acquisition costs: deferred acquisition costs (“DAC”) will be amortized on a constant-level basis, independent of profitability on the underlying business;
3.Liability for future policy benefits: annual review and, if necessary, update of cash flow assumptions used to measure the liability for future policy benefits for nonparticipating traditional and limited-payment insurance contracts will be required. These liabilities will be discounted using an upper-medium grade fixed income instrument yield which will be updated quarterly, with related changes in the liability recognized in OCI; and
10
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 2. New Accounting Standards
4.Enhanced disclosures: enhanced disclosures, including disaggregated roll-forwards of certain balance sheet accounts that provide information about actual and expected cash flows, as well as information about significant inputs, judgments, assumptions and methods used in measurement, will be required. The enhanced disclosures are intended to improve the ability of users of the financial statements to evaluate the timing, amount, and uncertainty of cash flows arising from long-duration contracts.
The Company will adopt the standard effective January 1, 2023, with a transition date of January 1, 2021, using a modified retrospective approach, except for market risk benefits for which we will apply a full retrospective transition approach. Under the modified retrospective approach, the Company will apply the guidance to contracts in force on the transition date on the basis of their existing carrying value, using updated future cash flow assumptions, and eliminate certain related amounts in accumulated other comprehensive income (loss) (“AOCI”). Under the full retrospective transition approach, the Company will apply the guidance as of the earliest period presented, using actual historical experience information as of contract inception, as if the accounting principle had always been applied.
In accordance with its established governance framework, the Company continues to progress with implementation efforts including determining significant accounting policy decisions, modifying actuarial valuation models, revising reporting processes, and updating internal controls over financial reporting.
Given the nature and extent of the required changes, the adoption of this standard is expected to have a significant impact on the Company’s consolidated financial statements and disclosures. Based upon the elected transition methods, the Company currently estimates the adoption of the standard will result in a decrease of between approximately $2 billion and $4 billion in the Company’s total equity at the transition date of January 1, 2021. This estimate is based on the economic conditions experienced at the transition date.
The most significant drivers of the transition adjustment are expected to be:
•changes to the measurement of certain benefits currently accounted for as insurance benefits (e.g., guaranteed minimum death benefits on variable annuities) which will be classified as market risk benefits upon adoption and remeasured at fair value, the impact of which is highly dependent on market conditions, including interest rates;
•changes to the discount rate used to measure liabilities for future policyholder benefits that will be remeasured using current upper-medium grade fixed-income instrument yields, which are generally considered to be those on single-A rated public corporate debt; and
•the removal of certain balances recorded in AOCI related to changes in unrealized appreciation (depreciation) on investments.
In March 2022, the FASB issued ASU 2022-01, “Derivatives and Hedging (Topic 815): Fair Value Hedging – Portfolio Layer Method.” The new guidance allows multiple hedged layers to be designated for a single closed portfolio of financial assets or one or more beneficial interests secured by a portfolio of financial instruments. If multiple hedged layers are designated, an entity is required to perform an analysis to support its expectation that the aggregate amount of the hedged layers is anticipated to be outstanding for the designated hedge periods. The amendments in this update are effective for fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. An entity may designate multiple hedged layers of a single closed portfolio solely on a prospective basis. All entities are required to apply the amendments related to hedge basis adjustments under the portfolio layer method, except for those related to disclosures, on a modified retrospective basis by means of a cumulative-effect adjustment to the opening balance of retained earnings on the initial application date. Early adoption is permitted. The Company does not anticipate any impact when adopting the new guidance and does not plan to early adopt.
11
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 3. Segment Information
In March 2022, the FASB issued ASU 2022-02, “Financial Instruments – Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures.” The new guidance eliminates the accounting guidance for troubled debt restructurings by creditors, and instead requires an entity to evaluate whether a modification represents a new loan or a continuation of an existing loan. The amendments also enhance disclosure requirements for certain loan refinancings and restructurings by creditors when a borrower is experiencing financial difficulty. New guidance for vintage disclosures requires that current-period gross write-offs be disclosed by year of origination for financing receivables and net investments in leases that fall within scope of the current expected credit loss model. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Updates should be applied prospectively. However, an entity has the option to apply the modified retrospective method related to the recognition and measurements of troubled debt restructurings. Early adoption is permitted. The Company does not anticipate a significant impact when adopting the new guidance and does not plan to early adopt.
3. Segment Information
The Company has three reportable segments consisting of Retail Annuities, Institutional Products, Closed Life and Annuity Block, plus its Corporate and Other segment. These segments reflect the manner by which the Company’s chief operating decision maker views and manages the business. The following is a brief description of the Company’s reportable segments.
Retail Annuities
The Company’s Retail Annuities segment offers a variety of retirement income and savings products through its diverse suite of products, consisting primarily of variable annuities, fixed index annuities, fixed annuities, immediate payout annuities, and registered index-linked annuities ("RILA"). These products are distributed through various wirehouses, insurance brokers and independent broker-dealers, as well as through banks and financial institutions, primarily to high net worth investors and the mass and affluent markets.
The Company’s variable annuities represent an attractive option for retirees and soon-to-be retirees, providing access to equity market appreciation and add-on benefits, including guaranteed lifetime income. A fixed index annuity is designed for investors who desire principal protection with the opportunity to participate in capped upside investment returns linked to a reference market index. The Company also provides access to guaranteed lifetime income as an add-on benefit. A fixed annuity is a guaranteed product designed to build wealth without market exposure, through a crediting rate that is likely to be superior to interest rates offered from banks or money market funds. A RILA product offers customers exposure to market returns through market index-linked investment options, subject to a cap, and offers a variety of guarantees designed to modify or limit losses.
The financial results of the variable annuity business within the Company’s Retail Annuities segment are largely dependent on the performance of the contract holder account value, which impacts both the level of fees collected and the benefits paid to the contract holder. The financial results of the Company’s fixed annuities, including the fixed portion of its variable annuity, RILA and fixed index annuities, are largely dependent on the Company’s ability to earn a spread between earned investment rates on general account assets and the interest credited to contract holders.
Institutional Products
The Company’s Institutional Products consist of traditional Guaranteed Investment Contracts (GICs), funding agreements (including agreements issued in conjunction with the Company’s participation in the U.S. Federal Home Loan Bank ("FHLB") program) and medium-term note funding agreements. The Company’s GIC products are marketed to defined contribution pension and profit-sharing retirement plans. Funding agreements are marketed to institutional investors, including corporate cash accounts and securities lending funds, as well as money market funds, and are issued to the FHLB in connection with its program.
The financial results of the Company’s institutional products business are primarily dependent on the Company’s ability to earn spreads on general account assets.
12
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 3. Segment Information
Closed Life and Annuity Blocks
The Company's Closed Life and Annuity Blocks segment is primarily composed of blocks of business that have been acquired since 2004. The segment includes various protection products, primarily whole life, universal life, variable universal life, and term life insurance products, as well as fixed, fixed index, and payout annuities. The Closed Life and Annuity Blocks segment also includes a block of group payout annuities that we assumed from John Hancock Life Insurance Company (USA) (“John Hancock”) and John Hancock Life Insurance Company of New York (“John Hancock NY”) through reinsurance transactions in 2018 and 2019, respectively. The Company historically offered traditional and interest-sensitive life insurance products but discontinued new sales of life insurance products in 2012, as we believe opportunistically acquiring mature blocks of life insurance policies is a more efficient means of diversifying our in-force business than selling new life insurance products.
The profitability of the Company’s Closed Life and Annuity Blocks segment is largely driven by its historical ability to appropriately price its products and purchase appropriately priced blocks of business, as realized through underwriting, expense and net gains (losses) on derivatives and investments, and the ability to earn an assumed rate of return on the assets supporting that business.
Corporate and Other
The Company’s Corporate and Other segment primarily consists of the operations of its investment management subsidiary, PPM, VIE’s, and unallocated corporate income and expenses. The Corporate and Other segment also includes certain eliminations and consolidation adjustments.
Segment Performance Measurement
Segment operating revenues and pretax adjusted operating earnings are non-GAAP financial measures that management believes are critical to the evaluation of the financial performance of the Company’s segments. The Company uses the same accounting policies and procedures to measure segment pretax adjusted operating earnings as used in its reporting of consolidated net income. Its primary measure is pretax adjusted operating earnings, which is defined as net income recorded in accordance with GAAP, excluding certain items that may be highly variable from period to period due to accounting treatment under GAAP, or that are non-recurring in nature, as well as certain other revenues and expenses which are not considered to drive underlying performance. Operating revenues and pretax adjusted operating earnings should not be used as a substitute for revenues and net income as calculated in accordance with GAAP.
Pretax adjusted operating earnings equals net income adjusted to eliminate the impact of the following items:
1.Guaranteed Benefits and Hedging Results: the fees attributed to guaranteed benefits, the associated movements in optional guaranteed benefit liabilities and related claims and benefit payments are excluded from pretax adjusted operating earnings, as we believe this approach appropriately removes the impact to both revenue and related expenses associated with the guaranteed benefit features that are offered for certain of our variable annuities and fixed index annuities and gives investors a better picture of what is driving our underlying performance. This adjustment includes the following components:
•Fees Attributable to Guarantee Benefits: fees earned in conjunction with guaranteed benefit features offered for certain of our variable annuities and fixed index annuities are set at a level intended to mitigate the cost of hedging and funding the liabilities associated with such guaranteed benefit features. The full amount of the fees attributable to guaranteed benefit features have been excluded from pretax adjusted operating earnings as the related net movements in freestanding derivatives and net reserve and embedded derivative movements, as described below, have been excluded from pretax adjusted operating earnings. This adjusted presentation of our earnings is intended to directly align revenue and related expenses associated with the guaranteed benefit features;
13
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 3. Segment Information
•Net Movement in Freestanding Derivatives, except earned income (periodic settlements and changes in settlement accruals) on derivatives that are hedges of investments, but do not qualify for hedge accounting treatment: changes in the fair value of our freestanding derivatives used to manage the risk associated with our life and annuity reserves, including those arising from the guaranteed benefit features offered for certain of our variable annuities and fixed index annuities. Net movements in freestanding derivatives have been excluded from pretax adjusted operating earnings as the market value of these derivatives may vary significantly from period to period as a result of near-term market conditions and therefore are not directly comparable or reflective of the underlying performance of our business;
•Net Reserve and Embedded Derivative Movements: changes in the valuation of certain life and annuity reserves, a portion of which are accounted for as embedded derivative instruments, and which are primarily composed of variable and fixed index annuity reserves, including those arising from the guaranteed benefit features offered for certain of our variable annuities. Net reserve and embedded derivative movements have been excluded from pretax adjusted operating earnings as the carrying values of these derivatives may vary significantly from period to period as the result of near-term market conditions and policyholder behavior-related inputs and therefore are not directly comparable or reflective of the underlying performance of our business. Movements in reserves attributable to the current period claims and benefit payments in excess of a customer’s account value on these policies are also excluded from pretax adjusted operating earnings as these benefit payments are affected by near-term market conditions and policyholder behavior-related inputs and therefore may vary significantly from period to period;
•DAC and Deferred Sales Inducements ("DSI") Impact: amortization of deferred acquisition costs and deferred sales inducements associated with the items excluded from pretax adjusted operating earnings;
•Assumption changes: the impact on the valuation of Net Derivative and Reserve Movements, including amortization on DAC, arising from changes in underlying actuarial assumptions on an annual basis;
2.Net Realized Investment Gains and Losses including change in fair value of funds withheld embedded derivative: Realized investment gains and losses associated with the periodic sales or disposals of securities, excluding those held within our trading portfolio, as well as impairments of securities, after adjustment for the non-credit component of the impairment charges and change in fair value of funds withheld embedded derivative related to the Athene Reinsurance Transaction;
3.Loss on Athene Reinsurance Transaction: includes contractual ceding commission, cost of reinsurance write-off and DAC and DSI write-off related to the Athene Reinsurance Transaction;
4.Net investment income on funds withheld assets: includes net investment income on funds withheld assets related to funds withheld reinsurance transactions;
5.Other items: one-time or other non-recurring items, such as costs relating to the Demerger and our separation from Prudential, the impact of discontinued operations and investments that are consolidated on our financial statements due to U.S. GAAP accounting requirements, such as our investments in CLOs, but for which the consolidation effects are not aligned with our economic interest or exposure to those entities.
Operating income taxes are calculated using the prevailing corporate federal income tax rate of 21% while taking into account any items recognized differently in our financial statements and federal income tax returns, including the dividends received deduction and other tax credits. For interim reporting periods, the Company uses an estimated annual effective tax rate ("ETR") in computing its tax provision including consideration of discrete items.
14
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 3. Segment Information
Set forth in the tables below is certain information with respect to the Company’s segments, as described above (in millions):
Three Months Ended June 30, 2022 | Retail Annuities | Institutional Products | Closed Life and Annuity Blocks | Corporate and Other | Total Consolidated | ||||||||||||
Operating Revenues | |||||||||||||||||
Fee income | $ | 949 | $ | — | $ | 119 | $ | 17 | $ | 1,085 | |||||||
Premiums | — | — | 35 | — | 35 | ||||||||||||
Net investment income | 124 | 72 | 185 | 35 | 416 | ||||||||||||
Income (loss) on operating derivatives | 7 | (4) | 13 | 8 | 24 | ||||||||||||
Other income | 11 | — | 9 | 1 | 21 | ||||||||||||
Total Operating Revenues | 1,091 | 68 | 361 | 61 | 1,581 | ||||||||||||
Operating Benefits and Expenses | |||||||||||||||||
Death, other policy benefits and change in policy reserves, net of deferrals | 9 | — | 217 | — | 226 | ||||||||||||
Interest credited on other contract holder funds, net of deferrals | 71 | 47 | 99 | — | 217 | ||||||||||||
Interest expense | 6 | — | — | 18 | 24 | ||||||||||||
Operating costs and other expenses, net of deferrals | 441 | 2 | 39 | 35 | 517 | ||||||||||||
Deferred acquisition and sales inducements amortization | 346 | — | — | 8 | 354 | ||||||||||||
Total Operating Benefits and Expenses | 873 | 49 | 355 | 61 | 1,338 | ||||||||||||
Pretax Adjusted Operating Earnings | $ | 218 | $ | 19 | $ | 6 | $ | — | $ | 243 |
Three Months Ended June 30, 2021 | Retail Annuities | Institutional Products | Closed Life and Annuity Blocks | Corporate and Other | Total Consolidated | ||||||||||||
Operating Revenues | |||||||||||||||||
Fee income | $ | 1,050 | $ | — | $ | 123 | $ | 19 | $ | 1,192 | |||||||
Premiums | — | — | 34 | — | 34 | ||||||||||||
Net investment income | 144 | 57 | 205 | 39 | 445 | ||||||||||||
Income (loss) on operating derivatives | 15 | — | 17 | 8 | 40 | ||||||||||||
Other income | 11 | — | 12 | 7 | 30 | ||||||||||||
Total Operating Revenues | 1,220 | 57 | 391 | 73 | 1,741 | ||||||||||||
Operating Benefits and Expenses | |||||||||||||||||
Death, other policy benefits and change in policy reserves, net of deferrals | 11 | — | 192 | — | 203 | ||||||||||||
Interest credited on other contract holder funds, net of deferrals | 66 | 48 | 103 | — | 217 | ||||||||||||
Interest expense | 6 | 1 | — | — | 7 | ||||||||||||
Operating costs and other expenses, net of deferrals | 485 | 2 | 38 | 49 | 574 | ||||||||||||
Deferred acquisition and sales inducements amortization | (31) | — | 2 | 8 | (21) | ||||||||||||
Total Operating Benefits and Expenses | 537 | 51 | 335 | 57 | 980 | ||||||||||||
Pretax Adjusted Operating Earnings | $ | 683 | $ | 6 | $ | 56 | $ | 16 | $ | 761 |
15
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 3. Segment Information
Six Months Ended June 30, 2022 | Retail Annuities | Institutional Products | Closed Life and Annuity Blocks | Corporate and Other | Total Consolidated | ||||||||||||
Operating Revenues | |||||||||||||||||
Fee income | $ | 1,965 | $ | — | $ | 240 | $ | 35 | $ | 2,240 | |||||||
Premiums | — | — | 72 | — | 72 | ||||||||||||
Net investment income | 242 | 136 | 381 | 88 | 847 | ||||||||||||
Income (loss) on operating derivatives | 18 | (5) | 28 | 18 | 59 | ||||||||||||
Other income | 22 | — | 17 | 2 | 41 | ||||||||||||
Total Operating Revenues | 2,247 | 131 | 738 | 143 | 3,259 | ||||||||||||
Operating Benefits and Expenses | |||||||||||||||||
Death, other policy benefits and change in policy reserves, net of deferrals | 25 | — | 459 | — | 484 | ||||||||||||
Interest credited on other contract holder funds, net of deferrals | 139 | 86 | 198 | — | 423 | ||||||||||||
Interest expense | 11 | — | — | 33 | 44 | ||||||||||||
Operating costs and other expenses, net of deferrals | 945 | 3 | 79 | 96 | 1,123 | ||||||||||||
Deferred acquisition and sales inducements amortization | 503 | — | 4 | 17 | 524 | ||||||||||||
Total Operating Benefits and Expenses | 1,623 | 89 | 740 | 146 | 2,598 | ||||||||||||
Pretax Adjusted Operating Earnings | $ | 624 | $ | 42 | $ | (2) | $ | (3) | $ | 661 |
Six Months Ended June 30, 2021 | Retail Annuities | Institutional Products | Closed Life and Annuity Blocks | Corporate and Other | Total Consolidated | ||||||||||||
Operating Revenues | |||||||||||||||||
Fee income | $ | 2,046 | $ | — | $ | 248 | $ | 39 | $ | 2,333 | |||||||
Premiums | — | — | 71 | — | 71 | ||||||||||||
Net investment income | 349 | 120 | 461 | 54 | 984 | ||||||||||||
Income (loss) on operating derivatives | 29 | — | 38 | 12 | 79 | ||||||||||||
Other income | 23 | — | 22 | 8 | 53 | ||||||||||||
Total Operating Revenues | 2,447 | 120 | 840 | 113 | 3,520 | ||||||||||||
Operating Benefits and Expenses | |||||||||||||||||
Death, other policy benefits and change in policy reserves, net of deferrals | 17 | — | 413 | — | 430 | ||||||||||||
Interest credited on other contract holder funds, net of deferrals | 133 | 100 | 207 | — | 440 | ||||||||||||
Interest expense | 11 | 2 | — | — | 13 | ||||||||||||
Operating costs and other expenses, net of deferrals | 961 | 2 | 78 | 107 | 1,148 | ||||||||||||
Deferred acquisition and sales inducements amortization | 73 | — | 7 | 15 | 95 | ||||||||||||
Total Operating Benefits and Expenses | 1,195 | 104 | 705 | 122 | 2,126 | ||||||||||||
Pretax Adjusted Operating Earnings | $ | 1,252 | $ | 16 | $ | 135 | $ | (9) | $ | 1,394 |
Intersegment eliminations in the above tables are included in the Corporate and Other segment. These include the elimination of investment income, net of deferred acquisition costs amortization, between Retail Annuities and the Corporate and Other segments, as well as the elimination from fee income and investment income of investment fees paid by Jackson to its affiliate PPM, which were $15 million for both the three months ended June 30, 2022 and 2021, respectively, and $29 million and $30 million for the six months ended June 30, 2022 and 2021, respectively.
16
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 3. Segment Information
The following table summarizes the reconciling items from the non-GAAP measure of operating revenues to the GAAP measure of total revenues attributable to the Company (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Total operating revenues | $ | 1,581 | $ | 1,741 | $ | 3,259 | $ | 3,520 | ||||||||||||||||||
Fees attributed to variable annuity benefit reserves | 765 | 701 | 1,529 | 1,373 | ||||||||||||||||||||||
Net gains (losses) on derivatives and investments | 3,843 | (2,561) | 5,413 | 106 | ||||||||||||||||||||||
Net investment income (loss) related to noncontrolling interests | 31 | 56 | 62 | 124 | ||||||||||||||||||||||
Consolidated investments | (65) | 1 | (67) | 31 | ||||||||||||||||||||||
Net investment income on funds withheld assets | 364 | 294 | 624 | 585 | ||||||||||||||||||||||
Total revenues (1) | $ | 6,519 | $ | 232 | $ | 10,820 | $ | 5,739 |
(1) Substantially all of the Company's revenues originated in the United States. There were no individual customers that exceeded 10% of total revenues.
The following table summarizes the reconciling items from the non-GAAP measure of operating benefits and expenses to the GAAP measure of total benefits and expenses attributable to the Company (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Total operating benefits and expenses | $ | 1,338 | $ | 980 | $ | 2,598 | $ | 2,126 | ||||||||||||||||||
Benefits attributed to variable annuity benefit reserves | 54 | 29 | 93 | 66 | ||||||||||||||||||||||
Amortization of DAC and DSI related to non-operating revenues and expenses | 845 | (243) | 1,190 | 453 | ||||||||||||||||||||||
SOP 03-1 reserve movements | 632 | (21) | 901 | (4) | ||||||||||||||||||||||
Other items | (1) | 25 | 1 | 51 | ||||||||||||||||||||||
Total benefits and expenses | $ | 2,868 | $ | 770 | $ | 4,783 | $ | 2,692 |
The following table summarizes the reconciling items, net of deferred acquisition costs and deferred sales inducements, from the non-GAAP measure of pretax adjusted operating earnings to the GAAP measure of net income attributable to the Company (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Pretax adjusted operating earnings | $ | 243 | $ | 761 | $ | 661 | $ | 1,394 | ||||||||||||||||||
Non-operating adjustments (income) loss: | ||||||||||||||||||||||||||
Guaranteed benefits and hedging results: | ||||||||||||||||||||||||||
Fees attributable to guarantee benefit reserves | 765 | 701 | 1,529 | 1,373 | ||||||||||||||||||||||
Net movement in freestanding derivatives | 2,847 | (442) | 1,371 | (3,473) | ||||||||||||||||||||||
Net reserve and embedded derivative movements | (772) | (1,374) | 1,067 | 3,219 | ||||||||||||||||||||||
DAC and DSI impact | (845) | 243 | (1,190) | (453) | ||||||||||||||||||||||
Assumption changes | — | — | — | — | ||||||||||||||||||||||
Total guaranteed benefits and hedging results | 1,995 | (872) | 2,777 | 666 | ||||||||||||||||||||||
Net realized investment gains (losses) including change in fair value of funds withheld embedded derivative | 1,082 | (752) | 1,980 | 298 | ||||||||||||||||||||||
Net investment income on funds withheld assets | 364 | 294 | 624 | 585 | ||||||||||||||||||||||
Other items | (64) | (25) | (67) | (20) | ||||||||||||||||||||||
Pretax income (loss) attributable to Jackson Financial Inc. | 3,620 | (594) | 5,975 | 2,923 | ||||||||||||||||||||||
Income tax expense (benefit) | 717 | (54) | 1,047 | 531 | ||||||||||||||||||||||
Net income (loss) attributable to Jackson Financial Inc. | $ | 2,903 | $ | (540) | $ | 4,928 | $ | 2,392 |
17
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
4. Investments
Investments are comprised primarily of fixed-income securities and loans, primarily publicly-traded corporate and government bonds, asset-backed securities and mortgage loans. Asset-backed securities include mortgage-backed and other structured securities. The Company generates the majority of its general account deposits from interest-sensitive individual annuity contracts, life insurance products and institutional products on which it has committed to pay a declared rate of interest. The Company's strategy of investing in fixed-income securities and loans aims to ensure matching of the asset yield with the amounts credited to the interest-sensitive liabilities and to earn a stable return on its investments.
Debt Securities
The following table sets forth the composition of the fair value of debt securities at June 30, 2022 and December 31, 2021, classified by rating categories as assigned by nationally recognized statistical rating organizations (“NRSRO”), the National Association of Insurance Commissioners (“NAIC”), or if not rated by such organizations, the Company’s investment advisors. The Company uses the second lowest rating by an NRSRO when NRSRO ratings are not equivalent and, for purposes of the table, if not otherwise rated by a NRSRO, the NAIC rating of a security is converted to an equivalent NRSRO-style rating. At June 30, 2022 and December 31, 2021, the carrying value of investments rated by the Company’s consolidated investment advisor totaled $76 million and $13 million, respectively.
Percent of Total Debt Securities Carrying Value | |||||||||||
June 30, 2022 | December 31, 2021 | ||||||||||
Investment Rating | |||||||||||
AAA | 12.4% | 14.5% | |||||||||
AA | 9.2% | 9.6% | |||||||||
A | 30.4% | 28.5% | |||||||||
BBB | 40.3% | 40.9% | |||||||||
Investment grade | 92.3% | 93.5% | |||||||||
BB | 4.0% | 3.6% | |||||||||
B and below | 3.7% | 2.9% | |||||||||
Below investment grade | 7.7% | 6.5% | |||||||||
Total debt securities | 100.0% | 100.0% |
At June 30, 2022, based on ratings by NRSROs, of the total carrying value of debt securities in an unrealized loss position, 76% were investment grade, 3% were below investment grade and 21% were not rated. Unrealized losses on debt securities that were below investment grade or not rated were approximately 20% of the aggregate gross unrealized losses on available-for-sale debt securities.
At December 31, 2021, based on ratings by NRSROs, of the total carrying value of debt securities in an unrealized loss position, 76% were investment grade, 2% were below investment grade and 22% were not rated. Unrealized losses on debt securities that were below investment grade or not rated were approximately 16% of the aggregate gross unrealized losses on available for sale debt securities.
Corporate securities in an unrealized loss position were diversified across industries. As of June 30, 2022, the industries accounting for the largest percentage of unrealized losses included utilities (13% of corporate gross unrealized losses) and energy (10%). The largest unrealized loss related to a single corporate obligor was $52 million at June 30, 2022.
As of December 31, 2021, the industries accounting for the largest percentage of unrealized losses included financial services (16% of corporate gross unrealized losses) and consumer goods (15%). The largest unrealized loss related to a single corporate obligor was $16 million at December 31, 2021.
18
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
At June 30, 2022 and December 31, 2021, the amortized cost, allowance for credit loss ("ACL"), gross unrealized gains and losses, and fair value of debt securities, including trading securities and securities carried at fair value under the fair value option, were as follows (in millions):
Allowance | Gross | Gross | |||||||||||||||||||||||||||||||||
Amortized | for | Unrealized | Unrealized | Fair | |||||||||||||||||||||||||||||||
June 30, 2022 | Cost (1) | Credit Loss | Gains | Losses | Value | ||||||||||||||||||||||||||||||
U.S. government securities | $ | 3,733 | $ | — | $ | — | $ | 745 | $ | 2,988 | |||||||||||||||||||||||||
Other government securities | 1,659 | 6 | 3 | 155 | 1,501 | ||||||||||||||||||||||||||||||
Public utilities | 5,927 | 1 | 57 | 465 | 5,518 | ||||||||||||||||||||||||||||||
Corporate securities | 30,145 | 30 | 84 | 3,008 | 27,191 | ||||||||||||||||||||||||||||||
Residential mortgage-backed | 479 | 6 | 26 | 29 | 470 | ||||||||||||||||||||||||||||||
Commercial mortgage-backed | 1,769 | — | — | 111 | 1,658 | ||||||||||||||||||||||||||||||
Other asset-backed securities | 6,619 | — | 14 | 373 | 6,260 | ||||||||||||||||||||||||||||||
Total debt securities | $ | 50,331 | $ | 43 | $ | 184 | $ | 4,886 | $ | 45,586 | |||||||||||||||||||||||||
Allowance | Gross | Gross | |||||||||||||||||||||||||||||||||
Amortized | for | Unrealized | Unrealized | Fair | |||||||||||||||||||||||||||||||
December 31, 2021 | Cost (1) | Credit Loss | Gains | Losses | Value | ||||||||||||||||||||||||||||||
U.S. government securities | $ | 4,525 | $ | — | $ | 97 | $ | 301 | $ | 4,321 | |||||||||||||||||||||||||
Other government securities | 1,489 | — | 147 | 17 | 1,619 | ||||||||||||||||||||||||||||||
Public utilities | 6,069 | — | 671 | 25 | 6,715 | ||||||||||||||||||||||||||||||
Corporate securities | 29,701 | — | 1,682 | 237 | 31,146 | ||||||||||||||||||||||||||||||
Residential mortgage-backed | 528 | 2 | 46 | 3 | 569 | ||||||||||||||||||||||||||||||
Commercial mortgage-backed | 1,968 | — | 76 | 6 | 2,038 | ||||||||||||||||||||||||||||||
Other asset-backed securities | 6,926 | 7 | 71 | 23 | 6,967 | ||||||||||||||||||||||||||||||
Total debt securities | $ | 51,206 | $ | 9 | $ | 2,790 | $ | 612 | $ | 53,375 | |||||||||||||||||||||||||
(1) Amortized cost, apart from the carrying value for securities carried at fair value under the fair value option and trading securities. |
The amortized cost, ACL, gross unrealized gains and losses, and fair value of debt securities at June 30, 2022, by contractual maturity, are shown below (in millions). Actual maturities may differ from contractual maturities where securities can be called or prepaid with or without early redemption penalties.
Allowance | Gross | Gross | |||||||||||||||||||||||||||
Amortized | for | Unrealized | Unrealized | Fair | |||||||||||||||||||||||||
Cost (1) | Credit Loss | Gains | Losses | Value | |||||||||||||||||||||||||
Due in 1 year or less | $ | 988 | $ | — | $ | 2 | $ | 3 | $ | 987 | |||||||||||||||||||
Due after 1 year through 5 years | 8,792 | 4 | 21 | 253 | 8,556 | ||||||||||||||||||||||||
Due after 5 years through 10 years | 14,468 | 26 | 31 | 1,302 | 13,171 | ||||||||||||||||||||||||
Due after 10 years through 20 years | 9,192 | 3 | 83 | 1,230 | 8,042 | ||||||||||||||||||||||||
Due after 20 years | 8,024 | 4 | 7 | 1,585 | 6,442 | ||||||||||||||||||||||||
Residential mortgage-backed | 479 | 6 | 26 | 29 | 470 | ||||||||||||||||||||||||
Commercial mortgage-backed | 1,769 | — | — | 111 | 1,658 | ||||||||||||||||||||||||
Other asset-backed securities | 6,619 | — | 14 | 373 | 6,260 | ||||||||||||||||||||||||
Total | $ | 50,331 | $ | 43 | $ | 184 | $ | 4,886 | $ | 45,586 |
(1) Amortized cost, apart from the carrying value for securities carried at fair value under the fair value option and trading securities.
19
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
Securities with a carrying value of $98 million and $117 million at June 30, 2022 and December 31, 2021, respectively, were on deposit with regulatory authorities, as required by law in various states in which business is conducted.
Residential mortgage-backed securities (“RMBS”) include certain RMBS that are collateralized by residential mortgage loans and are neither explicitly nor implicitly guaranteed by U.S. government agencies (“non-agency RMBS”). The Company’s non-agency RMBS include investments in securities backed by prime, Alt-A, and subprime loans as follows (in millions):
Allowance | Gross | Gross | ||||||||||||||||||||||||||||||
Amortized | for | Unrealized | Unrealized | Fair | ||||||||||||||||||||||||||||
June 30, 2022 | Cost (1) | Credit Loss | Gains | Losses | Value | |||||||||||||||||||||||||||
Prime | $ | 190 | $ | 4 | $ | 3 | $ | 14 | $ | 175 | ||||||||||||||||||||||
Alt-A | 83 | 2 | 12 | 2 | 91 | |||||||||||||||||||||||||||
Subprime | 31 | — | 11 | — | 42 | |||||||||||||||||||||||||||
Total non-agency RMBS | $ | 304 | $ | 6 | $ | 26 | $ | 16 | $ | 308 | ||||||||||||||||||||||
Allowance | Gross | Gross | ||||||||||||||||||||||||||||||
Amortized | for | Unrealized | Unrealized | Fair | ||||||||||||||||||||||||||||
December 31, 2021 | Cost (1) | Credit Loss | Gains | Losses | Value | |||||||||||||||||||||||||||
Prime | $ | 228 | $ | 1 | $ | 10 | $ | 2 | $ | 235 | ||||||||||||||||||||||
Alt-A | 94 | 1 | 21 | — | 114 | |||||||||||||||||||||||||||
Subprime | 39 | — | 13 | — | 52 | |||||||||||||||||||||||||||
Total non-agency RMBS | $ | 361 | $ | 2 | $ | 44 | $ | 2 | $ | 401 | ||||||||||||||||||||||
(1) Amortized cost, apart from carrying value for securities carried at fair value under the fair value option and trading securities. |
The Company defines its exposure to non-agency residential mortgage loans as follows:
•Prime loan-backed securities are collateralized by mortgage loans made to the highest rated borrowers.
•Alt-A loan-backed securities are collateralized by mortgage loans made to borrowers who lack credit documentation or necessary requirements to obtain prime borrower rates.
•Subprime loan-backed securities are collateralized by mortgage loans made to borrowers that have a FICO score of 660 or lower.
20
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
The following table summarizes the number of securities, fair value and the gross unrealized losses of debt securities, aggregated by investment category and length of time that individual debt securities have been in a continuous loss position (dollars in millions):
June 30, 2022 | December 31, 2021 | |||||||||||||||||||||||||||||||||||||
Less than 12 months | Less than 12 months | |||||||||||||||||||||||||||||||||||||
Gross | Fair Value | Gross | Fair Value | |||||||||||||||||||||||||||||||||||
Unrealized | # of | Unrealized | # of | |||||||||||||||||||||||||||||||||||
Losses | securities | Losses | securities | |||||||||||||||||||||||||||||||||||
U.S. government securities | $ | 172 | $ | 1,013 | 29 | $ | 2 | $ | 107 | 16 | ||||||||||||||||||||||||||||
Other government securities | 154 | 1,282 | 153 | 17 | 252 | 23 | ||||||||||||||||||||||||||||||||
Public utilities | 398 | 4,453 | 508 | 17 | 721 | 93 | ||||||||||||||||||||||||||||||||
Corporate securities | 2,426 | 20,501 | 2,585 | 180 | 6,343 | 728 | ||||||||||||||||||||||||||||||||
Residential mortgage-backed | 26 | 288 | 205 | 3 | 174 | 109 | ||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 97 | 1,567 | 203 | 5 | 314 | 37 | ||||||||||||||||||||||||||||||||
Other asset-backed securities | 360 | 5,081 | 625 | 22 | 3,224 | 338 | ||||||||||||||||||||||||||||||||
Total temporarily impaired securities | $ | 3,633 | $ | 34,185 | 4,308 | $ | 246 | $ | 11,135 | 1,344 | ||||||||||||||||||||||||||||
12 months or longer | 12 months or longer | |||||||||||||||||||||||||||||||||||||
Gross | Fair Value | Gross | Fair Value | |||||||||||||||||||||||||||||||||||
Unrealized | # of | Unrealized | # of | |||||||||||||||||||||||||||||||||||
Losses | securities | Losses | securities | |||||||||||||||||||||||||||||||||||
U.S. government securities | $ | 573 | $ | 1,801 | 8 | $ | 299 | $ | 3,190 | 7 | ||||||||||||||||||||||||||||
Other government securities | 1 | 10 | 5 | — | 4 | 2 | ||||||||||||||||||||||||||||||||
Public utilities | 67 | 171 | 29 | 7 | 99 | 8 | ||||||||||||||||||||||||||||||||
Corporate securities | 582 | 1,729 | 217 | 58 | 661 | 69 | ||||||||||||||||||||||||||||||||
Residential mortgage-backed | 3 | 45 | 47 | — | 11 | 12 | ||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 14 | 72 | 6 | 1 | 30 | 3 | ||||||||||||||||||||||||||||||||
Other asset-backed securities | 13 | 119 | 20 | 1 | 11 | 3 | ||||||||||||||||||||||||||||||||
Total temporarily impaired securities | $ | 1,253 | $ | 3,947 | 332 | $ | 366 | $ | 4,006 | 104 | ||||||||||||||||||||||||||||
Total | Total | |||||||||||||||||||||||||||||||||||||
Gross | Fair Value | Gross | Fair Value | |||||||||||||||||||||||||||||||||||
Unrealized | # of | Unrealized | # of | |||||||||||||||||||||||||||||||||||
Losses | securities | Losses | securities | |||||||||||||||||||||||||||||||||||
U.S. government securities | $ | 745 | $ | 2,814 | 33 | $ | 301 | $ | 3,297 | 23 | ||||||||||||||||||||||||||||
Other government securities | 155 | 1,292 | 157 | 17 | 256 | 25 | ||||||||||||||||||||||||||||||||
Public utilities | 465 | 4,624 | 530 | 24 | 820 | 101 | ||||||||||||||||||||||||||||||||
Corporate securities (1) | 3,008 | 22,230 | 2,728 | 238 | 7,004 | 797 | ||||||||||||||||||||||||||||||||
Residential mortgage-backed | 29 | 333 | 252 | 3 | 185 | 121 | ||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 111 | 1,639 | 208 | 6 | 344 | 40 | ||||||||||||||||||||||||||||||||
Other asset-backed securities | 373 | 5,200 | 637 | 23 | 3,235 | 341 | ||||||||||||||||||||||||||||||||
Total temporarily impaired securities | $ | 4,886 | $ | 38,132 | 4,545 | $ | 612 | $ | 15,141 | 1,448 |
(1) Certain corporate securities contain multiple lots and fit the criteria of both aging groups.
Debt securities in an unrealized loss position as of June 30, 2022 did not require an impairment recognized in earnings as (i) the Company did not intend to sell these debt securities, (ii) it is not more likely than not that the Company will be required to sell these securities before recovery of their amortized cost basis, and (iii) the difference in the fair value compared to the amortized cost was due to factors other than credit loss. Based upon this evaluation, the Company believes it has the ability to generate adequate amounts of cash from normal operations to meet cash requirements with a reasonable margin of safety without requiring the sale of impaired securities.
21
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
As of June 30, 2022, unrealized losses associated with debt securities are primarily due to widening credit spreads or rising risk-free rates since purchase. The Company performed a detailed analysis of the financial performance of the underlying issues in an unrealized loss position and determined that recovery of the entire amortized cost of each impaired security is expected. In addition, mortgage-backed and asset-backed securities were assessed for credit impairment using a cash flow model that incorporates key assumptions including default rates, severities, and prepayment rates. The Company estimated losses for a security by forecasting performance in the underlying loans in each transaction. The forecasted loan performance was used to project cash flows to the various tranches in the structure, as applicable. The forecasted cash flows also considered, as applicable, independent industry analyst reports and forecasts, and other independent market data. Based upon this assessment of the expected credit losses of the security given the performance of the underlying collateral compared to subordination or other credit enhancement, the Company expects to recover the entire amortized cost of each impaired security.
Evaluation of Available-for-Sale Debt Securities for Credit Loss
For debt securities in an unrealized loss position, management first assesses whether the Company has the intent to sell, or whether it is more likely than not it will be required to sell the security before the amortized cost basis is fully recovered. If either criteria is met, the amortized cost is written down to fair value through net gains (losses) on derivatives and investments as an impairment.
Debt securities in an unrealized loss position for which the Company does not have the intent to sell or is not more likely than not to sell the security before recovery to amortized cost are further evaluated to determine if the cause of the decline in fair value resulted from credit losses or other factors, which includes estimates about the operations of the issuer and future earnings potential.
The credit loss evaluation may consider the following: the extent to which the fair value is below amortized cost; changes in ratings of the security; whether a significant covenant related to the security has been breached; whether an issuer has filed or indicated a possibility of filing for bankruptcy, has missed or announced it intends to miss a scheduled interest or principal payment, or has experienced a specific material adverse change that may impair its creditworthiness; judgments about an obligor’s current and projected financial position; an issuer’s current and projected ability to service and repay its debt obligations; the existence of, and realizable value of, any collateral backing the obligations; and the macro-economic and micro-economic outlooks for specific industries and issuers.
In addition to the above, the credit loss review of investments in asset-backed securities includes the review of future estimated cash flows, including expected and stress case scenarios, to identify potential shortfalls in contractual payments. These estimated cash flows are developed using available performance indicators from the underlying assets including current and projected default or delinquency rates, levels of credit enhancement, current subordination levels, vintage, expected loss severity and other relevant characteristics. These estimates reflect a combination of data derived by third parties and internally developed assumptions. Where possible, this data is benchmarked against third-party sources.
For mortgage-backed securities, credit losses are assessed using a cash flow model that estimates the cash flows on the underlying mortgages, using the security-specific collateral characteristics and transaction structure. The model estimates cash flows from the underlying mortgage loans and distributes those cash flows to various tranches of securities, considering the transaction structure and any subordination and credit enhancements existing in that structure. The cash flow model incorporates actual cash flows on the mortgage-backed securities through the current period and then projects the remaining cash flows using a number of assumptions, including prepayment timing, default rates and loss severity. Specifically, for prime and Alt-A RMBS, the assumed default percentage is dependent on the severity of delinquency status, with foreclosures and real estate owned receiving higher rates, but also includes the currently performing loans.
These estimates reflect a combination of data derived by third parties and internally developed assumptions. Where possible, this data is benchmarked against other third-party sources. In addition, these estimates are extrapolated along a default timing curve to estimate the total lifetime pool default rate. When a credit loss is determined to exist and the present value of cash flows expected to be collected is less than the amortized cost of the security, an allowance for credit loss is recorded along with a charge to net gains (losses) on derivatives and investments, limited by the amount that the fair value is less than amortized cost. Any remaining unrealized loss after recording the allowance for credit loss is the non-credit amount and is recorded to other comprehensive income.
22
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
The allowance for credit loss for specific debt securities may be increased or reversed in subsequent periods due to changes in the assessment of the present value of cash flows that are expected to be collected. Any changes to the allowance for credit loss is recorded as a provision for (or reversal of) credit loss expense in net gains (losses) on derivatives and investments.
When all, or a portion, of a security is deemed uncollectible, the uncollectible portion is written-off with an adjustment to amortized cost and a corresponding reduction to the allowance for credit losses.
Accrued interest receivables are presented separate from the amortized cost basis of debt securities. Accrued interest receivables that are determined to be uncollectible are written off with a corresponding reduction to net investment income. Accrued interest of nil was written off both during the three and six months ended June 30, 2022 and 2021.
The roll forward of the allowance for credit loss for available-for-sale securities by sector is as follows (in millions):
Three Months Ended June 30, 2022 | US government securities | Other government securities | Public utilities | Corporate securities | Residential mortgage-backed | Commercial mortgage-backed | Other asset-backed securities | Total | ||||||||||||||||||
Balance at April 1, 2022 | $ | — | $ | 6 | $ | — | $ | 22 | $ | 2 | $ | — | $ | 2 | $ | 32 | ||||||||||
Additions for which credit loss was not previously recorded | — | — | 1 | 3 | 2 | — | — | 6 | ||||||||||||||||||
Changes for securities with previously recorded credit loss | — | — | — | 5 | 3 | — | (2) | 6 | ||||||||||||||||||
Additions for purchases of PCD debt securities (1) | — | — | — | — | — | — | — | — | ||||||||||||||||||
Reductions from charge-offs | — | — | — | — | (1) | — | — | (1) | ||||||||||||||||||
Reductions for securities disposed | — | — | — | — | — | — | — | — | ||||||||||||||||||
Securities intended/required to be sold before recovery of amortized cost basis | — | — | — | — | — | — | — | — | ||||||||||||||||||
Balance at June 30, 2022 (2) | $ | — | $ | 6 | $ | 1 | $ | 30 | $ | 6 | $ | — | $ | — | $ | 43 |
Three Months Ended June 30, 2021 | US government securities | Other government securities | Public utilities | Corporate securities | Residential mortgage-backed | Commercial mortgage-backed | Other asset-backed securities | Total | ||||||||||||||||||
Balance at April 1, 2021 | $ | — | $ | — | $ | — | $ | — | $ | 1 | $ | — | $ | 4 | $ | 5 | ||||||||||
Additions for which credit loss was not previously recorded | — | — | — | — | — | — | — | — | ||||||||||||||||||
Changes for securities with previously recorded credit loss | — | — | — | — | — | — | 2 | 2 | ||||||||||||||||||
Additions for purchases of PCD debt securities (1) | — | — | — | — | — | — | — | — | ||||||||||||||||||
Reductions from charge-offs | — | — | — | — | — | — | — | — | ||||||||||||||||||
Reductions for securities disposed | — | — | — | — | — | — | — | — | ||||||||||||||||||
Securities intended/required to be sold before recovery of amortized cost basis | — | — | — | — | — | — | — | — | ||||||||||||||||||
Balance at June 30, 2021 (2) | $ | — | $ | — | $ | — | $ | — | $ | 1 | $ | — | $ | 6 | $ | 7 |
23
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
Six Months Ended June 30, 2022 | US government securities | Other government securities | Public utilities | Corporate securities | Residential mortgage-backed | Commercial mortgage-backed | Other asset-backed securities | Total | ||||||||||||||||||
Balance at January 1, 2022 | $ | — | $ | — | $ | — | $ | — | $ | 2 | $ | — | $ | 7 | $ | 9 | ||||||||||
Additions for which credit loss was not previously recorded | — | 6 | 1 | 30 | 2 | — | — | 39 | ||||||||||||||||||
Changes for securities with previously recorded credit loss | — | — | — | 5 | 3 | — | (7) | 1 | ||||||||||||||||||
Additions for purchases of PCD debt securities (1) | — | — | — | — | — | — | — | — | ||||||||||||||||||
Reductions from charge-offs | — | — | — | — | — | — | — | — | ||||||||||||||||||
Reductions for securities disposed | — | — | — | — | (1) | — | — | (1) | ||||||||||||||||||
Securities intended/required to be sold before recovery of amortized cost basis | — | — | — | (5) | — | — | — | (5) | ||||||||||||||||||
Balance at June 30, 2022 (2) | $ | — | $ | 6 | $ | 1 | $ | 30 | $ | 6 | $ | — | $ | — | $ | 43 |
Six Months Ended June 30, 2021 | US government securities | Other government securities | Public utilities | Corporate securities | Residential mortgage-backed | Commercial mortgage-backed | Other asset-backed securities | Total | ||||||||||||||||||
Balance at January 1, 2021 | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 14 | $ | 14 | ||||||||||
Additions for which credit loss was not previously recorded | — | — | — | — | 1 | — | — | 1 | ||||||||||||||||||
Changes for securities with previously recorded credit loss | — | — | — | — | — | — | (8) | (8) | ||||||||||||||||||
Additions for purchases of PCD debt securities (1) | — | — | — | — | — | — | — | — | ||||||||||||||||||
Reductions from charge-offs | — | — | — | — | — | — | — | — | ||||||||||||||||||
Reductions for securities disposed | — | — | — | — | — | — | — | — | ||||||||||||||||||
Securities intended/required to be sold before recovery of amortized cost basis | — | — | — | — | — | — | — | — | ||||||||||||||||||
Balance at June 30, 2021 (2) | $ | — | $ | — | $ | — | $ | — | $ | 1 | $ | — | $ | 6 | $ | 7 |
(1) Represents purchased credit-deteriorated ("PCD") fixed maturity available-for-sale securities. | |||||||||||
(2) Accrued interest receivable on debt securities totaled $382 million and $397 million as of June 30, 2022 and 2021, respectively, and was excluded from the determination of credit losses for the three and six months ended June 30, 2022 and 2021. |
24
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
Net Investment Income
The sources of net investment income were as follows (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Debt securities (1) | $ | 213 | $ | 277 | $ | 486 | $ | 601 | ||||||||||||||||||
Equity securities | 6 | 7 | 7 | 7 | ||||||||||||||||||||||
Mortgage loans | 68 | 80 | 141 | 162 | ||||||||||||||||||||||
Policy loans | 17 | 17 | 34 | 36 | ||||||||||||||||||||||
Limited partnerships | 50 | 150 | 158 | 393 | ||||||||||||||||||||||
Other investment income | 10 | 5 | 11 | 8 | ||||||||||||||||||||||
Total investment income excluding funds withheld assets | 364 | 536 | 837 | 1,207 | ||||||||||||||||||||||
Net investment income on funds withheld assets (see Note 8) | 364 | 294 | 624 | 585 | ||||||||||||||||||||||
Investment expenses: | ||||||||||||||||||||||||||
Derivative trading commission | (1) | (1) | (2) | (1) | ||||||||||||||||||||||
Depreciation on real estate | (3) | (2) | (6) | (5) | ||||||||||||||||||||||
Expenses related to consolidated entities (2) | (15) | (9) | (36) | (17) | ||||||||||||||||||||||
Other investment income (expense) (3) | 38 | (22) | 50 | (45) | ||||||||||||||||||||||
Total investment expenses | 19 | (34) | 6 | (68) | ||||||||||||||||||||||
Net investment income | $ | 747 | $ | 796 | $ | 1,467 | $ | 1,724 |
(1) Includes unrealized gains and losses on trading securities and includes $(95) million and $(85) million for the three and six months ended June 30, 2022, respectively, and nil and $38 million for the three and six months ended June 30, 2021, respectively, related to the change in fair value for securities carried under the fair value option.
(2) Includes management fees, administrative fees, legal fees, and other expenses related to the consolidation of certain investments.
(3) Includes interest expense and market appreciation on deferred compensation; investment software expense, custodial fees, and other bank fees; institutional product issuance related expenses; and other expenses.
Unrealized gains (losses) included in investment income that were recognized on equity securities held were $(13) million and $10 million, for the three months ended June 30, 2022 and 2021, respectively, and $(31) million and $15 million, for the six months ended June 30, 2022 and 2021, respectively.
25
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
Net Gains (Losses) on Derivatives and Investments
The following table summarizes net gains (losses) on derivatives and investments (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Available-for-sale securities | ||||||||||||||||||||||||||
Realized gains on sale | $ | 5 | $ | 96 | $ | 29 | $ | 121 | ||||||||||||||||||
Realized losses on sale | (63) | (52) | (241) | (58) | ||||||||||||||||||||||
Credit loss income (expense) | 1 | (1) | 1 | 7 | ||||||||||||||||||||||
Credit loss income (expense) on mortgage loans | (9) | (10) | 3 | 48 | ||||||||||||||||||||||
Other (1) | 71 | (18) | 83 | 50 | ||||||||||||||||||||||
Net gains (losses) excluding derivatives and funds withheld assets | 5 | 15 | (125) | 168 | ||||||||||||||||||||||
Net gains (losses) on derivative instruments (see Note 5) | 2,785 | (1,768) | 3,492 | (113) | ||||||||||||||||||||||
Net gains (losses) on funds withheld reinsurance treaties (see Note 8) | 1,077 | (768) | 2,105 | 130 | ||||||||||||||||||||||
Total net gains (losses) on derivatives and investments | $ | 3,867 | $ | (2,521) | $ | 5,472 | $ | 185 | ||||||||||||||||||
(1) Includes the foreign currency gain or loss related to foreign denominated trust instruments supporting funding agreements. |
Net gains (losses) on funds withheld reinsurance treaties represents income (loss) from the sale of investments held in segregated funds withheld accounts in support of reinsurance agreements for which Jackson retains legal ownership of the underlying investments. These gains (losses) are increased or decreased by changes in the embedded derivative liability related to the Athene Reinsurance Agreement and also include (i) changes in the related funds withheld payable, as all economic performance of the investments held in the segregated accounts inure to the benefit of the reinsurers under the respective reinsurance agreements with each reinsurer, and (ii) amortization of the difference between book value and fair value of the investments as of the effective date of the reinsurance agreements with each reinsurer.
The aggregate fair value of securities sold at a loss for the three and six months ended June 30, 2022 was $506 million and $2,898 million, which was approximately 93% and 92% of book value, respectively. The aggregate fair value of securities sold at a loss for the three and six months ended June 30, 2021 was $888 million and $1,184 million, which was approximately 94% of book value in both periods.
Proceeds from sales of available-for-sale debt securities were $0.8 billion and $4.9 billion during the three and six months ended June 30, 2022, respectively, and $2.8 billion and $5.6 billion during the three and six months ended June 30, 2021, respectively.
There are inherent uncertainties in assessing the fair values assigned to the Company’s investments. The Company’s reviews of net present value and fair value involve several criteria including economic conditions, credit loss experience, other issuer-specific developments and estimated future cash flows. These assessments are based on the best available information at the time. Factors such as market liquidity, the widening of bid/ask spreads and a change in the cash flow assumptions can contribute to future price volatility. If actual experience differs negatively from the assumptions and other considerations used in the consolidated financial statements, unrealized losses currently reported in accumulated other comprehensive income (loss) may be recognized in the consolidated income statements in future periods.
The Company currently has no intent to sell securities with unrealized losses considered to be temporary until they mature or recover in value and believes that it has the ability to do so. However, if the specific facts and circumstances surrounding an individual security, or the outlook for its industry sector change, the Company may sell the security prior to its maturity or recovery and realize a loss.
26
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
Consolidated Variable Interest Entities ("VIEs")
The Company funds affiliated limited liability companies to facilitate the issuance of collateralized loan obligations ("CLOs"). The Company concluded that these limited liability companies are VIEs and that the Company is the primary beneficiary as it has the power to direct the most significant activities affecting the performance of the entity as well as the obligation to absorb losses or the right to receive benefits that could potentially be significant to the entity. In April 2022, the Company reinvested in collateralized loan obligation issuances resulting in the increase of consolidated assets and liabilities. The Company’s exposure to loss is limited to the capital invested and unfunded capital commitments.
Private Equity Funds III – VIII are limited partnership structures that invest the ownership capital in portfolios of various other limited partnership structures. The Company concluded that the Private Equity Funds are VIEs and that the Company is the primary beneficiary as it has the power to direct the most significant activities affecting the performance of the funds as well as the obligation to absorb losses or the right to receive benefits that could potentially be significant to the funds. In the fourth quarter of 2021, the Company entered into a commitment to invest up to $300 million in the newly formed Private Equity Fund VIII. The Company’s exposure to loss is limited to the capital invested and unfunded capital commitments.
PPM has created and managed institutional share class mutual funds, where Jackson seeds new funds, or new share classes within a fund, when deemed necessary to develop the requisite track record prior to allowing investment by external parties. Jackson may sell its interest in the fund once opened to investment by external parties. The Company concluded that these funds are VIEs and that the Company is the primary beneficiary as it has both the power to direct the most significant activities of the VIE as well as the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE. The Company’s exposure to loss related to these mutual funds is limited to the capital invested.
Asset and liability information for the consolidated VIEs included on the Condensed Consolidated Balance Sheets are as follows (in millions):
June 30, 2022 | December 31, 2021 | ||||||||||
Assets | |||||||||||
Debt securities, at fair value under fair value option | $ | 1,991 | $ | 1,546 | |||||||
Debt securities, trading | 103 | 117 | |||||||||
Equity securities | 128 | 129 | |||||||||
Limited partnerships | 1,491 | 1,309 | |||||||||
Cash and cash equivalents | 45 | 120 | |||||||||
Other assets | 36 | 45 | |||||||||
Total assets | $ | 3,794 | $ | 3,266 | |||||||
Liabilities | |||||||||||
Debt owed to non-controlling interests | $ | 1,757 | $ | 1,404 | |||||||
Other liabilities | 417 | 307 | |||||||||
Total other liabilities | 2,174 | 1,711 | |||||||||
Securities lending payable | 5 | 4 | |||||||||
Total liabilities | $ | 2,179 | $ | 1,715 | |||||||
Equity | |||||||||||
Noncontrolling interests | $ | 747 | $ | 680 |
27
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
Unconsolidated VIEs
The Company invests in certain limited partnerships ("LPs") and limited liability companies ("LLCs") that it has concluded are VIEs. Based on the analysis of these entities, the Company is not the primary beneficiary of the VIEs as it does not have the power to direct the activities of the VIE that most significantly impact the VIE’s economic performance. In addition, the Company does not have the obligation to absorb losses or the right to receive benefits that could potentially be significant to the entities. Therefore, the Company does not consolidate these VIEs and the carrying amounts of the Company’s investments in these LPs and LLCs are recognized in other invested assets on the consolidated balance sheets. Unfunded capital commitments for these investments are detailed in Note 14. The Company’s exposure to loss is limited to the capital invested and unfunded capital commitments related to the LPs/LLCs, for both consolidated and unconsolidated VIEs, which was $4,276 million and $3,860 million as of June 30, 2022 and December 31, 2021, respectively. The capital invested in an LP or LLC equals the original capital contributed, increased for additional capital contributed after the initial investment, and reduced for any returns of capital from the LP or LLC. LPs and LLCs are carried at fair value.
The Company invests in certain mutual funds that it has concluded are VIEs. Based on the analysis of these entities, the Company is not the primary beneficiary of the VIEs. Mutual funds for which the Company does not have the obligation to absorb losses or the right to receive benefits that could potentially be significant to the entities are recognized in equity securities on the Condensed Consolidated Balance Sheets and were $28 million and $33 million as of June 30, 2022 and December 31, 2021, respectively. The Company’s maximum exposure to loss on these mutual funds is limited to the amortized cost for these investments.
The Company makes investments in structured debt securities issued by VIEs for which they are not the manager. These structured debt securities include RMBS, Commercial Mortgage-Backed Securities ("CMBS"), and asset-backed securities ("ABS"). The Company does not consolidate the securitization trusts utilized in these transactions because they do not have the power to direct the activities that most significantly impact the economic performance of these securitization trusts. The Company does not consider its continuing involvement with these VIEs to be significant because they either invest in securities issued by the VIE and were not involved in the design of the VIE or no transfers have occurred between the Company and the VIE. The Company’s maximum exposure to loss on these structured debt securities is limited to the amortized cost of these investments. The Company does not have any further contractual obligations to the VIE. The Company recognizes the variable interest in these VIEs at fair value on the consolidated balance sheets.
Commercial and Residential Mortgage Loans
Commercial mortgage loans of $10.8 billion and $10.5 billion at June 30, 2022 and December 31, 2021, respectively, are reported net of an allowance for credit losses of $77 million and $85 million at each date, respectively. At June 30, 2022, commercial mortgage loans were collateralized by properties located in 38 states, the District of Columbia, and Europe. Accrued interest receivable on commercial mortgage loans was $35 million and $32 million at June 30, 2022 and December 31, 2021, respectively.
Residential mortgage loans of $1,170 million and $939 million at June 30, 2022 and December 31, 2021, respectively, are reported net of an allowance for credit losses of $3 million and $9 million at each date, respectively. Loans were collateralized by properties located in 50 states, the District of Columbia, Mexico, and Europe. Accrued interest receivable on residential mortgage loans was $9 million and $13 million at June 30, 2022 and December 31, 2021, respectively.
28
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
Mortgage Loan Concessions
In response to the adverse economic impact of the COVID-19 pandemic, the Company granted concessions to certain of its commercial mortgage loan borrowers, including payment deferrals and other loan modifications. The Company has elected the option under the Coronavirus Aid, Relief, and Economic Security Act, the Consolidated Appropriations Act of 2021, and the Interagency Statement on Loan Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus (Revised) issued by bank regulatory agencies, not to account for or report qualifying concessions as troubled debt restructurings and does not classify such loans as past due during the payment deferral period. Additionally, in accordance with the FASB’s published response to a COVID-19 Pandemic technical inquiry, the Company
continues to accrue interest income on such loans that have deferred payment. For some commercial mortgage loan borrowers (principally in the hotel and retail sectors), the Company granted concessions which were primarily interest and/
or principal payment deferrals generally ranging from 6 to 14 months and, to a much lesser extent, maturity date extensions. Repayment periods are generally within one year but may extend until maturity date. Deferred commercial mortgage loan interest and principal payments were $11 million at June 30, 2022. The concessions granted had no impact on the Company’s results of operations or financial position as the Company has not granted concessions that would have been disclosed and accounted for as troubled debt restructurings.
Evaluation for Credit Losses on Mortgage Loans
The Company reviews mortgage loans that are not carried at fair value under the fair value option on a quarterly basis to estimate the ACL with changes in the ACL recorded in net gains (losses) on derivatives and investments. Apart from an ACL recorded on individual mortgage loans where the borrower is experiencing financial difficulties, the Company records an ACL on the pool of mortgage loans based on lifetime expected credit losses. The Company utilizes a third-party forecasting model to estimate lifetime expected credit losses at a loan level for mortgage loans. The model forecasts net operating income and property values for the economic scenario selected. The debt service coverage ratios (“DSCR”) and loan to values (“LTV”) are calculated over the forecastable period by comparing the projected net operating income and property valuations to the loan payment and principal amounts of each loan. The model utilizes historical mortgage loan performance based on DSCRs and LTV to derive probability of default and expected losses based on the economic scenario that is similar to the Company’s expectations of economic factors such as unemployment, GDP growth, and interest rates. The Company determined the forecastable period to be reasonable and supportable for a period of two years beyond the end of the reporting period. Over the following one-year period, the model reverts to the historical performance of the portfolio for the remainder of the contractual term of the loans. In cases where the Company does not have an appropriate length of historical performance, the relevant historical rate from an index or the lifetime expected credit loss calculated from the model may be used.
Unfunded commitments are included in the model and an ACL is determined accordingly. Credit loss estimates are pooled by property type and the Company does not include accrued interest in the determination of ACL.
For individual loans or for types of loans for which the third-party model is deemed not suitable, the Company utilizes relevant current market data, industry data, and publicly available historical loss rates to calculate an estimate of the lifetime expected credit loss.
Mortgage loans on real estate deemed uncollectible are charged against the ACL, and subsequent recoveries, if any, are credited to the ACL, limited to the aggregate of amounts previously charged-off and expected to be charged-off. Mortgage loans on real estate are presented net of the allowance for credit losses on the Condensed Consolidated Balance Sheets.
29
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
The following table provides a summary of the allowance for credit losses in the Company’s mortgage loan portfolios (in millions):
Three Months Ended June 30, 2022 | Apartment | Hotel | Office | Retail | Warehouse | Residential Mortgage | Total | ||||||||||||||||
Balance at April 1, 2022 | $ | 21 | $ | 9 | $ | 22 | $ | 14 | $ | 12 | $ | 6 | $ | 84 | |||||||||
Charge offs, net of recoveries | — | — | — | — | — | — | — | ||||||||||||||||
Provision (release) | — | 9 | (6) | (1) | (3) | (3) | (4) | ||||||||||||||||
Balance at June 30, 2022 (1) | $ | 21 | $ | 18 | $ | 16 | $ | 13 | $ | 9 | $ | 3 | $ | 80 |
Three Months Ended June 30, 2021 | Apartment | Hotel | Office | Retail | Warehouse | Residential Mortgage | Total | ||||||||||||||||
Balance at April 1, 2021 | $ | 27 | $ | 22 | $ | 16 | $ | 15 | $ | 13 | $ | 20 | $ | 113 | |||||||||
Charge offs, net of recoveries | — | — | — | — | — | — | — | ||||||||||||||||
Provision (release) | — | 11 | 4 | 8 | (1) | 1 | 23 | ||||||||||||||||
Balance at June 30, 2021 (1) | $ | 27 | $ | 33 | $ | 20 | $ | 23 | $ | 12 | $ | 21 | $ | 136 |
Six Months Ended June 30, 2022 | Apartment | Hotel | Office | Retail | Warehouse | Residential Mortgage | Total | ||||||||||||||||
Balance at January 1, 2022 | $ | 19 | $ | 9 | $ | 28 | $ | 17 | $ | 12 | $ | 9 | $ | 94 | |||||||||
Charge offs, net of recoveries | — | — | — | — | — | — | — | ||||||||||||||||
Provision (release) | 2 | 9 | (12) | (4) | (3) | (6) | (14) | ||||||||||||||||
Balance at June 30, 2022 (1) | $ | 21 | $ | 18 | $ | 16 | $ | 13 | $ | 9 | $ | 3 | $ | 80 |
Six Months Ended June 30, 2021 | Apartment | Hotel | Office | Retail | Warehouse | Residential Mortgage | Total | ||||||||||||||||
Balance at January 1, 2021 | $ | 58 | $ | 34 | $ | 25 | $ | 24 | $ | 24 | $ | 14 | $ | 179 | |||||||||
Charge offs, net of recoveries | — | — | — | — | — | — | — | ||||||||||||||||
Provision (release) | (31) | (1) | (5) | (1) | (12) | 7 | (43) | ||||||||||||||||
Balance at June 30, 2021 (1) | $ | 27 | $ | 33 | $ | 20 | $ | 23 | $ | 12 | $ | 21 | $ | 136 |
(1) Accrued interest receivable totaled $44 million and $40 million as of June 30, 2022 and 2021, respectively, and was excluded from the determination of credit losses. |
The Company’s mortgage loans that are current and in good standing are accruing interest. Interest is not accrued on loans greater than 90 days delinquent and in process of foreclosure, when deemed uncollectible. Delinquency status is determined from the date of the first missed contractual payment.
At June 30, 2022, there was $18 million of recorded investment, $19 million of unpaid principal balance, no related loan allowance, $12 million of average recorded investment, and no investment income recognized on impaired residential mortgage loans.
At December 31, 2021, there was $6 million of recorded investment, $7 million of unpaid principal balance, no related loan allowance, $2 million of average recorded investment, and no investment income recognized on impaired residential mortgage loans.
30
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
The following tables provide information about the credit quality with vintage year and category of mortgage loans (in millions):
June 30, 2022 | |||||||||||||||||||||||||||||
2022 | 2021 | 2020 | 2019 | 2018 | Prior | Revolving Loans | Total | % of Total | |||||||||||||||||||||
Commercial mortgage loans | |||||||||||||||||||||||||||||
Loan to value ratios: | |||||||||||||||||||||||||||||
Less than 70% | $ | 396 | $ | 1,376 | $ | 1,343 | $ | 1,542 | $ | 1,498 | $ | 3,866 | $ | 4 | $ | 10,025 | 93 | % | |||||||||||
70% - 80% | 80 | 374 | 33 | — | 52 | 144 | — | 683 | 6 | % | |||||||||||||||||||
80% - 100% | — | — | — | 38 | 5 | — | — | 43 | — | % | |||||||||||||||||||
Greater than 100% | — | — | — | — | — | 10 | — | 10 | — | % | |||||||||||||||||||
Total commercial mortgage loans | 476 | 1,750 | 1,376 | 1,580 | 1,555 | 4,020 | 4 | 10,761 | 100 | % | |||||||||||||||||||
Debt service coverage ratios: | |||||||||||||||||||||||||||||
Greater than 1.20x | 442 | 963 | 859 | 1,453 | 1,347 | 3,727 | 4 | 8,795 | 82 | % | |||||||||||||||||||
1.00x - 1.20x | 34 | 529 | 375 | 85 | 79 | 144 | — | 1,246 | 12 | % | |||||||||||||||||||
Less than 1.00x | — | 258 | 142 | 42 | 129 | 149 | — | 720 | 7 | % | |||||||||||||||||||
Total commercial mortgage loans | 476 | 1,750 | 1,376 | 1,580 | 1,555 | 4,020 | 4 | 10,761 | 100 | % | |||||||||||||||||||
Residential mortgage loans | |||||||||||||||||||||||||||||
Performing | 96 | 465 | 54 | 43 | 17 | 416 | — | 1,091 | 93 | % | |||||||||||||||||||
Nonperforming (2) | — | 3 | 10 | 6 | 8 | 52 | — | 79 | 7 | % | |||||||||||||||||||
Total residential mortgage loans | 96 | 468 | 64 | 49 | 25 | 468 | — | 1,170 | 100 | % | |||||||||||||||||||
Total mortgage loans | $ | 572 | $ | 2,218 | $ | 1,440 | $ | 1,629 | $ | 1,580 | $ | 4,488 | $ | 4 | $ | 11,931 | 100 | % |
December 31, 2021 | |||||||||||||||||||||||||||||
2021 | 2020 | 2019 | 2018 | 2017 | Prior | Revolving Loans | Total | % of Total | |||||||||||||||||||||
Commercial mortgage loans | |||||||||||||||||||||||||||||
Loan to value ratios: | |||||||||||||||||||||||||||||
Less than 70% | $ | 1,270 | $ | 1,346 | $ | 1,592 | $ | 1,599 | $ | 1,305 | $ | 2,703 | $ | 4 | $ | 9,819 | 93 | % | |||||||||||
70% - 80% | 345 | 35 | — | 52 | 85 | 153 | — | 670 | 6 | % | |||||||||||||||||||
80% - 100% | — | — | 39 | 5 | — | — | — | 44 | — | % | |||||||||||||||||||
Greater than 100% | — | — | — | — | — | 10 | — | 10 | — | % | |||||||||||||||||||
Total commercial mortgage loans | 1,615 | 1,381 | 1,631 | 1,656 | 1,390 | 2,866 | 4 | 10,543 | 100 | % | |||||||||||||||||||
Debt service coverage ratios: | |||||||||||||||||||||||||||||
Greater than 1.20x | 796 | 974 | 1,532 | 1,293 | 1,257 | 2,609 | 4 | 8,465 | 80 | % | |||||||||||||||||||
1.00x - 1.20x | 651 | 329 | 81 | 90 | 11 | 68 | — | 1,230 | 12 | % | |||||||||||||||||||
Less than 1.00x | 168 | 78 | 18 | 273 | 122 | 189 | — | 848 | 8 | % | |||||||||||||||||||
Total commercial mortgage loans | 1,615 | 1,381 | 1,631 | 1,656 | 1,390 | 2,866 | 4 | 10,543 | 100 | % | |||||||||||||||||||
Residential mortgage loans | |||||||||||||||||||||||||||||
Performing | 268 | 22 | 18 | 16 | 7 | 396 | — | 727 | 77 | % | |||||||||||||||||||
Nonperforming (2) | 4 | 44 | 22 | 19 | 23 | 100 | — | 212 | 23 | % | |||||||||||||||||||
Total residential mortgage loans | 272 | 66 | 40 | 35 | 30 | 496 | — | 939 | 100 | % | |||||||||||||||||||
Total mortgage loans | $ | 1,887 | $ | 1,447 | $ | 1,671 | $ | 1,691 | $ | 1,420 | $ | 3,362 | $ | 4 | $ | 11,482 | 100 | % |
31
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
June 30, 2022 | ||||||||||||||||||||||||||||||||
In Good Standing (1) | Restructured | Greater than 90 Days Delinquent | In the Process of Foreclosure | Total Carrying Value | ||||||||||||||||||||||||||||
Apartment | $ | 3,920 | $ | — | $ | — | $ | — | $ | 3,920 | ||||||||||||||||||||||
Hotel | 1,067 | — | — | — | 1,067 | |||||||||||||||||||||||||||
Office | 1,894 | — | — | — | 1,894 | |||||||||||||||||||||||||||
Retail | 2,134 | — | — | — | 2,134 | |||||||||||||||||||||||||||
Warehouse | 1,746 | — | — | — | 1,746 | |||||||||||||||||||||||||||
Total commercial | 10,761 | — | — | — | 10,761 | |||||||||||||||||||||||||||
Residential (2) | 1,091 | — | 61 | 18 | 1,170 | |||||||||||||||||||||||||||
Total | $ | 11,852 | $ | — | $ | 61 | $ | 18 | $ | 11,931 |
December 31, 2021 | ||||||||||||||||||||||||||||||||
In Good Standing (1) | Restructured | Greater than 90 Days Delinquent | In the Process of Foreclosure | Total Carrying Value | ||||||||||||||||||||||||||||
Apartment | $ | 3,755 | $ | — | $ | — | $ | — | $ | 3,755 | ||||||||||||||||||||||
Hotel | 1,054 | — | — | — | 1,054 | |||||||||||||||||||||||||||
Office | 1,889 | — | — | — | 1,889 | |||||||||||||||||||||||||||
Retail | 2,104 | — | — | — | 2,104 | |||||||||||||||||||||||||||
Warehouse | 1,741 | — | — | — | 1,741 | |||||||||||||||||||||||||||
Total commercial | 10,543 | — | — | — | 10,543 | |||||||||||||||||||||||||||
Residential (2) | 727 | — | 206 | 6 | 939 | |||||||||||||||||||||||||||
Total | $ | 11,270 | $ | — | $ | 206 | $ | 6 | $ | 11,482 |
(1) At June 30, 2022 and December 31, 2021, includes mezzanine loans of $420 million and $278 million in the Apartment category, $69 million and $75 million in the Hotel category, $259 million and $252 million in the Office category, $27 million and $27 million in the Retail category, and $55 million and $26 million in the Warehouse category, respectively.
(2) At June 30, 2022 and December 31, 2021, includes $56 million and $202 million of loans purchased when the loans were greater than 90 days delinquent and $15 million and $5 million of loans in process of foreclosure, and are supported with insurance or other guarantees provided by various governmental programs, respectively.
As of June 30, 2022 and December 31, 2021, there were no commercial mortgage loans involved in troubled debt restructuring, and stressed mortgage loans for which the Company is dependent, or expects to be dependent, on the underlying property to satisfy repayment were $3 million.
Other Invested Assets
Other invested assets primarily include investments in Federal Home Loan Bank capital stock, limited partnerships (“LPs”), and real estate. Federal Home Loan Bank capital stock is carried at cost and adjusted for any impairment. At June 30, 2022 and December 31, 2021, FHLB capital stock had carrying value of $146 million and $125 million, respectively. Real estate is carried at the lower of depreciated cost or fair value. At June 30, 2022 and December 31, 2021, real estate totaling $241 million and $243 million, respectively, included foreclosed properties with a book value of $1 million at both June 30, 2022 and December 31, 2021. Carrying values for limited partnership investments are generally determined by using the proportion of the Company’s investment in each fund (Net Asset Value (“NAV”) equivalent) as a practical expedient for fair value, and generally are recorded on a three-month lag, with changes in value included in net investment income. At June 30, 2022 and December 31, 2021, investments in LPs had carrying values of $3,261 million and $2,831 million, respectively.
In June 2021, the Company entered into an arrangement to sell $420 million of limited partnership investments, of which $236 million and $168 million were sold in the second and third quarter of 2021, respectively, and the remainder was sold in January 2022. The LPs sold were carried at estimated sales price. The Company expects to reinvest in new LPs as attractive opportunities become available.
32
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 4. Investments
Securities Lending
The Company has entered into securities lending agreements with agent banks whereby blocks of securities are loaned to third parties, primarily major brokerage firms. As of June 30, 2022 and December 31, 2021, the estimated fair value of loaned securities was $31 million and $17 million, respectively. The agreements require a minimum of 102 percent of the fair value of the loaned securities to be held as collateral, calculated on a daily basis. To further minimize the credit risks related to these programs, the financial condition of counterparties is monitored on a regular basis. At June 30, 2022 and December 31, 2021, cash collateral received in the amount of $32 million and $17 million, respectively, was invested by the agent banks and included in cash and cash equivalents of the Company. A securities lending payable for the overnight and continuous loans is included in liabilities in the amount of cash collateral received. Securities lending transactions are used to generate income. Income and expenses associated with these transactions are reported as net investment income.
Repurchase Agreements
The Company routinely enters into repurchase agreements whereby the Company agrees to sell and repurchase securities. These agreements are accounted for as financing transactions, with the assets and associated liabilities included in the Condensed Consolidated Balance Sheets. Short-term borrowings under such agreements averaged $271 million for six months ended June 30, 2022 and $1,548 million for the year ended December 31, 2021, with weighted average interest rates of 0.19% and 0.07%, respectively. At June 30, 2022 and December 31, 2021, the outstanding repurchase agreement balance was nil and $1,572 million, respectively, collateralized with U.S. Treasury notes and corporate securities and maturing within 30 days, and was included within repurchase agreements and securities lending payable in the Condensed Consolidated Balance Sheets. In the event of a decline in the fair value of the pledged collateral under these agreements, the Company may be required to transfer cash or additional securities as pledged collateral. Interest expense totaled nil both for the three and six months ended June 30, 2022, respectively, and nil and $1 million for the three and six months ended June 30, 2021. The highest level of short-term borrowings at any month end was $584 million and $2,257 million for the six months ended June 30, 2022 and 2021, respectively.
33
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 5. Derivative Instruments
5. Derivative Instruments
The Company’s business model includes the acceptance, monitoring and mitigation of risk. Specifically, the Company considers, among other factors, exposures to interest rate and equity market movements, foreign exchange rates and other asset or liability prices. The Company uses derivative instruments to mitigate or reduce these risks in accordance with established policies and goals. The Company’s derivative holdings, while effective in managing defined risks, are not structured to meet accounting requirements to be designated as hedging instruments. As a result, freestanding derivatives are carried at fair value with changes recorded in net gains (losses) on derivatives and investments.
A summary of the aggregate contractual or notional amounts and fair values of the Company’s freestanding and embedded derivative instruments are as follows (in millions):
June 30, 2022 | ||||||||||||||||||||
Contractual/ | Assets | Liabilities | Net | |||||||||||||||||
Notional | Fair | Fair | Fair Value | |||||||||||||||||
Amount (1) | Value | Value | Asset (Liability) | |||||||||||||||||
Freestanding derivatives | ||||||||||||||||||||
Cross-currency swaps | $ | 1,802 | $ | 48 | $ | 108 | $ | (60) | ||||||||||||
Equity index call options | 24,000 | 13 | — | 13 | ||||||||||||||||
Equity index futures (2) | 25,272 | — | — | — | ||||||||||||||||
Equity index put options | 32,500 | 1,030 | — | 1,030 | ||||||||||||||||
Interest rate swaps | 7,728 | 30 | 60 | (30) | ||||||||||||||||
Interest rate swaps - cleared (2) | 1,500 | — | — | — | ||||||||||||||||
Put-swaptions | 22,000 | — | 1,029 | (1,029) | ||||||||||||||||
Treasury futures (2) | 14 | — | — | — | ||||||||||||||||
Total return swaps | 700 | 12 | 4 | 8 | ||||||||||||||||
Total freestanding derivatives | 115,516 | 1,133 | 1,201 | (68) | ||||||||||||||||
Embedded derivatives | ||||||||||||||||||||
Variable annuity embedded derivatives (3) | N/A | — | 601 | (601) | ||||||||||||||||
Fixed index annuity embedded derivatives (4) | N/A | — | 1,087 | (1,087) | ||||||||||||||||
Registered index linked annuity embedded derivatives (4) | N/A | — | 4 | (4) | ||||||||||||||||
Total embedded derivatives | N/A | — | 1,692 | (1,692) | ||||||||||||||||
Derivatives related to funds withheld under reinsurance treaties | ||||||||||||||||||||
Cross-currency swaps | 158 | 24 | 1 | 23 | ||||||||||||||||
Cross-currency forwards | 1,190 | 86 | 15 | 71 | ||||||||||||||||
Funds withheld embedded derivative (5) | N/A | 2,508 | — | 2,508 | ||||||||||||||||
Total derivatives related to funds withheld under reinsurance treaties | 1,348 | 2,618 | 16 | 2,602 | ||||||||||||||||
Total | $ | 116,864 | $ | 3,751 | $ | 2,909 | $ | 842 |
(1) The notional amount for swaps and swaptions represents the stated principal balance used as a basis for calculating payments. The contractual amount for futures and options represents the market exposure of open positions. | ||||||||||||||||||||||||||
(2) Variation margin is considered settlement resulting in the netting of cash received/paid for variation margin against the fair value of the trades. | ||||||||||||||||||||||||||
(3) Included within reserves for future policy benefits and claims payable on the Condensed Consolidated Balance Sheets. The nonperformance risk adjustment is included in the balance above. | ||||||||||||||||||||||||||
(4) Included within other contract holder funds on the Condensed Consolidated Balance Sheets. The nonperformance risk adjustment is included in the balance above. | ||||||||||||||||||||||||||
(5) Included within funds withheld payable under reinsurance treaties on the Condensed Consolidated Balance Sheets. |
34
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 5. Derivative Instruments
December 31, 2021 | ||||||||||||||||||||
Contractual/ | Assets | Liabilities | Net | |||||||||||||||||
Notional | Fair | Fair | Fair Value | |||||||||||||||||
Amount (1) | Value | Value | Asset (Liability) | |||||||||||||||||
Freestanding derivatives | ||||||||||||||||||||
Cross-currency swaps | $ | 1,767 | $ | 55 | $ | 35 | $ | 20 | ||||||||||||
Equity index call options | 21,000 | 606 | — | 606 | ||||||||||||||||
Equity index futures (2) | 18,258 | — | — | — | ||||||||||||||||
Equity index put options | 27,500 | 150 | — | 150 | ||||||||||||||||
Interest rate swaps | 7,728 | 430 | — | 430 | ||||||||||||||||
Interest rate swaps - cleared (2) | 1,500 | — | — | — | ||||||||||||||||
Put-swaptions | 19,000 | 133 | — | 133 | ||||||||||||||||
Treasury futures (2) | 912 | — | — | — | ||||||||||||||||
Total return swaps | — | — | — | — | ||||||||||||||||
Total freestanding derivatives | 97,665 | 1,374 | 35 | 1,339 | ||||||||||||||||
Embedded derivatives | ||||||||||||||||||||
Variable annuity embedded derivatives (3) | N/A | — | 2,626 | (2,626) | ||||||||||||||||
Fixed index annuity embedded derivatives (4) | N/A | — | 1,439 | (1,439) | ||||||||||||||||
Registered index linked annuity embedded derivatives (4) | N/A | — | 6 | (6) | ||||||||||||||||
Total embedded derivatives | N/A | — | 4,071 | (4,071) | ||||||||||||||||
Derivatives related to funds withheld under reinsurance treaties | ||||||||||||||||||||
Cross-currency swaps | 158 | 10 | 1 | 9 | ||||||||||||||||
Cross-currency forwards | 1,119 | 33 | 5 | 28 | ||||||||||||||||
Funds withheld embedded derivative (5) | N/A | — | 120 | (120) | ||||||||||||||||
Total derivatives related to funds withheld under reinsurance treaties | 1,277 | 43 | 126 | (83) | ||||||||||||||||
Total | $ | 98,942 | $ | 1,417 | $ | 4,232 | $ | (2,815) |
(1) The notional amount for swaps and swaptions represents the stated principal balance used as a basis for calculating payments. The contractual amount for futures and options represents the market exposure of open positions. | ||||||||||||||||||||||||||
(2) Variation margin is considered settlement resulting in the netting of cash received/paid for variation margin against the fair value of the trades. | ||||||||||||||||||||||||||
(3) Included within reserves for future policy benefits and claims payable on the Condensed Consolidated Balance Sheets. The nonperformance risk adjustment is included in the balance above. | ||||||||||||||||||||||||||
(4) Included within other contract holder funds on the Condensed Consolidated Balance Sheets. The nonperformance risk adjustment is included in the balance above. | ||||||||||||||||||||||||||
(5) Included within funds withheld payable under reinsurance treaties on the Condensed Consolidated Balance Sheets. |
35
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 5. Derivative Instruments
The following table reflects the results of the Company’s derivatives, including gains (losses) and change in fair value of freestanding derivative instruments and embedded derivatives (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Derivatives excluding funds withheld under reinsurance treaties | ||||||||||||||||||||||||||
Cross-currency swaps | $ | (50) | $ | 21 | $ | (82) | $ | (44) | ||||||||||||||||||
Equity index call options | (642) | 667 | (1,231) | 799 | ||||||||||||||||||||||
Equity index futures | 3,618 | (1,377) | 4,241 | (2,670) | ||||||||||||||||||||||
Equity index put options | 822 | (260) | 507 | (611) | ||||||||||||||||||||||
Interest rate swaps | (150) | 117 | (411) | (148) | ||||||||||||||||||||||
Interest rate swaps - cleared | (49) | 36 | (137) | (50) | ||||||||||||||||||||||
Put-swaptions | (686) | 395 | (1,154) | 103 | ||||||||||||||||||||||
Treasury futures | (1) | — | (312) | (773) | ||||||||||||||||||||||
Total return swaps | 8 | — | 8 | — | ||||||||||||||||||||||
Fixed index annuity embedded derivatives | 4 | (2) | 5 | (2) | ||||||||||||||||||||||
Registered index linked annuity embedded derivative | 60 | — | 63 | — | ||||||||||||||||||||||
Variable annuity embedded derivatives | (149) | (1,365) | 1,995 | 3,283 | ||||||||||||||||||||||
Total net gains (losses) on derivative instruments excluding derivative instruments related to funds withheld under reinsurance treaties | 2,785 | (1,768) | 3,492 | (113) | ||||||||||||||||||||||
Derivatives related to funds withheld under reinsurance treaties | ||||||||||||||||||||||||||
Cross-currency swaps | 12 | 8 | 15 | 6 | ||||||||||||||||||||||
Cross-currency forwards | 51 | (6) | 69 | 13 | ||||||||||||||||||||||
Funds withheld embedded derivative | 1,347 | (544) | 2,628 | 454 | ||||||||||||||||||||||
Total net gains (losses) on derivative instruments related to funds withheld under reinsurance treaties | 1,410 | (542) | 2,712 | 473 | ||||||||||||||||||||||
Total net gains (losses) on derivative instruments including derivative instruments related to funds withheld under reinsurance treaties | $ | 4,195 | $ | (2,310) | $ | 6,204 | $ | 360 |
All of the Company’s trade agreements for freestanding, over-the-counter derivatives, contain credit downgrade provisions that allow a party to assign or terminate derivative transactions if the counterparty’s credit rating declines below an established limit. At June 30, 2022 and December 31, 2021, the fair value of the Company’s net non-cleared, over-the-counter derivative assets by counterparty were $977 million and $1,376 million, respectively, and held collateral was $879 million and $1,576 million, respectively, related to these agreements. At June 30, 2022 and December 31, 2021, the fair value of the Company’s net non-cleared, over-the-counter derivative liabilities by counterparty were $951 million and nil, respectively, and provided collateral was $1,128 million and nil, respectively, related to these agreements. If all of the downgrade provisions had been triggered at June 30, 2022 and December 31, 2021, in aggregate, the Company would have had to disburse nil and $200 million, respectively, and would have been allowed to claim $275 million and nil, respectively.
Offsetting Assets and Liabilities
The Company’s derivative instruments, repurchase agreements and securities lending agreements are subject to master netting arrangements and collateral arrangements. A master netting arrangement with a counterparty creates a right of offset for amounts due to and due from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company recognizes amounts subject to master netting arrangements on a gross basis within the Condensed Consolidated Balance Sheets.
36
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 5. Derivative Instruments
The following tables present the gross and net information about the Company’s financial instruments subject to master netting arrangements (in millions):
June 30, 2022 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Gross Amounts Recognized | Gross Amounts Offset in the Condensed Consolidated Balance Sheets | Net Amounts Presented in the Condensed Consolidated Balance Sheets | ||||||||||||||||||||||||||||||||||||||||||||||||
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets | ||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Instruments (1) | Cash Collateral | Securities Collateral (2) | Net Amount | |||||||||||||||||||||||||||||||||||||||||||||||
Financial Assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Freestanding derivative | ||||||||||||||||||||||||||||||||||||||||||||||||||
assets | $ | 1,243 | $ | — | $ | 1,243 | $ | 266 | $ | 610 | $ | 246 | $ | 121 | ||||||||||||||||||||||||||||||||||||
Financial Liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Freestanding derivative | ||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities | $ | 1,217 | $ | — | $ | 1,217 | $ | 266 | $ | 66 | $ | 885 | $ | — | ||||||||||||||||||||||||||||||||||||
Securities loaned | 32 | — | 32 | — | 32 | — | — | |||||||||||||||||||||||||||||||||||||||||||
Repurchase agreements | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||||||||
Total financial liabilities | $ | 1,249 | $ | — | $ | 1,249 | $ | 266 | $ | 98 | $ | 885 | $ | — |
(1) Represents the amount that could be offset under master netting or similar arrangements that management elects not to offset on the Condensed Consolidated Balance Sheets. | |||||||||||||||||||||||||||||||||||||||||
(2) Excludes initial margin amounts for exchange-traded derivatives. |
December 31, 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||
Gross Amounts Recognized | Gross Amounts Offset in the Condensed Consolidated Balance Sheets | Net Amounts Presented in the Condensed Consolidated Balance Sheets | ||||||||||||||||||||||||||||||||||||||||||||||||
Gross Amounts Not Offset in the Condensed Consolidated Balance Sheets | ||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Instruments (1) | Cash Collateral | Securities Collateral (2) | Net Amount | |||||||||||||||||||||||||||||||||||||||||||||||
Financial Assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Freestanding derivative | ||||||||||||||||||||||||||||||||||||||||||||||||||
assets | $ | 1,417 | $ | — | $ | 1,417 | $ | 41 | $ | 817 | $ | 555 | $ | 4 | ||||||||||||||||||||||||||||||||||||
Financial Liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Freestanding derivative | ||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities | $ | 41 | $ | — | $ | 41 | $ | 41 | $ | — | $ | — | $ | — | ||||||||||||||||||||||||||||||||||||
Securities loaned | 17 | — | 17 | — | 17 | — | — | |||||||||||||||||||||||||||||||||||||||||||
Repurchase agreements | 1,572 | — | 1,572 | — | — | 1,572 | — | |||||||||||||||||||||||||||||||||||||||||||
Total financial liabilities | $ | 1,630 | $ | — | $ | 1,630 | $ | 41 | $ | 17 | $ | 1,572 | $ | — |
(1) Represents the amount that could be offset under master netting or similar arrangements that management elects not to offset on the Condensed Consolidated Balance Sheets. | |||||||||||||||||||||||||||||||||||||||||
(2) Excludes initial margin amounts for exchange-traded derivatives. |
In the above tables, the amounts of assets or liabilities presented in the Company’s Condensed Consolidated Balance Sheets are offset first by financial instruments that have the right of offset under master netting or similar arrangements with any remaining amount reduced by the amount of cash and securities collateral. The actual amount of collateral may be greater than amounts presented in the tables. The above tables exclude net embedded derivative liabilities of $1,692 million and $4,071 million as of June 30, 2022 and December 31, 2021, respectively, as these derivatives are not subject to master netting arrangements. The above tables also exclude the funds withheld embedded derivative asset (liability) of $2,508 million and $(120) million at June 30, 2022 and December 31, 2021.
37
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
6. Fair Value Measurements
The following table summarizes the fair value and carrying value of the Company’s financial instruments (in millions):
June 30, 2022 | December 31, 2021 | |||||||||||||||||||
Carrying Value | Fair Value | Carrying Value | Fair Value | |||||||||||||||||
Assets | ||||||||||||||||||||
Debt securities (1) | $ | 45,586 | $ | 45,586 | $ | 53,375 | $ | 53,375 | ||||||||||||
Equity securities | 260 | 260 | 279 | 279 | ||||||||||||||||
Mortgage loans (1) | 11,931 | 11,586 | 11,482 | 11,910 | ||||||||||||||||
Limited partnerships | 3,261 | 3,261 | 2,831 | 2,831 | ||||||||||||||||
Policy loans (1) | 4,459 | 4,459 | 4,475 | 4,475 | ||||||||||||||||
Freestanding derivative instruments | 1,243 | 1,243 | 1,417 | 1,417 | ||||||||||||||||
Federal Home Loan Bank of Indianapolis ("FHLBI") capital stock | 146 | 146 | 125 | 125 | ||||||||||||||||
Cash and cash equivalents | 5,258 | 5,258 | 2,623 | 2,623 | ||||||||||||||||
Guaranteed minimum income benefits ("GMIB") reinsurance recoverable | 232 | 232 | 262 | 262 | ||||||||||||||||
Separate account assets | 196,184 | 196,184 | 248,949 | 248,949 | ||||||||||||||||
Liabilities | ||||||||||||||||||||
Annuity reserves (2) | 38,787 | 35,844 | 40,389 | 50,116 | ||||||||||||||||
Reserves for guaranteed investment contracts (3) | 1,181 | 1,156 | 894 | 923 | ||||||||||||||||
Trust instruments supported by funding agreements (3) | 5,301 | 5,174 | 5,986 | 6,175 | ||||||||||||||||
FHLB funding agreements (3) | 2,001 | 2,090 | 1,950 | 1,938 | ||||||||||||||||
Funds withheld payable under reinsurance treaties (1) | 25,506 | 25,506 | 29,007 | 29,007 | ||||||||||||||||
Long-term debt | 2,634 | 2,422 | 2,649 | 2,745 | ||||||||||||||||
Securities lending payable | 32 | 32 | 17 | 17 | ||||||||||||||||
Freestanding derivative instruments | 1,217 | 1,217 | 41 | 41 | ||||||||||||||||
Repurchase agreements | — | — | 1,572 | 1,572 | ||||||||||||||||
FHLB advances | — | — | — | — | ||||||||||||||||
Separate account liabilities | 196,184 | 196,184 | 248,949 | 248,949 | ||||||||||||||||
(1) Includes items carried at fair value under the fair value option and trading securities. (2) Annuity reserves represent only the components of other contract holder funds and reserves for future policy benefits and claims payable that are considered to be financial instruments. (3) Included as a component of other contract holder funds on the Condensed Consolidated Balance Sheets. |
The following is a discussion of the methodologies used to determine fair values of the financial instruments measured on both a recurring and nonrecurring basis reported in the following tables.
Debt and Equity Securities
The fair values for debt and equity securities are determined using information available from independent pricing services, broker-dealer quotes, or internally derived estimates. Priority is given to publicly available prices from independent sources, when available. Securities for which the independent pricing service does not provide a quotation are either submitted to independent broker-dealers for prices or priced internally. Typical inputs used by these three pricing methods include reported trades, benchmark yields, credit spreads, liquidity premiums and/or estimated cash flows based on default and prepayment assumptions.
As a result of typical trading volumes and the lack of specific quoted market prices for most debt securities, independent pricing services will normally derive the security prices through recently reported trades for identical or similar securities, making adjustments through the reporting date based upon available market observable information as outlined above. If there are no recently reported trades, the independent pricing services and broker-dealers may use matrix or pricing model processes to develop a security price where future cash flow expectations are developed based upon collateral performance and discounted at relevant market rates. Certain securities are priced using broker-dealer quotes, which may utilize
38
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
proprietary inputs and models. Additionally, the majority of these quotes are non-binding.
Included in the pricing of asset-backed securities are estimates of the rate of future prepayments of principal over the remaining life of the securities. Such estimates are derived based on the characteristics of the underlying structure and prepayment assumptions believed to be relevant for the underlying collateral. Actual prepayment experience may vary from these estimates.
Internally derived estimates may be used to develop a fair value for securities for which the Company is unable to obtain either a reliable price from an independent pricing service or a suitable broker-dealer quote. These fair value estimates may incorporate Level 2 and Level 3 inputs and are generally derived using expected future cash flows, discounted at market interest rates available from market sources based on the credit quality and duration of the instrument. For securities that may not be reliably priced using these internally developed pricing models, a fair value may be estimated using indicative market prices. These prices are indicative of an exit price, but the assumptions used to establish the fair value may not be observable or corroborated by market observable information and, therefore, represent Level 3 inputs.
The Company performs an analysis on the prices and credit spreads received from third parties to ensure that the prices represent a reasonable estimate of the fair value. This process involves quantitative and qualitative analysis and is overseen by investment and accounting professionals. Examples of procedures performed include initial and ongoing review of third-party pricing service methodologies, review of pricing statistics and trends, back testing recent trades and monitoring of trading volumes. In addition, the Company considers whether prices received from independent broker-dealers represent a reasonable estimate of fair value through the use of internal and external cash flow models, which are developed based on spreads and, when available, market indices. As a result of this analysis, if the Company determines there is a more appropriate fair value based upon the available market data, the price received from the third party may be adjusted accordingly.
For those securities that were internally valued at June 30, 2022 and December 31, 2021, the pricing model used by the Company utilizes current spread levels of similarly rated securities to determine the market discount rate for the security. Furthermore, appropriate risk premiums for illiquidity and non-performance are incorporated in the discount rate. Cash flows, as estimated by the Company using issuer-specific default statistics and prepayment assumptions, are discounted to determine an estimated fair value.
On an ongoing basis, the Company reviews the independent pricing services’ valuation methodologies and related inputs and evaluates the various types of securities in its investment portfolio to determine an appropriate fair value hierarchy distribution based upon trading activity and the observability of market inputs. Based on the results of this evaluation, each price is classified into Level 1, 2, or 3. Most prices provided by independent pricing services, including broker-dealer quotes, are classified into Level 2 due to their use of market observable inputs.
Limited Partnerships
Fair values for limited partnership interests, which are included in other invested assets, is generally determined using the proportion of the Company’s investment in the value of the net assets of each fund (“NAV equivalent”) as a practical expedient for fair value, and generally, are recorded on a three-month lag. No adjustments to these amounts were deemed necessary at June 30, 2022 and December 31, 2021. As a result of using the net asset value per share practical expedient, limited partnership interests are not classified in the fair value hierarchy.
The Company’s limited partnership interests are not redeemable and distributions received are generally the result of liquidation of the underlying assets of the partnerships. The Company generally has the ability under the partnership agreements to sell its interest to another limited partner with the prior written consent of the general partner. In cases when the Company expects to sell the limited partnership interest, the estimated sales price is used to determine the fair value rather than the practical expedient. These limited partnership interests are classified as Level 2 in the fair value hierarchy.
In cases when a limited partnership’s financial statements are unavailable and a NAV equivalent is not available or practical, an internally developed model is used to determine fair value for that fund. These investments are classified as Level 3 in the fair value hierarchy.
39
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
Policy Loans
Policy loans are funds provided to policyholders in return for a claim on the policies values and function like demand deposits which are redeemable upon repayment, death or surrender, and there is only one market price at which the transaction could be settled – the then current carrying value. The funds provided are limited to the cash surrender value of the underlying policy. The nature of policy loans is to have a negligible default risk as the loans are fully collateralized by the value of the policy. Policy loans do not have a stated maturity and the balances and accrued interest are repaid either by the policyholder or with proceeds from the policy. Due to the collateralized nature of policy loans and unpredictable timing of payments, the Company believes the carrying value of policy loans approximates fair value. The reinsurance related component of policy loans at fair value under the fair value option have been classified as Level 3 within the fair value hierarchy.
Freestanding Derivative Instruments
Freestanding derivative instruments are reported at fair value, which reflects the estimated amounts, net of payment accruals, which the Company would receive or pay upon sale or termination of the contracts at the reporting date. Changes in fair value are included in net gains (losses) on derivatives and investments. Freestanding derivatives priced using third party pricing services incorporate inputs that are predominantly observable in the market. Inputs used to value derivatives include interest rate swap curves, credit spreads, interest rates, counterparty credit risk, equity volatility and equity index levels.
Freestanding derivative instruments classified as Level 1 include futures, which are traded on active exchanges. Freestanding derivative instruments classified as Level 2 include interest rate swaps, cross currency swaps, cross-currency forwards, credit default swaps, total return swaps, put-swaptions and certain equity index call and put options. These derivative valuations are determined by third-party pricing services using pricing models with inputs that are observable in the market or can be derived principally from, or corroborated by, observable market data. Freestanding derivative instruments classified as Level 3 include interest rate contingent options that are valued by third-party pricing services utilizing significant unobservable inputs.
Cash and Cash Equivalents
Cash and cash equivalents primarily include money market instruments and bank deposits. Cash equivalents also includes all highly liquid securities and other investments purchased with an original or remaining maturity of three months or less at the date of purchase. Certain money market instruments are valued using unadjusted quoted prices in active markets and are classified as Level 1.
Funds Withheld Payable Under Reinsurance Treaties
The funds withheld payable under reinsurance treaties includes both the funds withheld payable which are held at fair value under the fair value option and the funds withheld embedded derivative liability. The fair value of the funds withheld payable which are held at fair value under the fair value option is equal to the fair value of the assets held as collateral, which primarily consists of policy loans using industry standard valuation techniques. The funds withheld embedded derivative liability is determined based upon a total return swap technique referencing the fair value of the investments held under the reinsurance contract and requires certain significant unobservable inputs. The funds withheld payable which are held at fair value under the fair value option and the funds withheld embedded derivative are considered Level 3 in the fair value hierarchy.
Separate Account Assets
Separate account assets are comprised of investments in mutual funds that transact regularly, but do not trade in active markets as they are not publicly available, and, are categorized as Level 2 assets.
40
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
Variable Annuity Guarantees
Variable annuity contracts issued by the Company offer various guaranteed minimum death, withdrawal, income and accumulation benefits. Certain benefits, including non-life contingent components of guaranteed minimum withdrawal benefits (“GMWB”) and guaranteed minimum withdrawal benefits for life (“GMWB for Life”), guaranteed minimum accumulation benefits (“GMAB”), and the reinsurance recoverable on the Company’s GMIB, are recorded at fair value. Guaranteed benefits that are not subject to fair value accounting are accounted for as insurance benefits. The Company discontinued offering the GMIB in 2009 and GMAB in 2011.
GMABs and non-life contingent components of GMWB and GMWB for Life contracts are recorded at fair value with changes in fair value recorded in net gains (losses) on derivatives and investments. The fair value of the reserve is based on the expectations of future benefit payments and certain future fees associated with the benefits. At the inception of the contract, the Company attributes to the embedded derivative a portion of rider fees collected from the contract holder, which is then held static in future valuations. Those fees, generally referred to as the attributed fees, are set such that the present value of the attributed fees is equal to the present value of future claims expected to be paid under the guaranteed benefit at the inception of the contract. In subsequent valuations, both the present value of future benefits and the present value of attributed fees are revalued based on current market conditions and policyholder behavior assumptions. The difference between each of the two components represents the fair value of the embedded derivative. Thus, when unfavorable equity market movements cause declines in the contract holder’s account value relative to the guarantee benefit, the valuation of future expected claims would generally increase relative to the measurement performed at the inception of the contract, resulting in an increase in the fair value of the embedded derivative liability (and vice versa).
The Company’s GMIB book is reinsured through an unrelated party, and due to the net settlement provisions of the reinsurance agreement, this contract meets the definition of a derivative. Accordingly, the GMIB reinsurance agreement is recorded at fair value, with changes in fair value recorded in net gains (losses) on derivatives and investments. Due to the inability to economically reinsure or hedge new issues of the GMIB, the Company discontinued offering the benefit in 2009.
Fair values for GMWB, GMWB for Life, and GMAB embedded derivatives, as well as GMIB reinsurance recoverables, are calculated using internally developed models because active, observable markets do not exist for those guaranteed benefits.
The fair value calculation is based on the present value of future cash flows comprised of future expected benefit payments, less future attributed rider fees, over the lives of the contracts. Estimating these cash flows requires numerous estimates and subjective judgments related to capital market inputs, as well as actuarially determined assumptions related to expectations concerning policyholder behavior. Capital market inputs include expected market rates of return, market volatility, correlations of market index returns to funds, fund performance and discount rates. The more significant actuarial assumptions include benefit utilization by policyholders, lapse, mortality, and withdrawal rates. Best estimate assumptions plus risk margins are used as applicable.
At each valuation date, the fair value calculation reflects expected returns based on the greater of LIBOR swap rates and constant maturity treasury rates as of that date to determine the value of expected future cash flows produced in a stochastic process. Volatility assumptions are based on a weighting of available market data for implied market volatility for durations up to 10 years, grading to a historical volatility level by year 15, where such long-term historical volatility levels contain an explicit risk margin. Additionally, non-performance risk is incorporated into the calculation through the use of discount rates based on a blend of yields on similarly-rated peer debt and yields on JFI debt (adjusted to operating company levels). Risk margins are also incorporated into the model assumptions, particularly for policyholder behavior. Estimates of future policyholder behavior are subjective and are based primarily on the Company’s experience.
As markets change, mature and evolve and actual policyholder behavior emerges, management continually evaluates the appropriateness of its assumptions for this component of the fair value model.
41
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
The use of the models and assumptions described above requires a significant amount of judgment. Management believes the aggregation of each of these components results in an amount that the Company would be required to transfer for a liability, or receive for an asset, to or from a willing buyer or seller, if one existed, for those market participants to assume the risks associated with the guaranteed benefits and the related reinsurance. However, the ultimate settlement amount of the asset or liability, which is currently unknown, could likely be significantly different than this fair value.
Fixed Index Annuities
The fair value of the fixed index annuities embedded option, incorporating such factors as the volatility of returns, the level of interest rates and the time remaining until the option expires, is calculated using the closed form Black-Scholes Option Pricing model or Monte Carlo simulations, as appropriate for the type of option. Additionally, assumed withdrawal rates are used to estimate the expected volume of embedded options that will be realized by policyholders.
RILA
The fair value of the RILA embedded option, incorporating such factors as the volatility of returns, the level of interest rates and the time remaining until the option expires, is calculated using the closed form Black-Scholes Option Pricing model. Additionally, assumed withdrawal rates are used to estimate the expected volume of embedded options that will be realized by policyholders.
Fair Value Option
The Company elected the fair value option for debt securities related to certain consolidated investments totaling $1,991 million and $1,546 million at June 30, 2022 and December 31, 2021, respectively. These debt securities are reflected on the Company’s Condensed Consolidated Balance Sheets as debt securities, at fair value under the fair value option.
The Company has elected the fair value option for certain funds withheld assets, which are held as collateral for reinsurance, totaling $3,999 million and $3,632 million at June 30, 2022 and December 31, 2021, respectively, as discussed above, and includes mortgage loans as discussed below.
The Company elected the fair value option for certain mortgage loans held under the funds withheld reinsurance agreement. The fair value option was elected for these mortgage loans, purchased or funded after December 31, 2021, to mitigate inconsistency in earnings that would otherwise result between these mortgage loan assets and the funds withheld liability, including the associated embedded derivative, and are valued using third-party pricing services. Changes in fair value are reflected in net investment income on the Condensed Consolidated Income Statements.
The fair value and aggregate contractual principal for mortgage loans where the fair value option was elected after December 31, 2021, were as follows (in millions):
June 30, | |||||
2022 | |||||
Fair value | $ | 357 | |||
Aggregate contractual principal | 362 |
As of June 30, 2022, no loans for which the fair value option was elected were in non-accrual status, and no loans were more than 90 days past due and still accruing interest.
Income and changes in unrealized gains and losses on other assets for which the Company has elected the fair value option are immaterial to the Company’s Condensed Consolidated Financial Statements.
42
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following tables summarize the Company’s assets and liabilities that are carried at fair value by hierarchy levels (in millions):
June 30, 2022 | ||||||||||||||||||||
Total | Level 1 | Level 2 | Level 3 | |||||||||||||||||
Assets | ||||||||||||||||||||
Debt securities | ||||||||||||||||||||
U.S. government securities | $ | 2,988 | $ | 2,988 | $ | — | $ | — | ||||||||||||
Other government securities | 1,501 | — | 1,501 | — | ||||||||||||||||
Public utilities | 5,518 | — | 5,518 | — | ||||||||||||||||
Corporate securities | 27,191 | — | 27,144 | 47 | ||||||||||||||||
Residential mortgage-backed | 470 | — | 470 | — | ||||||||||||||||
Commercial mortgage-backed | 1,658 | — | 1,658 | — | ||||||||||||||||
Other asset-backed securities | 6,260 | — | 6,260 | — | ||||||||||||||||
Equity securities | 260 | 81 | 55 | 124 | ||||||||||||||||
Mortgage loans | 357 | — | — | 357 | ||||||||||||||||
Limited partnerships (1) | 1 | — | — | 1 | ||||||||||||||||
Policy loans | 3,485 | — | — | 3,485 | ||||||||||||||||
Freestanding derivative instruments | 1,243 | — | 1,243 | — | ||||||||||||||||
Cash and cash equivalents | 5,258 | 5,258 | — | — | ||||||||||||||||
GMIB reinsurance recoverable | 232 | — | — | 232 | ||||||||||||||||
Separate account assets | 196,184 | — | 196,184 | — | ||||||||||||||||
Total | $ | 252,606 | $ | 8,327 | $ | 240,033 | $ | 4,246 | ||||||||||||
Liabilities | ||||||||||||||||||||
Embedded derivative liabilities (2) | $ | 1,692 | $ | — | $ | 1,091 | $ | 601 | ||||||||||||
Funds withheld payable under reinsurance treaties (3) | 1,141 | — | — | 1,141 | ||||||||||||||||
Freestanding derivative instruments | 1,217 | — | 1,217 | — | ||||||||||||||||
Total | $ | 4,050 | $ | — | $ | 2,308 | $ | 1,742 | ||||||||||||
(1) Excludes $3,260 million of limited partnership investments measured at NAV. | ||||||||||||||||||||
(2) Includes the embedded derivative liabilities of $601 million related to GMWB reserves included in reserves for future policy benefits and claims payable, $4 million of RILA and $1,087 million of fixed index annuities, both included in other contract holder funds on the Condensed Consolidated Balance Sheets. | ||||||||||||||||||||
(3) Includes the Athene embedded derivative asset of $2,508 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. |
43
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
December 31, 2021 | |||||||||||||||||
Total | Level 1 | Level 2 | Level 3 | ||||||||||||||
Assets | |||||||||||||||||
Debt securities | |||||||||||||||||
U.S. government securities | $ | 4,321 | $ | 4,321 | $ | — | $ | — | |||||||||
Other government securities | 1,619 | — | 1,619 | — | |||||||||||||
Public utilities | 6,715 | — | 6,715 | — | |||||||||||||
Corporate securities | 31,146 | — | 31,137 | 9 | |||||||||||||
Residential mortgage-backed | 569 | — | 569 | — | |||||||||||||
Commercial mortgage-backed | 2,038 | — | 2,038 | — | |||||||||||||
Other asset-backed securities | 6,967 | — | 6,967 | — | |||||||||||||
Equity securities | 279 | 111 | 56 | 112 | |||||||||||||
Limited partnerships (1) | 18 | — | 17 | 1 | |||||||||||||
Policy loans | 3,467 | — | — | 3,467 | |||||||||||||
Freestanding derivative instruments | 1,417 | — | 1,417 | — | |||||||||||||
Cash and cash equivalents | 2,623 | 2,623 | — | — | |||||||||||||
GMIB reinsurance recoverable | 262 | — | — | 262 | |||||||||||||
Separate account assets | 248,949 | — | 248,949 | — | |||||||||||||
Total | $ | 310,390 | $ | 7,055 | $ | 299,484 | $ | 3,851 | |||||||||
Liabilities | |||||||||||||||||
Embedded derivative liabilities (2) | $ | 4,071 | $ | — | $ | 1,445 | $ | 2,626 | |||||||||
Funds withheld payable under reinsurance treaties (3) | 3,759 | — | — | 3,759 | |||||||||||||
Freestanding derivative instruments | 41 | — | 41 | — | |||||||||||||
Total | $ | 7,871 | $ | — | $ | 1,486 | $ | 6,385 | |||||||||
(1) Excludes $2,813 million of limited partnership investments measured at NAV. | |||||||||||||||||
(2) Includes the embedded derivative liabilities of $2,626 million related to GMWB reserves included in reserves for future policy benefits and claims payable, $6 million of RILA and $1,439 million of fixed index annuities, both included in other contract holder funds on the consolidated balance sheets. | |||||||||||||||||
(3) Includes the Athene embedded derivative liability of $120 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. |
44
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
Assets and Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3)
Level 3 Assets and Liabilities by Price Source
The table below presents the balances of Level 3 assets and liabilities measured at fair value with their corresponding pricing sources (in millions):
June 30, 2022 | |||||||||||
Assets | Total | Internal | External | ||||||||
Debt securities: | |||||||||||
Corporate | $ | 47 | $ | — | $ | 47 | |||||
Equity securities | 124 | 1 | 123 | ||||||||
Mortgage loans | 357 | — | 357 | ||||||||
Limited partnerships | 1 | 1 | — | ||||||||
Policy loans | 3,485 | 3,485 | — | ||||||||
GMIB reinsurance recoverable | 232 | 232 | — | ||||||||
Total | $ | 4,246 | $ | 3,719 | $ | 527 | |||||
Liabilities | |||||||||||
Embedded derivative liabilities (1) | $ | 601 | $ | 601 | $ | — | |||||
Funds withheld payable under reinsurance treaties (2) | 1,141 | 1,141 | — | ||||||||
Total | $ | 1,742 | $ | 1,742 | $ | — | |||||
(1) Includes the embedded derivative related to GMWB reserves. | |||||||||||
(2) Includes the Athene embedded derivative asset of $2,508 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. | |||||||||||
December 31, 2021 | |||||||||||
Assets | Total | Internal | External | ||||||||
Debt securities: | |||||||||||
Corporate | $ | 9 | $ | — | $ | 9 | |||||
Equity securities | 112 | 1 | 111 | ||||||||
Limited partnerships | 1 | 1 | — | ||||||||
Policy loans | 3,467 | 3,467 | — | ||||||||
GMIB reinsurance recoverable | 262 | 262 | — | ||||||||
Total | $ | 3,851 | $ | 3,731 | $ | 120 | |||||
Liabilities | |||||||||||
Embedded derivative liabilities (1) | $ | 2,626 | $ | 2,626 | $ | — | |||||
Funds withheld payable under reinsurance treaties (2) | 3,759 | 3,759 | — | ||||||||
Total | $ | 6,385 | $ | 6,385 | $ | — | |||||
(1) Includes the embedded derivative related to GMWB reserves. | |||||||||||
(2) Includes the Athene embedded derivative liability of $120 million and funds withheld payable under reinsurance treaties at fair value under the fair value option. |
External pricing sources for securities represent unadjusted prices from independent pricing services and independent indicative broker quotes where pricing inputs are not readily available.
45
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
Quantitative Information Regarding Internally-Priced Level 3 Assets and Liabilities
The table below presents quantitative information on significant internally-priced Level 3 assets and liabilities (in millions):
As of June 30, 2022 | |||||||||||||||||
Fair Value | Valuation Technique(s) | Significant Unobservable Input(s) | Assumption or Input Range | Impact of Increase in Input on Fair Value | |||||||||||||
Assets | |||||||||||||||||
GMIB reinsurance recoverable | $ | 232 | Discounted cash flow | Mortality(1) | 0.01% - 23.42% | Decrease | |||||||||||
Lapse(2) | 3.30% - 9.00% | Decrease | |||||||||||||||
Utilization(3) | 0.00% - 20.00% | Increase | |||||||||||||||
Withdrawal(4) | 3.75% - 4.50% | Increase | |||||||||||||||
Nonperformance risk(5) | 0.00% - 2.32% | Decrease | |||||||||||||||
Long-term Equity Volatility(6) | 18.50% - 23.00% | Increase | |||||||||||||||
Liabilities | |||||||||||||||||
Embedded derivative liabilities | $ | 601 | Discounted cash flow | Mortality(1) | 0.04% - 21.45% | Decrease | |||||||||||
Lapse(2) | 0.20% - 30.90% | Decrease | |||||||||||||||
Utilization(3) | 5.00% - 100.00% | Increase | |||||||||||||||
Withdrawal(4) | 58.00% - 97.00% | Increase | |||||||||||||||
Nonperformance risk(5) | 0.00% - 2.32% | Decrease | |||||||||||||||
Long-term Equity Volatility(6) | 18.50% - 23.00% | Increase |
(1) Mortality rates vary by attained age, tax qualification status, GMWB benefit election, and duration. The range displayed reflects ages from the minimum issue age for the benefit through age 95, which corresponds to the typical maturity age. A mortality improvement assumption is also applied.
(2) Base lapse rates vary by contract-level factors, such as product type, surrender charge schedule and optional benefits election. Lapse rates are further adjusted based on the degree to which a guaranteed benefit is in-the-money, with lower lapse applying when benefits are more in-the-money. Lapse rates are also adjusted to reflect lower lapse expectations when GMWB benefits are utilized.
(3) The utilization rate represents the expected percentage of contracts that will utilize the benefit through annuitization (GMIB) or commencement of withdrawals (GMWB). Utilization may vary by benefit type, attained age, duration, tax qualification status, benefit provision, and degree to which the guaranteed benefit is in-the-money.
(4) The withdrawal rate represents the utilization rate of the contract’s free partial withdrawal provision (GMIB) or the percentage of annual withdrawal assumed relative to the maximum allowable withdrawal amount (GMWB). Withdrawal rates on contracts with a GMIB vary based on the product type and duration. Withdrawal rates on contracts with a GMWB vary based on attained age, tax qualification status, GMWB type and GMWB benefit provisions.
(5) Nonperformance risk spread varies by projection year.
(6) Long-term equity volatility represents the equity volatility beyond the period for which observable equity volatilities are available.
46
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
As of December 31, 2021 | |||||||||||||||||
Fair Value | Valuation Technique(s) | Significant Unobservable Input(s) | Assumption or Input Range | Impact of Increase in Input on Fair Value | |||||||||||||
Assets | |||||||||||||||||
GMIB reinsurance recoverable | $ | 262 | Discounted cash flow | Mortality(1) | 0.01% - 23.42% | Decrease | |||||||||||
Lapse(2) | 3.30% - 9.00% | Decrease | |||||||||||||||
Utilization(3) | 0.00% - 20.00% | Increase | |||||||||||||||
Withdrawal(4) | 3.75% - 4.50% | Increase | |||||||||||||||
Nonperformance risk(5) | 0.11% - 1.50% | Decrease | |||||||||||||||
Long-term Equity Volatility(6) | 18.50% - 22.06% | Increase | |||||||||||||||
Liabilities | |||||||||||||||||
Embedded derivative liabilities | $ | 2,626 | Discounted cash flow | Mortality(1) | 0.04% - 21.45% | Decrease | |||||||||||
Lapse(2) | 0.20% - 30.90% | Decrease | |||||||||||||||
Utilization(3) | 5.00% - 100.00% | Increase | |||||||||||||||
Withdrawal(4) | 58.00% - 97.00% | Increase | |||||||||||||||
Nonperformance risk(5) | 0.11% - 1.50% | Decrease | |||||||||||||||
Long-term Equity Volatility(6) | 18.50% - 22.06% | Increase |
(1) Mortality rates vary by attained age, tax qualification status, GMWB benefit election, and duration. The range displayed reflects ages from the minimum issue age for the benefit through age 95, which corresponds to the typical maturity age. A mortality improvement assumption is also applied.
(2) Base lapse rates vary by contract-level factors, such as product type, surrender charge schedule and optional benefits election. Lapse rates are further adjusted based on the degree to which a guaranteed benefit is in-the-money, with lower lapse applying when benefits are more in-the-money. Lapse rates are also adjusted to reflect lower lapse expectations when GMWB benefits are utilized.
(3) The utilization rate represents the expected percentage of contracts that will utilize the benefit through annuitization (GMIB) or commencement of withdrawals (GMWB). Utilization may vary by benefit type, attained age, duration, tax qualification status, benefit provision, and degree to which the guaranteed benefit is in-the-money.
(4) The withdrawal rate represents the utilization rate of the contract’s free partial withdrawal provision (GMIB) or the percentage of annual withdrawal assumed relative to the maximum allowable withdrawal amount (GMWB). Withdrawal rates on contracts with a GMIB vary based on the product type and duration. Withdrawal rates on contracts with a GMWB vary based on attained age, tax qualification status, GMWB type and GMWB benefit provisions.
(5) Nonperformance risk spread varies by projection year.
(6) Long-term equity volatility represents the equity volatility beyond the period for which observable equity volatilities are available.
47
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
Sensitivity to Changes in Unobservable Inputs
The following is a general description of sensitivities of significant unobservable inputs and their impact on the fair value measurement for the assets and liabilities reflected in the tables above.
At both June 30, 2022 and December 31, 2021, securities of $2 million are fair valued using techniques incorporating unobservable inputs and are classified in Level 3 of the fair value hierarchy. For these assets, their unobservable inputs and ranges of possible inputs do not materially affect their fair valuations and have been excluded from the quantitative information in the tables above.
Policy loans that support funds withheld reinsurance agreements that are held at fair value under the fair value option on the Company’s Condensed Consolidated Balance Sheets are excluded from the tables above. These policy loans do not have a stated maturity and the balances, plus accrued investment income, are repaid either by the policyholder or with proceeds from the policy. Due to the collateralized nature of policy loans and unpredictable timing of payments, the Company believes the carrying value of policy loans, which includes accrued investment income, approximates fair value and have been classified as Level 3 within the fair value hierarchy.
Funds withheld payable under reinsurance treaties, for funds withheld payable held at fair value under the fair value option and the Athene embedded derivative, are excluded from the tables above. The fair value of Funds withheld payable under reinsurance treaties, excluding the Athene embedded derivative, is determined based upon the fair value of the investments held by the Company related to the Company’s funds withheld payable under reinsurance treaties. The Athene embedded derivative utilizes a total return swap technique which incorporates the fair value of the invested assets supporting the reinsurance agreement as a component of the valuation. As a result, these valuations for the funds withheld payable under reinsurance treaties and the Athene embedded derivative require certain significant inputs which are generally not observable and, accordingly, the valuation is considered Level 3 in the fair value hierarchy.
The GMIB reinsurance recoverable fair value calculation is based on the present value of future cash flows comprised of future expected reinsurance benefit receipts, less future attributed premium payments to reinsurers, over the lives of the contracts. Estimating these cash flows requires actuarially determined assumptions related to expectations concerning policyholder behavior and long-term market volatility. The more significant policyholder behavior actuarial assumptions include benefit utilization, fund allocation, lapse, and mortality.
Embedded derivative liabilities classified in Level 3 represent the fair value of guaranteed minimum withdrawal benefits (“GMWB”) and guaranteed minimum accumulation benefits (“GMAB”) liabilities. These fair value calculations are based on the present value of future cash flows comprised of future expected benefit payments, less future attributed rider fees, over the lives of the contracts. Estimating these cash flows requires actuarially determined assumptions related to expectations concerning policyholder behavior and long-term market volatility. The more significant policyholder behavior actuarial assumptions include benefit utilization, fund allocation, lapse, and mortality.
48
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
The tables below provide rollforwards for the three and six months ended June 30, 2022 and 2021 of the financial instruments for which significant unobservable inputs (Level 3) are used in the fair value measurement. Gains and losses in the tables below include changes in fair value due partly to observable and unobservable factors. The Company utilizes derivative instruments to manage the risk associated with certain assets and liabilities. However, the derivative instruments hedging the related risks may not be classified within the same fair value hierarchy level as the associated assets and liabilities. Therefore, the impact of the derivative instruments reported in Level 3 may vary significantly from the total income effect of the hedged instruments.
Total Realized/Unrealized Gains (Losses) Included in | |||||||||||||||||||||||
Purchases, | |||||||||||||||||||||||
Fair Value | Sales, | Transfers | Fair Value | ||||||||||||||||||||
as of | Other | Issuances | in and/or | as of | |||||||||||||||||||
April 1, | Net | Comprehensive | and | (out of) | June 30, | ||||||||||||||||||
Three Months Ended June 30, 2022 | 2022 | Income | Income | Settlements | Level 3 | 2022 | |||||||||||||||||
Assets | |||||||||||||||||||||||
Debt securities | |||||||||||||||||||||||
Corporate securities | $ | 14 | $ | 5 | $ | — | $ | 1 | $ | 27 | $ | 47 | |||||||||||
Equity securities | 115 | 13 | — | (4) | — | 124 | |||||||||||||||||
Mortgage loans | 190 | (5) | — | 172 | — | 357 | |||||||||||||||||
Limited partnerships | 1 | — | — | — | — | 1 | |||||||||||||||||
GMIB reinsurance recoverable | 232 | — | — | — | — | 232 | |||||||||||||||||
Policy loans | 3,472 | 76 | — | (63) | — | 3,485 | |||||||||||||||||
Liabilities | |||||||||||||||||||||||
Embedded derivative liabilities | $ | (452) | $ | (149) | $ | — | $ | — | $ | — | $ | (601) | |||||||||||
Funds withheld payable under reinsurance treaties | (2,479) | 1,272 | — | 66 | — | (1,141) |
Total Realized/Unrealized Gains (Losses) Included in | |||||||||||||||||||||||
Purchases, | |||||||||||||||||||||||
Fair Value | Sales, | Transfers | Fair Value | ||||||||||||||||||||
as of | Other | Issuances | in and/or | as of | |||||||||||||||||||
April 1, | Net | Comprehensive | and | (out of) | June 30, | ||||||||||||||||||
Three Months Ended June 30, 2021 | 2021 | Income | Income | Settlements | Level 3 | 2021 | |||||||||||||||||
Assets | |||||||||||||||||||||||
Debt securities | |||||||||||||||||||||||
Corporate securities | $ | 19 | $ | 1 | $ | — | $ | 5 | $ | 7 | $ | 32 | |||||||||||
Equity securities | 102 | 9 | — | (8) | — | 103 | |||||||||||||||||
Limited partnerships | 1 | — | — | — | — | 1 | |||||||||||||||||
GMIB reinsurance recoverable | 266 | 1 | — | — | — | 267 | |||||||||||||||||
Policy loans | 3,486 | 70 | — | (18) | — | 3,538 | |||||||||||||||||
Liabilities | |||||||||||||||||||||||
Embedded derivative liabilities | $ | (869) | $ | (1,367) | $ | — | $ | — | $ | — | $ | (2,236) | |||||||||||
Funds withheld payable under reinsurance treaties | (3,486) | (585) | — | (11) | — | (4,082) |
49
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
Total Realized/Unrealized Gains (Losses) Included in | |||||||||||||||||||||||
Purchases, | |||||||||||||||||||||||
Fair Value | Sales, | Transfers | Fair Value | ||||||||||||||||||||
as of | Other | Issuances | in and/or | as of | |||||||||||||||||||
January 1, | Net | Comprehensive | and | (out of) | June 30, | ||||||||||||||||||
Six Months Ended June 30, 2022 | 2022 | Income | Income | Settlements | Level 3 | 2022 | |||||||||||||||||
Assets | |||||||||||||||||||||||
Debt securities | |||||||||||||||||||||||
Corporate securities | $ | 9 | $ | 5 | $ | — | $ | 3 | $ | 30 | $ | 47 | |||||||||||
Equity securities | 112 | 16 | — | (4) | — | 124 | |||||||||||||||||
Mortgage loans | — | (3) | — | 360 | — | 357 | |||||||||||||||||
Limited partnerships | 1 | — | — | — | — | 1 | |||||||||||||||||
GMIB reinsurance recoverable | 262 | (30) | — | — | — | 232 | |||||||||||||||||
Policy loans | 3,467 | 136 | — | (118) | — | 3,485 | |||||||||||||||||
Liabilities | |||||||||||||||||||||||
Embedded derivative liabilities | $ | (2,626) | $ | 2,025 | $ | — | $ | — | $ | — | $ | (601) | |||||||||||
Funds withheld payable under reinsurance treaties | (3,759) | 2,492 | — | 126 | — | (1,141) |
Total Realized/Unrealized Gains (Losses) Included in | |||||||||||||||||||||||
Purchases, | |||||||||||||||||||||||
Fair Value | Sales, | Transfers | Fair Value | ||||||||||||||||||||
as of | Other | Issuances | in and/or | as of | |||||||||||||||||||
January 1, | Net | Comprehensive | and | (out of) | June 30, | ||||||||||||||||||
Six Months Ended June 30, 2021 | 2021 | Income | Income | Settlements | Level 3 | 2021 | |||||||||||||||||
Assets | |||||||||||||||||||||||
Debt securities | |||||||||||||||||||||||
Corporate securities | $ | 29 | $ | 2 | $ | — | $ | 6 | $ | (5) | $ | 32 | |||||||||||
Equity securities | 104 | 7 | — | (8) | — | 103 | |||||||||||||||||
Limited partnerships | 1 | — | — | — | — | 1 | |||||||||||||||||
GMIB reinsurance recoverable | 340 | (73) | — | — | — | 267 | |||||||||||||||||
Policy loans | 3,454 | 125 | — | (41) | — | 3,538 | |||||||||||||||||
Liabilities | |||||||||||||||||||||||
Embedded derivative liabilities | $ | (5,592) | $ | 3,356 | $ | — | $ | — | $ | — | $ | (2,236) | |||||||||||
Funds withheld payable under reinsurance treaties | (4,453) | 329 | 2 | 40 | — | (4,082) |
50
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
The components of the amounts included in purchases, sales, issuances and settlements for the three and six months ended June 30, 2022 and 2021 shown above are as follows (in millions):
Three Months Ended June 30, 2022 | Purchases | Sales | Issuances | Settlements | Total | ||||||||||||||||||
Assets | |||||||||||||||||||||||
Debt securities | |||||||||||||||||||||||
Corporate securities | $ | 1 | $ | — | $ | — | $ | — | $ | 1 | |||||||||||||
Equity securities | — | (4) | — | — | (4) | ||||||||||||||||||
Mortgage loans | 172 | — | — | — | 172 | ||||||||||||||||||
Policy loans | — | — | 1 | (64) | (63) | ||||||||||||||||||
Total | $ | 173 | $ | (4) | $ | 1 | $ | (64) | $ | 106 | |||||||||||||
Liabilities | |||||||||||||||||||||||
Funds withheld payable under reinsurance treaties | $ | — | $ | — | $ | (1) | $ | 67 | $ | 66 | |||||||||||||
Three Months Ended June 30, 2021 | Purchases | Sales | Issuances | Settlements | Total | ||||||||||||||||||
Assets | |||||||||||||||||||||||
Debt securities | |||||||||||||||||||||||
Corporate securities | $ | 5 | $ | — | $ | — | $ | — | $ | 5 | |||||||||||||
Equity securities | — | (8) | — | — | (8) | ||||||||||||||||||
Policy loans | — | — | 8 | (26) | (18) | ||||||||||||||||||
Total | $ | 5 | $ | (8) | $ | 8 | $ | (26) | $ | (21) | |||||||||||||
Liabilities | |||||||||||||||||||||||
Funds withheld payable under reinsurance treaties | $ | — | $ | — | $ | (129) | $ | 118 | $ | (11) |
Six Months Ended June 30, 2022 | Purchases | Sales | Issuances | Settlements | Total | ||||||||||||||||||
Assets | |||||||||||||||||||||||
Debt securities | |||||||||||||||||||||||
Corporate securities | $ | 3 | $ | — | $ | — | $ | — | $ | 3 | |||||||||||||
Equity securities | — | (4) | — | — | (4) | ||||||||||||||||||
Mortgage loans | 360 | — | — | — | 360 | ||||||||||||||||||
Policy loans | — | — | 31 | (149) | (118) | ||||||||||||||||||
Total | $ | 363 | $ | (4) | $ | 31 | $ | (149) | $ | 241 | |||||||||||||
Liabilities | |||||||||||||||||||||||
Funds withheld payable under reinsurance treaties | $ | — | $ | — | $ | (32) | $ | 158 | $ | 126 | |||||||||||||
Six Months Ended June 30, 2021 | Purchases | Sales | Issuances | Settlements | Total | ||||||||||||||||||
Assets | |||||||||||||||||||||||
Debt securities | |||||||||||||||||||||||
Corporate securities | $ | 6 | $ | — | $ | — | $ | — | $ | 6 | |||||||||||||
Equity securities | — | (8) | — | — | (8) | ||||||||||||||||||
Policy loans | — | — | 36 | (77) | (41) | ||||||||||||||||||
Total | $ | 6 | $ | (8) | $ | 36 | $ | (77) | $ | (43) | |||||||||||||
Liabilities | |||||||||||||||||||||||
Funds withheld payable under reinsurance treaties | $ | — | $ | — | $ | (211) | $ | 251 | $ | 40 |
For the three and six months ended June 30, 2022 and 2021, there were no transfers from Level 3 to NAV. For the three and six months ended June 30, 2022, transfers from Level 3 to Level 2 of the fair value hierarchy were $1 million and $5 million, respectively, and transfers from Level 2 to Level 3 were $28 million and $35 million, respectively.
51
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
For the three and six months ended June 30, 2021, transfers from Level 3 to Level 2 of the fair value hierarchy were $13 million and $23 million, respectively, and transfers from Level 2 to Level 3 were $21 million and $18 million, respectively.
The portion of gains (losses) included in net income (loss) or other comprehensive income (loss) ("OCI") attributable to the change in unrealized gains and losses on Level 3 financial instruments still held was as follows (in millions):
Three Months Ended June 30, | ||||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||
Included in Net Income | Included in OCI | Included in Net Income | Included in OCI | |||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Debt securities | ||||||||||||||||||||||||||
Corporate securities | $ | 5 | $ | — | $ | 1 | $ | — | ||||||||||||||||||
Equity securities | 13 | — | 9 | — | ||||||||||||||||||||||
Mortgage loans | (5) | — | — | — | ||||||||||||||||||||||
GMIB reinsurance recoverable | — | — | 1 | — | ||||||||||||||||||||||
Policy loans | 76 | — | 70 | — | ||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||
Embedded derivative liabilities | $ | (149) | $ | — | $ | (1,367) | $ | — | ||||||||||||||||||
Funds withheld payable under reinsurance treaties | 1,272 | — | (543) | — |
Six Months Ended June 30, | ||||||||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||||||||
Included in Net Income | Included in OCI | Included in Net Income | Included in OCI | |||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||
Debt securities | ||||||||||||||||||||||||||
Corporate securities | $ | 5 | $ | — | $ | 2 | $ | — | ||||||||||||||||||
Equity securities | 16 | — | 7 | — | ||||||||||||||||||||||
Mortgage loans | (3) | — | — | — | ||||||||||||||||||||||
GMIB reinsurance recoverable | (30) | — | (73) | — | ||||||||||||||||||||||
Policy loans | 136 | — | 125 | — | ||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||
Embedded derivative liabilities | $ | 2,025 | $ | — | $ | 3,356 | $ | — | ||||||||||||||||||
Funds withheld payable under reinsurance treaties | 2,492 | — | 456 | — |
52
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
Fair Value of Financial Instruments Carried at Other Than Fair Value
Mortgage Loans
Fair values are generally determined by discounting expected future cash flows at current market interest rates, inclusive of a credit spread, for similar quality loans. For loans whose value is dependent upon the underlying property, fair value is determined to be the estimated value of the collateral. Certain characteristics considered significant in determining the spread or collateral value may be based on internally developed estimates. As a result, these investments have been classified as Level 3 within the fair value hierarchy.
Mortgage loans held under the funds withheld reinsurance agreement are valued using third-party pricing services, which may use economic inputs, geographical information, and property specific assumptions in deriving the fair value price. The Company reviews the valuations from these pricing providers to ensure they are reasonable. Due to lack of observable inputs, these investments have been classified as Level 3 within the fair value hierarchy.
Policy Loans
Policy loans are funds provided to policyholders in return for a claim on the policies values and function like demand deposits which are redeemable upon repayment, death or surrender, and there is only one market price at which the transaction could be settled – the then current carrying value. The funds provided are limited to the cash surrender value of the underlying policy. The nature of policy loans is to have a negligible default risk as the loans are fully collateralized by the value of the policy. Policy loans do not have a stated maturity and the balances and accrued interest are repaid either by the policyholder or with proceeds from the policy. Due to the collateralized nature of policy loans and unpredictable timing of payments, the Company believes the carrying value of policy loans approximates fair value. The non-reinsurance related component of policy loans has been classified as Level 3 within the fair value hierarchy.
FHLBI Capital Stock
FHLBI capital stock, which is included in other invested assets, can only be sold to FHLBI at a constant price of $100 per share. Due to the lack of valuation uncertainty, the investment has been classified as Level 1.
Other Contract Holder Funds
Fair values for immediate annuities without mortality features are derived by discounting the future estimated cash flows using current market interest rates for similar maturities. Fair values for deferred annuities, including the fixed option on variable annuities, fixed annuities, fixed index annuities and RILAs, are determined using projected future cash flows discounted at current market interest rates.
Fair values for guaranteed investment contracts are based on the present value of future cash flows discounted at current market interest rates.
Fair values for trust instruments supported by funding agreements are based on the present value of future cash flows discounted at current market interest rates.
Fair values of the FHLB funding agreements are based on the present value of future cash flows discounted at current market interest rates.
Funds Withheld Payable Under Reinsurance Treaties
The fair value of the funds withheld payable is equal to the fair value of the assets held as collateral, which primarily consists of bonds, mortgages, limited partnerships, and cash and cash equivalents. The fair value of the assets generally use industry standard valuation techniques as described above and the funds withheld payable components are valued consistent with the assets in the fair value hierarchy.
53
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
Debt
Fair values for the Company’s surplus notes and long-term debt are generally determined by prices obtained from independent broker dealers or discounted cash flow models. Such prices are derived from market observable inputs and are classified as Level 2.
Securities Lending Payable
The Company’s securities lending payable is set equal to the cash collateral received. Due to the short-term nature of the loans, carrying value is a reasonable estimate of fair value and is classified as Level 2.
FHLB Advances
Carrying value of the Company’s FHLB advances, which are included in other liabilities, is considered a reasonable estimate of fair value due to their short-term maturities and are classified as Level 2.
Repurchase Agreements
Carrying value of the Company’s repurchase agreements is considered a reasonable estimate of fair value due to their short-term maturities and are classified as Level 2.
Separate Account Liabilities
The values of separate account liabilities are set equal to the values of separate account assets, which are comprised of investments in mutual funds that transact regularly, but do not trade in active markets as they are not publicly available, and, are categorized as Level 2.
54
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 6. Fair Value Measurements
The table below presents the carrying amount and fair value by fair value hierarchy level of certain financial instruments that are not reported at fair value (in millions).
June 30, 2022 | ||||||||||||||||||||
Fair Value | ||||||||||||||||||||
Carrying Value | Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||
Assets | ||||||||||||||||||||
Mortgage loans | $ | 11,574 | $ | 11,229 | $ | — | $ | — | $ | 11,229 | ||||||||||
Policy loans | 974 | 974 | — | — | 974 | |||||||||||||||
FHLBI capital stock | 146 | 146 | 146 | — | — | |||||||||||||||
Liabilities | ||||||||||||||||||||
Annuity reserves (1) | $ | 37,095 | $ | 34,152 | $ | — | $ | — | $ | 34,152 | ||||||||||
Reserves for guaranteed investment contracts (2) | 1,181 | 1,156 | — | — | 1,156 | |||||||||||||||
Trust instruments supported by funding agreements (2) | 5,301 | 5,174 | — | — | 5,174 | |||||||||||||||
FHLB funding agreements (2) | 2,001 | 2,090 | — | — | 2,090 | |||||||||||||||
Funds withheld payable under reinsurance treaties (3)(4) | 23,496 | 23,496 | 422 | 17,927 | 5,147 | |||||||||||||||
Debt | 2,634 | 2,422 | — | 2,422 | — | |||||||||||||||
Securities lending payable | 32 | 32 | — | 32 | — | |||||||||||||||
Repurchase agreements | — | — | — | — | — | |||||||||||||||
Separate Account Liabilities (5) | 196,184 | 196,184 | — | 196,184 | — | |||||||||||||||
December 31, 2021 | ||||||||||||||||||||
Fair Value | ||||||||||||||||||||
Carrying Value | Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||
Assets | ||||||||||||||||||||
Mortgage loans | $ | 11,482 | $ | 11,910 | $ | — | $ | — | $ | 11,910 | ||||||||||
Policy loans | 1,008 | 1,008 | — | — | 1,008 | |||||||||||||||
FHLBI capital stock | 125 | 125 | 125 | — | — | |||||||||||||||
Liabilities | ||||||||||||||||||||
Annuity reserves (1) | $ | 36,318 | $ | 46,045 | $ | — | $ | — | $ | 46,045 | ||||||||||
Reserves for guaranteed investment contracts (2) | 894 | 923 | — | — | 923 | |||||||||||||||
Trust instruments supported by funding agreements (2) | 5,986 | 6,175 | — | — | 6,175 | |||||||||||||||
FHLB funding agreements (2) | 1,950 | 1,938 | — | — | 1,938 | |||||||||||||||
Funds withheld payable under reinsurance treaties (3) | 24,533 | 24,533 | 537 | 19,127 | 4,869 | |||||||||||||||
Debt | 2,649 | 2,745 | — | 2,745 | — | |||||||||||||||
Securities lending payable | 17 | 17 | — | 17 | — | |||||||||||||||
Repurchase agreements | 1,572 | 1,572 | — | 1,572 | — | |||||||||||||||
Separate Account Liabilities (5) | 248,949 | 248,949 | — | 248,949 | — | |||||||||||||||
(1) Annuity reserves represent only the components of other contract holder funds that are considered to be financial instruments. | ||||||||||||||||||||
(2) Included as a component of other contract holder funds on the Condensed Consolidated Balance Sheets. | ||||||||||||||||||||
(3) Excludes $753 million and $715 million of limited partnership investments measured at NAV at June 30, 2022 and December 31, 2021, respectively. | ||||||||||||||||||||
(4) Excludes $117 million of non-financial instruments at June 30, 2022. | ||||||||||||||||||||
(5) The values of separate account liabilities are set equal to the values of separate account assets. |
55
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 7. Deferred Acquisition Costs
7. Deferred Acquisition Costs
The balances of, and changes, in deferred acquisition costs were as follows (in millions):
.
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Balance, beginning of period | $ | 14,249 | $ | 13,897 | |||||||
Deferrals of acquisition costs | 349 | 400 | |||||||||
Amortization | (1,713) | (548) | |||||||||
Unrealized investment (gains) losses | 230 | 64 | |||||||||
Balance, end of period | $ | 13,115 | $ | 13,813 |
See Note 7 of Notes to Consolidated Financial Statements in Part II, Item 8, Financial Statements and Supplementary Data of the Company’s 2021 Annual Report, for more information regarding deferred acquisition costs.
8. Reinsurance
The Company assumes and cedes reinsurance from and to other insurance companies in order to limit losses from large exposures. However, if the reinsurer is unable to meet its obligations, the originating issuer of the coverage retains the liability. The Company reinsures certain of its risks to other reinsurers under a coinsurance, modified coinsurance, or yearly renewable term basis. The Company regularly monitors the financial strength ratings of its reinsurers.
The Company has also acquired certain lines of business that are wholly ceded to non-affiliates. These include both direct and assumed accident and health business, direct and assumed life insurance business, and certain institutional annuities.
Athene Reinsurance
The Company entered into a funds withheld coinsurance agreement with Athene effective June 1, 2020 to reinsure on 100% quota share basis, a block of Jackson’s in-force fixed and fixed-index annuity product liabilities in exchange for a $1.2 billion ceding commission. The coinsurance with funds withheld agreement required Jackson to establish a segregated account in which the investments supporting the ceded obligations are maintained. While the economic benefits of the investments flow to Athene, Jackson retains physical possession and legal ownership of the investments supporting the reserve. Further, the investments in the segregated account are not available to settle any policyholder obligations other than those specifically covered by the coinsurance agreement and are not available to settle obligations to general creditors of Jackson. The profit and loss with respect to obligations ceded to Athene are included in periodic net settlements pursuant to the coinsurance agreement. To further support its obligations under the coinsurance agreement, Athene procured $1.2 billion in letters of credit for Jackson’s benefit and established a trust account for Jackson’s benefit, which had a book value of approximately $303 million at June 30, 2022.
Swiss Re Reinsurance
The Company has three retrocession reinsurance agreements (“retro treaties”) with Swiss Reinsurance Company Ltd. (“SRZ”). Pursuant to these retro treaties, the Company ceded certain blocks of business to SRZ on a 100% coinsurance basis, subject to pre-existing reinsurance with other parties.
56
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 8. Reinsurance
The following assets and liabilities were held in support of reserves associated with the Company’s funds withheld reinsurance agreements and were reported in the respective financial statement line items in the Condensed Consolidated Balance Sheets (in millions):
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
Assets | |||||||||||
Debt securities, available-for-sale | $ | 15,451 | $ | 19,094 | |||||||
Debt securities, at fair value under the fair value option | 157 | 164 | |||||||||
Equity securities | 88 | 116 | |||||||||
Mortgage loans | 4,639 | 4,739 | |||||||||
Mortgage loans, at fair value under the fair value option | 357 | — | |||||||||
Policy loans | 3,500 | 3,483 | |||||||||
Freestanding derivative instruments, net | 94 | 37 | |||||||||
Other invested assets | 889 | 715 | |||||||||
Cash and cash equivalents | 324 | 438 | |||||||||
Accrued investment income | 165 | 162 | |||||||||
Other assets and liabilities, net | (46) | (56) | |||||||||
Total assets (1) | $ | 25,618 | $ | 28,892 | |||||||
Liabilities | |||||||||||
Funds held under reinsurance treaties (2) | $ | 25,506 | $ | 29,007 | |||||||
Total liabilities | $ | 25,506 | $ | 29,007 |
(1) Certain assets are reported at amortized cost while the fair value of those assets is reported in the embedded derivative in the funds withheld liability.
(2) Includes funds withheld embedded derivative asset (liability) of $2,508 million and $(120) million at June 30, 2022 and December 31, 2021, respectively.
The sources of income related to funds withheld under reinsurance treaties reported in net investment income in the Condensed Consolidated Income Statements were as follows (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Debt securities (1) | $ | 180 | $ | 194 | $ | 330 | $ | 398 | |||||||||||||||
Equity securities | (9) | 4 | (25) | 2 | |||||||||||||||||||
Mortgage loans (2) | 49 | 43 | 101 | 78 | |||||||||||||||||||
Policy loans | 79 | 81 | 159 | 162 | |||||||||||||||||||
Limited partnerships | 86 | (2) | 102 | 1 | |||||||||||||||||||
Other investment income | 1 | — | 1 | — | |||||||||||||||||||
Total investment income on funds withheld assets | 386 | 320 | 668 | 641 | |||||||||||||||||||
Other investment expenses on funds withheld assets (3) | (22) | (26) | (44) | (56) | |||||||||||||||||||
Total net investment income on funds withheld reinsurance treaties | $ | 364 | $ | 294 | $ | 624 | $ | 585 |
(1) Includes $(2) million and $(8) million for the three and six months ended June 30, 2022, respectively, and nil and $(1) million for the three and six months ended June 30, 2021, respectively, related to the change in fair value for securities carried under the fair value option.
(2) Includes $(5) million and $(3) million for the three and six months ended June 30, 2022, respectively, and nil both for the three and six months ended June 30, 2021, respectively, related to the change in fair value for mortgage loans carried under the fair value option.
(3) Includes management fees.
57
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 8. Reinsurance
The gains and losses on funds withheld reinsurance treaties as a component of net gains (losses) on derivatives and investments in the Condensed Consolidated Income Statements were as follows (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Available-for-sale securities | |||||||||||||||||||||||
Realized gains on sale | $ | 3 | $ | 85 | $ | 40 | $ | 258 | |||||||||||||||
Realized losses on sale | (4) | (11) | (31) | (13) | |||||||||||||||||||
Credit loss expense | (12) | (1) | (40) | (1) | |||||||||||||||||||
Credit loss expense on mortgage loans | 13 | (12) | 11 | (5) | |||||||||||||||||||
Other | (43) | (2) | (59) | (11) | |||||||||||||||||||
Net gains (losses) on non-derivative investments | (43) | 59 | (79) | 228 | |||||||||||||||||||
Net gains (losses) on derivative instruments | 63 | 2 | 84 | 19 | |||||||||||||||||||
Net gains (losses) on funds withheld payable under reinsurance treaties (1) | 1,057 | (829) | 2,100 | (117) | |||||||||||||||||||
Total net gains (losses) on derivatives and investments | $ | 1,077 | $ | (768) | $ | 2,105 | $ | 130 | |||||||||||||||
(1) Includes the Athene embedded derivative gain (loss) of $1,347 million and $2,628 million for the three and six months ended June 30, 2022, respectively, and $(544) million and $454 million for the three and six months ended June 30, 2021, respectively. |
While the economic benefits of the funds withheld assets flow to the respective reinsurers, Jackson retains physical possession and legal ownership of the investments supporting the reserves. Net investment income and net gains (losses) on derivatives and investments related to the funds withheld assets are included in periodic settlements under the reinsurance agreements which results in the flow of returns on the assets to the reinsurers. Net gains (losses) on the funds withheld assets are increased or decreased by changes in the embedded derivative liability related to the Athene Reinsurance Agreement and also include (i) changes in the related funds withheld payable and (ii) amortization of the basis difference between book value and fair value of the investments as of the effective date of the reinsurance agreements.
Components of the Company’s reinsurance recoverable were as follows (in millions):
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
Reserves: | |||||||||||
Life | $ | 5,728 | $ | 5,829 | |||||||
Accident and health | 538 | 547 | |||||||||
Guaranteed minimum income benefits | 232 | 262 | |||||||||
Other annuity benefits (1) | 24,347 | 25,625 | |||||||||
Claims liability and other | 822 | 863 | |||||||||
Total | $ | 31,667 | $ | 33,126 |
(1) Other annuity benefits primarily attributable to fixed and fixed index annuities reinsured with Athene.
9. Reserves for Future Policy Benefits and Claims Payable and Other Contract Holder Funds
For traditional life insurance contracts, which include term and whole life, reserves for future policy benefits are determined using the net level premium method and assumptions as of the issue date or acquisition date as to mortality, interest, lapse and expenses, plus provisions for adverse deviations. These assumptions are not unlocked unless the reserve is determined to be deficient. Interest rate assumptions range from 2.5% to 6.0%. Lapse, mortality, and expense assumptions for recoverability are based primarily on Company experience. The Company’s liability for future policy benefits also includes net liabilities for guaranteed benefits related to certain nontraditional long-duration life and annuity contracts, which are further discussed in Note 10.
Group payout annuities consist of a closed block of defined benefit annuity plans. The liability for future benefits for these limited payment contracts is calculated using assumptions as of the acquisition date as to mortality and expense plus provisions for adverse deviation.
58
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 9. Reserves for Future Policy Benefits and Claims Payable and Other Contract Holder Funds
In conjunction with a prior acquisition, the Company recorded a fair value adjustment at acquisition related to certain annuity and interest sensitive liability blocks of business to reflect the cost of the interest guarantees within the in-force liabilities, based on the difference between the guaranteed interest rate and an assumed new money guaranteed interest rate at acquisition. This adjustment was recorded in reserves for future policy benefits and claims payable. This reserve is reassessed at the end of each period, taking into account changes in the in-force block. Any resulting change in the reserve is recorded as a change in policy reserve through the consolidated income statements.
The following table sets forth the Company’s reserves for future policy benefits and claims payable balances (in millions):
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
Traditional life | $ | 4,076 | $ | 4,187 | |||||||
Guaranteed benefits (1) | 4,231 | 5,477 | |||||||||
Claims payable | 1,041 | 1,050 | |||||||||
Accident and health | 1,177 | 1,204 | |||||||||
Group payout annuities | 4,734 | 4,895 | |||||||||
Other | 794 | 816 | |||||||||
Total | $ | 16,053 | $ | 17,629 |
(1) Primarily includes the embedded derivative liabilities related to the GMWB reserve.
The following table sets forth the Company’s liabilities for other contract holder funds balances (in millions):
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
Interest-sensitive life | $ | 11,363 | $ | 11,570 | |||||||
Variable annuity fixed option | 11,060 | 10,030 | |||||||||
RILA (1) | 735 | 110 | |||||||||
Fixed annuity | 15,320 | 15,816 | |||||||||
Fixed index annuity (2) | 12,615 | 13,333 | |||||||||
GICs, funding agreements and FHLB advances | 8,483 | 8,830 | |||||||||
Total | $ | 59,576 | $ | 59,689 |
(1) Includes the embedded derivative liabilities related to RILA of $4 million and $6 million at June 30, 2022 and December 31, 2021, respectively.
(2) Includes the embedded derivative liabilities related to fixed index annuity of $1,087 million and $1,439 million at June 30, 2022 and December 31, 2021, respectively.
For interest-sensitive life contracts, liabilities approximate the policyholder’s account value, plus the remaining balance of the fair value adjustment related to previously acquired business, which is further discussed below. The liability for fixed index annuities and registered index linked annuities is based on three components: 1) the imputed value of the underlying guaranteed host contract, 2) the fair value of the embedded option component of the contract, and 3) the liability for guaranteed benefits related to the optional lifetime income rider. For fixed annuities, variable annuity fixed option, and other investment contracts, as included in the above table, the liability is the account value, plus the unamortized balance of the fair value adjustment related to previously acquired business. For payout annuities, as included in the above table, reserves are determined under the methodology for limited-payment contracts (for those with significant life contingencies) or using a constant yield method and assumptions as of the issue date for mortality, interest rates, lapse and expenses plus provisions for adverse deviations. At June 30, 2022, the Company had interest sensitive life business with minimum guaranteed interest rates ranging from 2.5% to 6.0% with a 4.68% average guaranteed rate and fixed interest rate annuities with minimum guaranteed rates ranging from 1.0% to 5.5% and a 1.95% average guaranteed rate.
59
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 9. Reserves for Future Policy Benefits and Claims Payable and Other Contract Holder Funds
At June 30, 2022 and December 31, 2021, approximately 92% and 94%, respectively, of the Company’s annuity account values correspond to crediting rates that are at the minimum guaranteed interest rates. The following tables show the distribution of the annuity account values within the presented ranges of minimum guaranteed interest rates, excluding the reinsured business (in millions):
June 30,2022 | ||||||||||||||||||||||||||||||||
Minimum Guaranteed Interest Rate | Account Value | |||||||||||||||||||||||||||||||
Fixed | Fixed Index | RILA | Variable | Total | ||||||||||||||||||||||||||||
1.0% | $ | 178 | $ | 309 | $ | 10 | $ | 6,911 | $ | 7,408 | ||||||||||||||||||||||
>1.0% - 2.0% | 53 | 1 | — | 211 | 265 | |||||||||||||||||||||||||||
>2.0% - 3.0% | 1,091 | 169 | — | 3,347 | 4,607 | |||||||||||||||||||||||||||
>3.0% - 4.0% | 581 | — | — | — | 581 | |||||||||||||||||||||||||||
>4.0% - 5.0% | 273 | — | — | — | 273 | |||||||||||||||||||||||||||
>5.0% - 5.5% | 72 | — | — | — | 72 | |||||||||||||||||||||||||||
Subtotal | 2,248 | 479 | 10 | 10,469 | 13,206 | |||||||||||||||||||||||||||
Ceded reinsurance | 11,626 | 12,136 | — | — | 23,762 | |||||||||||||||||||||||||||
Total | $ | 13,874 | $ | 12,615 | $ | 10 | $ | 10,469 | $ | 36,968 | ||||||||||||||||||||||
December 31, 2021 | ||||||||||||||||||||||||||||||||
Minimum Guaranteed Interest Rate | Account Value | |||||||||||||||||||||||||||||||
Fixed | Fixed Index | RILA | Variable | Total | ||||||||||||||||||||||||||||
1.0% | $ | 156 | $ | 279 | $ | 1 | $ | 5,988 | $ | 6,424 | ||||||||||||||||||||||
>1.0% - 2.0% | 57 | 1 | — | 214 | 272 | |||||||||||||||||||||||||||
>2.0% - 3.0% | 1,113 | 183 | — | 3,254 | 4,550 | |||||||||||||||||||||||||||
>3.0% - 4.0% | 594 | — | — | — | 594 | |||||||||||||||||||||||||||
>4.0% - 5.0% | 276 | — | — | — | 276 | |||||||||||||||||||||||||||
>5.0% - 5.5% | 72 | — | — | — | 72 | |||||||||||||||||||||||||||
Subtotal | 2,268 | 463 | 1 | 9,456 | 12,188 | |||||||||||||||||||||||||||
Ceded reinsurance | 12,086 | 12,870 | — | — | 24,956 | |||||||||||||||||||||||||||
Total | $ | 14,354 | $ | 13,333 | $ | 1 | $ | 9,456 | $ | 37,144 |
At both June 30, 2022 and December 31, 2021, approximately 80% of the Company’s interest sensitive life business account values correspond to crediting rates that are at the minimum guaranteed interest rates. The following table shows the distribution of the interest sensitive life business account values within the presented ranges of minimum guaranteed interest rates, excluding the business that is subject to the previously mentioned retro treaties (in millions):
June 30, | December 31, | |||||||||||||
Minimum Guaranteed Interest Rate | 2022 | 2021 | ||||||||||||
Account Value - Interest Sensitive Life | ||||||||||||||
>2.0% - 3.0% | $ | 247 | $ | 252 | ||||||||||
>3.0% - 4.0% | 2,686 | 2,742 | ||||||||||||
>4.0% - 5.0% | 2,338 | 2,387 | ||||||||||||
>5.0% - 6.0% | 1,923 | 1,967 | ||||||||||||
Subtotal | 7,194 | 7,348 | ||||||||||||
Retro treaties | 4,169 | 4,222 | ||||||||||||
Total | $ | 11,363 | $ | 11,570 |
The Company has established a $27 billion aggregate Global Medium Term Note ("MTN") program. Jackson National Life Global Funding was formed as a statutory business trust, solely for the purpose of issuing Medium Term Note instruments to institutional investors, the proceeds of which are deposited with the Company and secured by the issuance of funding agreements. The carrying values at June 30, 2022 and December 31, 2021 totaled $5.3 billion and $6.0 billion, respectively.
60
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 9. Reserves for Future Policy Benefits and Claims Payable and Other Contract Holder Funds
Those Medium-Term Note instruments issued in a foreign currency have been hedged for changes in exchange rates using cross-currency swaps. The unrealized foreign currency gains and losses on those Medium-Term Note instruments are included in the carrying value of the trust instruments supported by funding agreements.
Trust instrument liabilities are adjusted to reflect the effects of foreign currency translation gains and losses using exchange rates as of the reporting date. Foreign currency translation gains and losses are included in net gains (losses) on derivatives and investments.
Jackson is a member of the FHLBI primarily for the purpose of participating in the bank’s mortgage-collateralized loan advance program with long-term funding facilities. Advances are in the form of long-term notes or funding agreements issued to FHLBI. At June 30, 2022 and December 31, 2021, the Company held $146 million and $125 million of FHLBI capital stock, respectively, supporting $2.1 billion and $2.0 billion in funding agreements and long-term borrowings at June 30, 2022 and December 31, 2021, respectively.
The Company’s institutional products business is comprised of the traditional guaranteed investment contracts, medium-term funding agreement-backed notes and funding agreements (including agreements issued in conjunction with the Company’s participation in the U.S. Federal Home Loan Bank ("FHLB") program) described above.
10. Certain Nontraditional Long-Duration Contracts and Variable Annuity Guarantees
The Company issues variable contracts through its separate accounts for which investment income and investment gains and losses accrue directly to, and investment risk is borne by, the contract holder (“traditional variable annuities”). The Company also issues variable annuity and life contracts through separate accounts where the Company contractually guarantees to the contract holder (“variable contracts with guarantees”) either a) return of no less than total deposits made to the account adjusted for any partial withdrawals, b) total deposits made to the account adjusted for any partial withdrawals plus a minimum return, or c) the highest account value on a specified anniversary date adjusted for any withdrawals following the contract anniversary. These guarantees include benefits that are payable in the event of death (guaranteed minimum death benefits, or "GMDB"), at annuitization (GMIB), upon the depletion of funds (GMWB) or at the end of a specified period (GMAB).
The assets supporting the variable portion of both traditional variable annuities and variable contracts with guarantees are carried at fair value and reported as summary total separate account assets with an equivalent summary total reported for separate account liabilities. Liabilities for guaranteed benefits are general account obligations and are reported in reserves for future policy benefits and claims payable. Amounts assessed against the contract holders for mortality, administrative, and other services are reported in revenue as fee income. Changes in liabilities for minimum guarantees are reported within death, other policy benefits and change in policy reserves within the Condensed Consolidated Income Statements with the exception of changes in embedded derivatives, which are included in net gains (losses) on derivatives and investments. Separate account net investment income, net investment realized and unrealized gains and losses, and the related liability changes are offset within the same line item in the Condensed Consolidated Income Statements.
61
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 10. Certain Nontraditional Long-Duration Contracts and Variable Annuity Guarantees
At June 30, 2022 and December 31, 2021, the Company provided variable annuity contracts with guarantees, for which the net amount at risk is defined as the amount of guaranteed benefit in excess of current account value, as follows (dollars in millions):
Minimum Return | Account Value | Net Amount at Risk | Weighted Average Attained Age | Average Period until Expected Annuitization | ||||||||||||||||||||||||||||
June 30, 2022 | ||||||||||||||||||||||||||||||||
Return of net deposits plus a minimum return | ||||||||||||||||||||||||||||||||
GMDB | 0-6% | $ | 152,355 | $ | 8,287 | 69 years | ||||||||||||||||||||||||||
GMWB - Premium only | 0% | 2,224 | 63 | |||||||||||||||||||||||||||||
GMWB | 0-5%* | 179 | 15 | |||||||||||||||||||||||||||||
Highest specified anniversary account value minus withdrawals post-anniversary | ||||||||||||||||||||||||||||||||
GMDB | 11,351 | 2,567 | 70.2 years | |||||||||||||||||||||||||||||
GMWB - Highest anniversary only | 2,985 | 591 | ||||||||||||||||||||||||||||||
GMWB | 877 | 137 | ||||||||||||||||||||||||||||||
Combination net deposits plus minimum return, highest specified anniversary account value minus withdrawals post-anniversary | ||||||||||||||||||||||||||||||||
GMDB | 0-6% | 7,727 | 2,332 | 72.1 years | ||||||||||||||||||||||||||||
GMIB | 0-6% | 1,256 | 751 | 0.6 years | ||||||||||||||||||||||||||||
GMWB | 0-8%* | 142,263 | 38,815 | |||||||||||||||||||||||||||||
Weighted Average Attained Age | Average Period until Expected Annuitization | |||||||||||||||||||||||||||||||
Minimum Return | Account Value | Net Amount at Risk | ||||||||||||||||||||||||||||||
December 31, 2021 | ||||||||||||||||||||||||||||||||
Return of net deposits plus a minimum return | ||||||||||||||||||||||||||||||||
GMDB | 0-6% | $ | 194,060 | $ | 2,124 | 68.7 years | ||||||||||||||||||||||||||
GMWB - Premium only | 0% | 2,937 | 7 | |||||||||||||||||||||||||||||
GMWB | 0-5%* | 245 | 8 | |||||||||||||||||||||||||||||
Highest specified anniversary account value minus withdrawals post-anniversary | ||||||||||||||||||||||||||||||||
GMDB | 14,806 | 93 | 69.8 years | |||||||||||||||||||||||||||||
GMWB - Highest anniversary only | 3,919 | 33 | ||||||||||||||||||||||||||||||
GMWB | 643 | 44 | ||||||||||||||||||||||||||||||
Combination net deposits plus minimum return, highest specified anniversary account value minus withdrawals post-anniversary | ||||||||||||||||||||||||||||||||
GMDB | 0-6% | 9,896 | 522 | 71.9 years | ||||||||||||||||||||||||||||
GMIB | 0-6% | 1,662 | 463 | 0.5 years | ||||||||||||||||||||||||||||
GMWB | 0-8%* | 181,457 | 4,295 |
* Ranges shown based on simple interest. The upper limits of 5% or 8% simple interest are approximately equal to 4.1% and 6.0%, respectively, on a compound interest basis over a typical 10-year bonus period. The combination GMWB category also includes benefits with a defined increase in the withdrawal percentage under pre-defined non-market conditions.
62
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 10. Certain Nontraditional Long-Duration Contracts and Variable Annuity Guarantees
Amounts shown as GMWB above include a ‘not-for-life’ component up to the point at which the guaranteed withdrawal benefit is exhausted, after which benefits paid are considered to be ‘for-life’ benefits. The liability related to this ‘not-for-life’ portion is valued as an embedded derivative, while the ‘for-life’ benefits are valued as an insurance liability (see below). For this table, the net amount at risk of the ‘not-for-life’ component is the undiscounted excess of the guaranteed withdrawal benefit over the account value, and that of the ‘for-life’ component is the estimated value of additional life contingent benefits paid after the guaranteed withdrawal benefit is exhausted.
Account balances of contracts with guarantees were invested in variable separate accounts as follows (in millions):
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
Fund type: | |||||||||||
Equity | $ | 117,636 | $ | 154,368 | |||||||
Bond | 16,834 | 20,207 | |||||||||
Balanced | 35,325 | 43,185 | |||||||||
Money market | 2,256 | 1,564 | |||||||||
Total | $ | 172,051 | $ | 219,324 | |||||||
GMDB liabilities reflected in the general account were as follows (in millions):
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
Balance as of beginning of period | $ | 1,370 | $ | 1,418 | |||||||
Incurred guaranteed benefits | 812 | 47 | |||||||||
Paid guaranteed benefits | (86) | (57) | |||||||||
Balance as of end of period | $ | 2,096 | $ | 1,408 |
The GMDB liability is determined by estimating the expected value of death benefits in excess of the projected account balance and recognizing the excess ratably over the accumulation period based on total expected assessments. The Company regularly evaluates estimates used and adjusts the liability balance through the Condensed Consolidated Income Statements, within death, other policy benefits and change in policy reserves, if actual experience or other evidence suggests that earlier assumptions should be revised.
The following assumptions and methodology were used to determine the GMDB liability at both June 30, 2022 and December 31, 2021 (except where otherwise noted):
•Use of a series of stochastic investment performance scenarios, based on historical average market volatility.
•Mean investment performance assumption of 7.15%, after investment management fees, but before external investment advisory fees and mortality and expense charges.
•Mortality equal to 38% to 100% of the 2012 Individual Annuity Mortality basic table improved using Scale G2 through 2020.
•Lapse rates varying by contract type, duration and degree the benefit is in-the-money and ranging from 0.3% to 27.9% (before application of dynamic adjustments).
•Discount rates: 7.15% on 2020 and later issues, 7.4% on 2013 through 2019 issues, 8.4% on 2012 and prior issues.
Most GMWB reserves are considered to be derivatives under current accounting guidance and are recognized at fair value, as previously defined, with the change in fair value reported in net income (as net gains (losses) on derivatives and investments). The fair value of these liabilities is determined using stochastic modeling and inputs as further described in Note 6. The fair valued GMWB had a reserve liability of $601 million and $2,626 million at June 30, 2022 and December 31, 2021, respectively, and was reported in reserves for future policy benefits and claims payable.
63
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 10. Certain Nontraditional Long-Duration Contracts and Variable Annuity Guarantees
The Company has also issued certain GMWB products that guarantee payments over a lifetime. Reserves for the portion of these benefits after the point where the guaranteed withdrawal balance is exhausted are calculated using assumptions and methodology similar to the GMDB liability. At June 30, 2022 and December 31, 2021, these GMWB reserves totaled $306 million and $196 million, respectively, and were reported in reserves for future policy benefits and claims payable.
GMAB benefits were offered on some variable annuity products. However, the Company no longer offers these benefits and all have expired as of June 30, 2021.
The direct GMIB liability is determined at each period end by estimating the expected value of the annuitization benefits in excess of the projected account balance at the date of annuitization and recognizing the excess ratably over the accumulation period based on total expected assessments. The assumptions used for calculating the direct GMIB liability are consistent with those used for calculating the GMDB liability. At June 30, 2022 and December 31, 2021, GMIB reserves before reinsurance totaled $132 million and $78 million, respectively.
Other Liabilities – Insurance and Annuitization Benefits
The Company has established additional reserves for life insurance business for universal life plans with secondary guarantees, interest-sensitive life plans that exhibit “profits followed by loss” patterns and account balance adjustments to tabular guaranteed cash values on one interest-sensitive life plan.
Liabilities for these benefits, as established according to the methodologies described below, are as follows:
June 30, 2022 | December 31, 2021 | |||||||||||||||||||||||||||||||||||||
Benefit Type | Liability (in millions) | Net Amount at Risk (in millions) | Weighted Average Attained Age | Liability (in millions) | Net Amount at Risk (in millions) | Weighted Average Attained Age | ||||||||||||||||||||||||||||||||
Insurance benefits * | $ | 949 | $ | 17,905 | 64.4 years | $ | 943 | $ | 18,506 | 64.0 years | ||||||||||||||||||||||||||||
Account balance adjustments | 143 | N/A | N/A | 141 | N/A | N/A |
* Amounts for the universal life benefits are for the total of the plans containing any policies having projected non-zero excess benefits, and thus may include some policies with zero projected excess benefits.
The following assumptions and methodology were used to determine the universal life insurance benefit liability for the periods referenced in the table above:
•Use of a series of deterministic premium persistency scenarios.
•Other experience assumptions similar to those used in amortization of deferred acquisition costs.
•Discount rates equal to credited interest rates, approximately 3.0% to 5.5% at both June 30, 2022 and December 31, 2021.
The Company also has a small closed block of two-tier annuities, where different crediting rates are used for annuitization and surrender benefit calculations. A liability is established to cover future annuitization benefits in excess of surrender values and was immaterial to the Condensed Consolidated Financial Statements at both June 30, 2022 and December 31, 2021, respectively. The Company also offers an optional lifetime income rider with certain of its fixed index annuities. The liability established for this rider before reinsurance was $49 million and $37 million at June 30, 2022 and December 31, 2021, respectively.
64
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 11. Long-Term Debt
11. Long-Term Debt
Liabilities for the Company’s debt are primarily carried at an amount equal to the unpaid principal balance. Original issuance discount or premium and any debt issue costs, if applicable, are recognized as a component of interest expense over the period the debt is expected to be outstanding.
The aggregate carrying value of long-term debt were as follows (in millions):
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
Long-Term Debt | |||||||||||
Senior Notes due 2023 | $ | 596 | $ | 596 | |||||||
Senior Notes due 2027 | 397 | — | |||||||||
Senior Notes due 2031 | 493 | 495 | |||||||||
Senior Notes due 2032 | 347 | — | |||||||||
Senior Notes due 2051 | 488 | 490 | |||||||||
Term loan due 2023 | — | 751 | |||||||||
Surplus notes | 250 | 250 | |||||||||
FHLBI bank loans | 63 | 67 | |||||||||
Total long-term debt | $ | 2,634 | $ | 2,649 |
The following table presents the contractual maturities of the Company's long-term debt as of June 30, 2022 (in millions):
Calendar Year | |||||||||||||||||||||||||||||||||||
2023 | 2024 | 2025 | 2026 | 2027 and thereafter | Total | ||||||||||||||||||||||||||||||
Long-term debt | $ | 596 | $ | — | $ | — | $ | — | $ | 2,038 | $ | 2,634 |
Senior Notes
On June 8, 2022, the Company issued $750 million aggregate principal amount of its senior unsecured notes, consisting of $400 million aggregate principal amount of 5.170% Senior Notes due June 8, 2027 (the “2027 Notes”) and $350 million aggregate principal amount of 5.670% Senior Notes due June 8, 2032 (the “2032 Notes”). The net proceeds of the 2027 Notes and 2032 Notes were used, together with cash on hand, to repay the Company’s $750 million aggregate principal senior unsecured amount term loan due February 2023 (the “2023 DDTL Facility”).
On November 23, 2021, the Company issued $1.6 billion aggregate principal amount of its senior unsecured notes consisting of $600 million aggregate principal amount of 1.1% Senior Notes due November 22, 2023 (the “2023 Senior Notes”), $500 million aggregate principal amount of 3.1% Senior Notes due November 23, 2031 (the “2031 Senior Notes”) and $500 million aggregate principal amount of 4.0% Senior Notes due November 23, 2051 (the “2051 Senior Notes” and, together with the 2023 Senior Notes and the 2031 Senior Notes, the “Senior Notes”). The proceeds of the Senior Notes were used, together with cash on hand, to repay the Company’s $1.6 billion aggregate principal amount senior unsecured term loan due May 2022 (the “2022 DDTL Facility”), as described below.
65
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 11. Long-Term Debt
Term Loans
On February 22, 2021, the Company entered into loan facilities including a $1.0 billion revolving credit facility (the “Revolving Facility”), a $1.7 billion 2022 DDTL Facility and a $1.0 billion 2023 DDTL Facility (the “Credit Facilities”) with a syndicate of banks. The Revolving Facility provides liquidity backstop. On September 10, 2021, the Company borrowed an aggregate principal amount of $2.4 billion under the term loan facilities as follows: $1.6 billion under the 2022 DDTL Facility and $750 million under the 2023 DDTL Facility. The proceeds of those borrowings were used for general corporate purposes, including liquidity at the holding company and capitalization of the insurance subsidiaries. Under the terms of the credit agreement for the DDTL Facilities, subject to certain exceptions, 100% of the net cash proceeds from any debt issuance, preferred equity issuance or hybrid instrument issuance by the Company or its subsidiaries is required to be applied (i) first to prepay the 2022 DDTL Facility and (ii) thereafter, to prepay the 2023 DDTL Facility. As noted above, both term loans have been retired through the application of the proceeds from senior unsecured notes and cash on hand.
12. Federal Home Loan Bank Advances
The Company, through its subsidiary, Jackson, entered into an advance program with the FHLBI in which interest rates were either fixed or variable based on the FHLBI cost of funds or market rates. Advances of nil were outstanding at both June 30, 2022 and December 31, 2021, respectively, and were recorded in other liabilities.
13. Income Taxes
The Company uses the estimated annual effective tax rate (“ETR”) method in computing the interim tax provision. Certain items, including those deemed unusual, infrequent, or that cannot be reliably estimated, are treated as discrete items and excluded from the estimated annual ETR. In these cases, the actual tax expense or benefit is reported in the same period as the related item. Certain tax effects are also not reflected in the estimated annual ETR, primarily certain changes in the realizability of deferred tax assets and uncertain tax positions and are recorded in the period in which the change occurs. The estimated annual ETR is revised, as necessary, at the end of successive interim reporting periods.
The Company’s effective income tax rate was 19.8% and 17.5% for the three and six months ended June 30, 2022, compared with 9.2% and 18.2% for the same periods in 2021. The ETR differs from the statutory rate of 21% primarily due to the dividends received deduction and utilization of foreign tax credits. The change in the ETR for the three and six months ended June 30, 2022 was due to the relationship of taxable income to consolidated pre-tax income. The ETR differs for the six months ended June 30, 2022 from the full year-ended December 31, 2021 ETR of 15.9% due to the relationship of taxable income to consolidated pre-tax income, the provision-to-return adjustments recorded in 2021 and the net interest related to income taxes recorded in 2021.
The Company is required to evaluate the recoverability of its deferred tax assets and establish a valuation allowance, if necessary, to reduce its deferred tax asset to an amount that is more likely than not to be realizable. Considerable judgment and the use of estimates are required when determining whether a valuation allowance is necessary and, if so, the amount of such valuation allowance. When evaluating the need for a valuation allowance, the Company considers many factors, including: the nature and character of the deferred tax assets and liabilities; taxable income in prior carryback years; future reversals of temporary differences; the length of time carryovers can be utilized; and any tax planning strategies the Company would employ to avoid a tax benefit from expiring unused.
For the three month period ended June 30, 2022, recent changes in market conditions, including rising interest rates, impacted the unrealized tax gains and losses in the available for sale securities portfolio resulting in deferred tax assets related to net unrealized tax capital losses. The deferred tax asset relates to the unrealized losses for which the carryforward period has not yet begun, and as such, when assessing its recoverability, we consider our ability and intent to hold the underlying securities to recovery. As of June 30, 2022, based on all available evidence, we concluded that a valuation allowance should be established on a portion of the deferred tax asset related to unrealized losses that are not more-likely-than-not to be realized. For the three months ending June 30, 2022, the Company established $320 million of valuation allowance associated with the unrealized tax losses in the companies’ available for sale securities portfolio. All of the valuation allowance establishment was allocated to other comprehensive income.
66
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 14. Commitments and Contingencies
14. Commitments and Contingencies
The Company and its subsidiaries are involved in litigation arising in the ordinary course of business. It is the opinion of management that the ultimate disposition of such litigation will not have a material adverse effect on the Company's financial condition. Jackson has been named in civil litigation proceedings, which appear to be substantially similar to other class action litigation brought against many life insurers including allegations of misconduct in the sale of insurance products. The Company accrues for legal contingencies once the contingency is deemed to be probable and reasonably estimable.
At June 30, 2022, the Company had unfunded commitments related to its investments in limited partnerships and limited liability companies totaling $1,676 million. At June 30, 2022, unfunded commitments related to fixed-rate mortgage loans and other debt securities totaled $1,596 million.
15. Other Related Party Transactions
The Company's investment management operation, PPM, provides investment services to certain Prudential affiliated entities. The Company recognized $9 million and $9 million of revenue during the three months ended June 30, 2022, and 2021, and $18 million and $19 million of revenue during the six months ended June 30, 2022 and 2021, associated with these investment services. This revenue was included in fee income in the accompanying Condensed Consolidated Income Statements.
The investments in the segregated account related to the coinsurance agreement with Athene are subject to an investment management agreement between Jackson and Apollo Insurance Solutions Group LP (“Apollo”), which merged with Athene in 2022. Apollo management fees, which are calculated and paid monthly in arrears, are paid directly from the funds withheld account, administered by Athene. These payments were $21 million and $26 million during the three months ended June 30, 2022, and 2021, and $43 million and $54 million during the six months ended June 30, 2022 and 2021, associated with these services.
16. Operating Costs and Other Expenses
The following table is a summary of the Company’s operating costs and other expenses (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
Asset-based commission expenses | $ | 250 | $ | 281 | $ | 525 | $ | 548 | |||||||||||||||
Other commission expenses | 229 | 264 | 469 | 530 | |||||||||||||||||||
General and administrative expenses | 208 | 257 | 479 | 521 | |||||||||||||||||||
Deferral of acquisition costs | (170) | (202) | (349) | (401) | |||||||||||||||||||
Total operating costs and other expenses | $ | 517 | $ | 600 | $ | 1,124 | $ | 1,198 | |||||||||||||||
67
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 17. Accumulated Other Comprehensive Income (Loss)
17. Accumulated Other Comprehensive Income (Loss)
The following table represents changes in the balance of AOCI, net of income tax, related to unrealized investment gains (losses) (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Balance, beginning of period (1) | $ | (939) | $ | 1,443 | $ | 1,744 | $ | 3,821 | ||||||||||||||||||
Change in unrealized appreciation (depreciation) of investments | (3,290) | 1,440 | (6,871) | (1,652) | ||||||||||||||||||||||
Change in unrealized appreciation (depreciation) - other | 141 | (84) | 312 | 71 | ||||||||||||||||||||||
Change in deferred tax asset | 362 | (293) | 1,100 | 343 | ||||||||||||||||||||||
Other comprehensive income (loss) before reclassifications | (2,787) | 1,063 | (5,459) | (1,238) | ||||||||||||||||||||||
Reclassifications from AOCI, net of tax | 4 | (115) | (7) | (192) | ||||||||||||||||||||||
Other comprehensive income (loss) | (2,783) | 948 | (5,466) | (1,430) | ||||||||||||||||||||||
Balance, end of period (1) | $ | (3,722) | $ | 2,391 | $ | (3,722) | $ | 2,391 |
(1)Includes $(1,677) million, $287 million and $632 million related to the investments held within the funds withheld account related to the Athene Reinsurance Transaction as of June 30, 2022, December 31, 2021 and June 30, 2021, respectively.
The following table represents amounts reclassified out of AOCI (in millions):
AOCI Components | Amounts Reclassified from AOCI | Affected Line Item in the Condensed Consolidated Income Statement | ||||||||||||||||||
Three Months Ended June 30, | ||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||
Net unrealized investment gain (loss): | ||||||||||||||||||||
Net realized gain (loss) on investments | $ | (7) | $ | (166) | Net gains (losses) on derivatives and investments | |||||||||||||||
Other impaired securities | 12 | — | Net gains (losses) on derivatives and investments | |||||||||||||||||
Net unrealized gain (loss) | 5 | (166) | ||||||||||||||||||
Amortization of deferred acquisition costs | 2 | 18 | ||||||||||||||||||
Reclassifications, before income taxes | 7 | (148) | ||||||||||||||||||
Income tax expense (benefit) | 3 | (33) | ||||||||||||||||||
Reclassifications, net of income taxes | $ | 4 | $ | (115) |
AOCI Components | Amounts Reclassified from AOCI | Affected Line Item in the Condensed Consolidated Income Statement | ||||||||||||||||||
Six Months Ended June 30, | ||||||||||||||||||||
2022 | 2021 | |||||||||||||||||||
Net unrealized investment gain (loss): | ||||||||||||||||||||
Net realized gain (loss) on investments | $ | (38) | $ | (268) | Net gains (losses) on derivatives and investments | |||||||||||||||
Other impaired securities | 30 | — | Net gains (losses) on derivatives and investments | |||||||||||||||||
Net unrealized gain (loss) | (8) | (268) | ||||||||||||||||||
Amortization of deferred acquisition costs | — | 23 | ||||||||||||||||||
Reclassifications, before income taxes | (8) | (245) | ||||||||||||||||||
Income tax expense (benefit) | (1) | (53) | ||||||||||||||||||
Reclassifications, net of income taxes | $ | (7) | $ | (192) |
68
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 18. Equity
18. Equity
Common Stock
The Company had two classes of common stock: Class A Common Stock and Class B Common Stock. Both classes had a par value of $0.01 per share. Each share of Class A Common Stock is entitled to one vote per share. Each share of Class B Common Stock was entitled to one-tenth of one vote per share. Except for voting rights, the Company’s Class A Common Stock and Class B Common Stock had the same dividend rights, were equal in all respects, and were otherwise treated as if they were one class of shares. On June 9, 2022, our Second Amended and Restated Certificate of Incorporation was further amended and restated, following shareholder approval, to eliminate the Class B Common Stock. At June 30, 2022 and December 31, 2021, the Company was authorized to issue up to 900 million shares of common stock (formerly known as the Class A Common Stock). At June 30, 2022 and December 31, 2021, the Company was authorized to issue nil and 100 million shares of Class B Common Stock, respectively.
Share Repurchase Program
On February 28, 2022, our Board of Directors authorized an increase of $300 million in our existing authorization to repurchase shares of our outstanding Class A Common Stock as part of the Company's share repurchase program. As of August 3, 2022, the Company had remaining authority to purchase $183 million of its common shares. The Company expects to repurchase shares from time to time in the open market or in privately negotiated transactions. The timing, form and amount of the share repurchases under the program are at the discretion of management and will depend on a variety of factors, including funds available at the parent company, other potential uses for such funds, market conditions, the Company's capital position, legal requirements and other factors. The repurchase program may be modified, extended or terminated by the Board at any time. It does not have an expiration date. There can be no assurance that we will continue share repurchases or approve any increase to, or approve any new, stock repurchase program, or as to the amount of any repurchases made pursuant to such programs.
The following table represents share repurchase activities as part of this share repurchase program:
Period | Number of Shares Repurchased | Total Payments (in millions) | Average Price Paid Per Share | ||||||||||||||
2021(October 1 - December 31) | 5,778,649 | $ | 211 | $ | 36.51 | ||||||||||||
Total 2021 | 5,778,649 | 211 | 36.51 | ||||||||||||||
2022 (January 1- March 31) | 3,433,610 | 140 | 40.84 | ||||||||||||||
2022 (April 1- June 30) | 1,870,854 | 66 | 35.15 | ||||||||||||||
Total 2022 | 5,304,464 | $ | 206 | $ | 38.83 |
The following table represents changes in the balance of common stock outstanding:
Common Stock Issued | Treasury Stock | Total Common Stock Outstanding | |||||||||||||||
Shares at December 31, 2021 | 94,464,343 | (5,778,649) | 88,685,694 | ||||||||||||||
Share-based compensation programs | 8,783 | 1,474,714 | (1) | 1,483,497 | |||||||||||||
Shares repurchased under repurchase program | — | (5,304,464) | (5,304,464) | ||||||||||||||
Shares at June 30, 2022 | 94,473,126 | (9,608,399) | 84,864,727 |
(1) Represents net shares issued from treasury stock pursuant to the Company’s share-based compensation programs.
On December 13, 2021, we repurchased 2,242,516 shares of our Class A Common Stock from Prudential and 1,134,767 shares of our Class A Common Stock from Athene. The price per share in the repurchase was $37.01. On December 13, 2021, Athene converted a total of 725,623 shares of its Class B common stock to Class A Common Stock on a one-for-one basis. On February 1, 2022, Athene converted the remaining 638,861 shares of its Class B Common Stock to Class A Common Stock on a one-for-one basis.
69
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 18. Equity
On March 12, 2022, we repurchased 750,000 shares of our Class A Common Stock from Athene. The price per share in the repurchase was $37.89.
Dividends to Shareholders
Any declaration of cash dividends will be at the discretion of JFI’s Board of Directors and will depend on our financial condition, earnings, liquidity and capital requirements, regulatory constraints, level of indebtedness, contractual restrictions with respect to paying cash dividends, restrictions imposed by Delaware law, general business conditions and any other factors that JFI’s Board of Directors deems relevant in making any such determination. Therefore, there can be no assurance that we will pay any cash dividends to holders of our common stock or as to the amount of any such cash dividend.
The following table presents declaration date, record date, payment date and dividends paid on per JFI’s Class A and Class B common shares:
Declaration Date | Record Date | Payment Date | Dividends Paid Per Share | ||||||||||||||||||||
03/31/2022 | February 28, 2022 | March 14, 2022 | March 23, 2022 | $0.55 | |||||||||||||||||||
06/30/2022 | May 9, 2022 | June 2, 2022 | June 16, 2022 | $0.55 | |||||||||||||||||||
19. Earnings Per Share
Basic earnings per share is calculated by dividing net income (loss) attributable to Jackson Financial Inc. shareholders by the weighted-average number of Class A and Class B common shares outstanding during the period. Except for voting rights, the Company’s Class A Common Stock and Class B Common Stock had the same dividend rights, were equal in all respects, and were otherwise treated as if they were one class of shares, including the treatment for the earnings per share calculations. Diluted earnings per share is calculated by dividing the net income (loss) attributable to Jackson Financial Inc. shareholders, by the weighted-average number of shares of Class A Common Stock and Class B Common Stock outstanding for the period, plus shares representing the dilutive effect of share-based awards. For the three and six months ended June 30, 2021, the Company did not have any outstanding share-based awards involving the issuance of the Company’s equity and, therefore, no impact to the diluted earnings per share calculation. The Company grants share-based awards subject to vesting provisions as provided in the Company's 2021 Omnibus Incentive Plan, which have a dilutive effect. See Note 16 for further description of share-based awards in the Company's 2021 Annual Report.
The following table sets forth the calculation of earnings per common share:
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||||||||||
(in millions, except share and per share data) | |||||||||||||||||||||||
Net income (loss) attributable to Jackson Financial Inc. | $ | 2,903 | $ | (540) | $ | 4,928 | $ | 2,392 | |||||||||||||||
Weighted average shares of common stock outstanding - basic | 85,968,564 | 94,464,343 | 86,649,493 | 94,464,343 | |||||||||||||||||||
Dilutive common shares | 3,200,211 | — | 3,402,618 | — | |||||||||||||||||||
Weighted average shares of common stock outstanding - diluted | 89,168,775 | 94,464,343 | 90,052,111 | 94,464,343 | |||||||||||||||||||
Earnings per share—common stock | |||||||||||||||||||||||
Basic | $ | 33.77 | $ | (5.72) | $ | 56.87 | $ | 25.32 | |||||||||||||||
Diluted | $ | 32.56 | $ | (5.72) | $ | 54.72 | $ | 25.32 |
70
Item 1 | Notes to Condensed Consolidated Financial Statements (Unaudited) | 20. Subsequent Events
20. Subsequent Events
The Company has evaluated subsequent events through the date these Condensed Consolidated Financial Statements were issued.
Dividends Declared to Shareholders
On August 8, 2022, our Board of Directors approved a third quarter cash dividend on JFI's Common Stock of $0.55 per share, payable on September 15, 2022 to shareholders of record on September 1, 2022.
71
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
FORWARD-LOOKING STATEMENTS – CAUTIONARY LANGUAGE
Certain statements made in this Quarterly Report on Form 10-Q (this "Report") are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. A forward-looking statement is a statement that is not a historical fact and includes any statement that may predict, forecast, indicate or imply future results, performance or achievements. Forward-looking statements may contain words like: “anticipate,” “believe,” “estimate,” “expect,” “project,” “shall,” “will” and other words or phrases with similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, trends in our businesses, prospective services or products, future performance or financial results and the outcome of contingencies, such as legal proceedings.
Forward-looking statements are subject to risks and uncertainties. Actual results could differ materially from those expressed in or implied by such forward-looking statements due to a variety of factors, including:
•conditions in the capital and credit markets and the economy, which impact liquidity, investment performance and valuation, hedge program performance, interest rates and credit spreads;
•Jackson Financial’s dependence on the ability of its subsidiaries to transfer funds to meet Jackson Financial’s obligations and liquidity needs;
•downgrade in our financial strength or credit ratings, which impact our business and costs of financing;
•changes in laws and regulations, which impact how we conduct our business, the relative appeal of our products versus those from other financial institutions, and changes in accounting standards, which impact how we account for and present our results of operations;
•operational failures, including failure of our information technology systems, failure to protect the confidentiality of customer information or proprietary business information, and disruptions from third-party outsourcing partners;
•a failure to adequately describe and administer, or meet any of the complex product and regulatory requirements relating to, the many complex features and options contained in our annuities;
•adverse impacts on our results of operations and capitalization as a result of optional guaranteed benefits within certain of our annuities;
•models that rely on a number of estimates, assumptions, sensitivities and projections, which models inform our business decisions and strategy, and which may contain misjudgments and errors and may not be as predictive as desired;
•risks related to natural and man-made disasters and catastrophes, diseases, epidemics, pandemics (including COVID-19), malicious acts, cyberattacks, terrorist acts, civil unrest and climate change;
•inadequate reserves due to differences between our actual experience and management’s estimates and assumptions;
•changes in the levels of amortization of deferred acquisition costs (“DAC”); and
•adverse outcomes of legal or regulatory actions.
The risks and uncertainties included here are not exhaustive. Our Annual Report on Form 10-K for the year ended December 31, 2021, as filed with the SEC on March 7, 2022, (the "2021 Annual Report") and other reports filed with the United States Securities and Exchange Commission (“SEC”) includes additional factors that could affect our businesses and financial performance. Moreover, we operate in a rapidly changing and competitive environment. New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors.
Further, it is not possible to assess the effect of all risk factors on our businesses or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances that occur after the date of this Report, except as otherwise required by law.
72
Item 2 | Management’s Discussion and Analysis | Available Information & Principal Definitions
Available Information
We make available free of charge, through our website, investors.jackson.com, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, our proxy statements, and any amendments to those reports or statements as soon as reasonably practicable after these materials are electronically filed with, or furnished to, the SEC. We use our website as a routine channel for distribution of important information, including news releases, analyst presentations, financial information, and corporate governance information. The content of Jackson’s website is not incorporated by reference into this Report or in any other report or document filed with the SEC, and any references to Jackson’s website are intended to be inactive textual references only. The SEC’s website, www.sec.gov, contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.
Principal Definitions, Abbreviations, and Acronyms Used in the Text and Notes of this Report
we, us, our and the Company | Jackson Financial Inc. and its consolidated subsidiaries, unless the context refers only to Jackson Financial Inc. as a corporate entity (which we refer to as "JFI" or "Jackson Financial") | ||||
Jackson | Jackson National Life Insurance Company, a Company subsidiary. | ||||
Brooke Life | Brooke Life Insurance Company, a Company subsidiary and the direct parent company of Jackson National Life Insurance Company. | ||||
Jackson Finance | Jackson Finance, LLC, a Company subsidiary. | ||||
PPMH | PPM Holdings, Inc., a Company subsidiary | ||||
PPM | PPM America Inc., a subsidiary of PPMH | ||||
ACL | Allowance for credit loss | ||||
Account value or account balance | The amount of money in a customer’s account. For example, the value increases with additional premiums and investment gains, and it decreases with withdrawals, investment losses and fees. | ||||
Athene | Athene Life Re Ltd. and its affiliates and permitted transferees, including Athene Co-Invest Reinsurance Affiliate 1A Ltd. | ||||
Athene Equity Investment | The July 2020 investment of $500 million by Athene in JFI for Class A Common Stock and Class B Common Stock, representing approximately 9.9% of the total combined voting power and approximately 11.1% of the total common stock of the Company | ||||
Athene Reinsurance Transaction | The funds withheld coinsurance agreement entered into with Athene on June 18, 2020, effective June 1, 2020, to reinsure a 100% quota share of a block of our in-force fixed and fixed index annuity liabilities in exchange for approximately $1.2 billion in ceding commissions | ||||
Athene Transactions | The Athene Reinsurance Transaction and the Athene Equity Investment, together. | ||||
AUM (Assets under management) | Investment assets that are managed by one of our subsidiaries and includes: (i) the assets in our investment portfolio managed by PPM, which excludes assets held in funds withheld accounts for reinsurance transactions, (ii) third-party assets managed by PPM, including those for Prudential and its affiliates or third parties, and (iii) the separate account assets of our Retail Annuities segment that Jackson National Asset Management, LLC ("JNAM") manages and administers. | ||||
Benefit base | A notional amount (not actual cash value) used to calculate the owner’s guaranteed benefits within an annuity contract. The death benefit and living benefit within the same contract may have different benefit bases. | ||||
CMBS | Commercial mortgage-backed securities | ||||
DAC (Deferred acquisition costs) | Represent the incremental costs related directly to the successful acquisition of new and certain renewal insurance policies and annuity contracts and which have been deferred on the balance sheet as an asset. | ||||
DDTL Facility | Delayed Draw Term Loan Facility |
73
Item 2 | Management’s Discussion and Analysis | Available Information & Principal Definitions
Deferred tax asset or Deferred tax liability | Assets or liabilities that are recorded for the difference between book basis and tax basis of an asset or a liability. | ||||
DSI (Deferred sales inducements) | Represent amounts that are credited to a policyholder’s account balance that are higher than the expected crediting rates on similar contracts without such an inducement and that are an incentive to purchase a contract and also meet the accounting criteria to be deferred as an asset that is amortized over the life of the contract. | ||||
Fixed Annuity | An annuity that guarantees a set annual rate of return with interest at rates we determine, subject to specified minimums. Credited interest rates are guaranteed not to change for certain limited periods of time. | ||||
Fixed Index Annuity | An annuity with an ability to share in the upside from certain financial markets, such as equity indices, and provides downside protection. | ||||
Form 10 | Form 10 registration statement registering the Company’s Class A Common Stock under the Securities Exchange Act of 1934, as amended, which became effective on August 6, 2021. | ||||
General account assets | The assets held in the general accounts of our insurance companies. | ||||
GIC | Guaranteed investment contract | ||||
Guarantee Fees | Fees charged on annuities for optional benefit guarantees | ||||
GMAB (Guaranteed minimum accumulation benefit) | An add-on benefit (enhanced benefits available for an additional cost) which entitles an owner to a minimum payment, typically in lump-sum, after a set period of time, typically referred to as the accumulation period. The minimum payment is based on the benefit base, which could be greater than the underlying account value. | ||||
GMDB (Guaranteed minimum death benefit) | An add-on benefit (enhanced benefits available for an additional cost) that guarantees an owner’s beneficiaries are entitled to a minimum payment based on the benefit base, which could be greater than the underlying account value, upon the death of the owner. | ||||
GMIB (Guaranteed minimum income benefit) | An add-on benefit (available for an additional cost) where an owner is entitled to annuitize the policy and receive a minimum payment stream based on the benefit base, which could be greater than the payment stream resulting from current annuitization of the underlying account value. | ||||
GMWB (Guaranteed minimum withdrawal benefit) | An add-on benefit (available for an additional cost) where an owner is entitled to withdraw a maximum amount of their benefit base each year, for which cumulative payments to the owner could be greater than the underlying account value. | ||||
GMWB for Life (Guaranteed minimum withdrawal benefit for life) | An add-on benefit (available for an additional cost) where an owner is entitled to withdraw the guaranteed annual withdrawal amount each year, for the duration of the policyholder’s life, regardless of account performance. | ||||
NAIC | National Association of Insurance Commissioners | ||||
NAV | Net asset value | ||||
Net flows | Net flows represent the net change in customer account balances during a period, including gross premiums, surrenders, withdrawals and benefits. Net flows exclude investment performance, interest credited to customer accounts and policy charges. | ||||
RBC (Risk-based capital) | Rules to determine insurance company statutory capital requirements. It is based on rules published by the NAIC. | ||||
RILA | A registered index-linked annuity that offers market index-linked investment options, subject to a cap, and offers a variety of guarantees designed to modify or limit losses. | ||||
RMBS | Residential mortgage-backed securities | ||||
Variable annuity | A type of annuity that offers tax-deferred investment into a range of asset classes and a variable return, which offers insurance features related to potential future income payments. | ||||
VIE | Variable interest entity |
74
Item 2 | Management’s Discussion and Analysis | Overview & Executive Summary
Overview of Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of operations should be read in its entirety and in conjunction with the Condensed Consolidated Financial Statements and related notes contained in Part I, Item 1 of this Quarterly Report on Form 10-Q, as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section in our 2021 Annual Report.
Jackson Financial Inc. (“Jackson Financial”) along with its subsidiaries (collectively, the “Company,” which also may be referred to as “we,” “our” or “us”), is a financial services company focused on helping Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Jackson Financial, domiciled in the United States (“U.S.”), was previously a majority-owned subsidiary of Prudential plc (“Prudential”), London, England and was the holding company for Prudential’s U.S. operations. The Company's demerger from Prudential was completed on September 13, 2021 (the "Demerger"), and the Company no longer is a majority-owned subsidiary of Prudential. See Note 1 to Condensed Consolidated Financial Statements for further discussion of the Demerger. Jackson Financial’s primary life insurance subsidiary, Jackson, is licensed to sell group and individual annuity products (including immediate, registered index-linked, deferred fixed, fixed index and variable annuities), and various protection products, primarily whole life, universal life and variable universal life and term life insurance products in all 50 states and the District of Columbia.
Executive Summary
This executive summary of Management’s Discussion and Analysis of Financial Condition and Results of Operation highlights selected information and may not contain all of the information that is important to current or potential investors in our securities. You should read this Quarterly Report on Form 10-Q, together with our 2021 Annual Report, in their entirety for a more detailed description of events, trends, uncertainties, risks and critical accounting estimates affecting us.
We help Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. We believe that we are uniquely positioned in our markets because of our differentiated products, well-known brand and disciplined risk management. Our market leadership is supported by our efficient and scalable operating platform and industry-leading distribution network. We believe these core strengths will enable us to grow profitably as an aging U.S. population transitions into retirement.
We offer a diverse suite of annuities to retail investors in the U.S. Our variable annuities have been among the best-selling products of their kind in the U.S. primarily due to the differentiated features we offer as compared to our competitors, in particular the wider range of investment options and greater freedom to invest across multiple investment options. We also offer fixed index annuities and fixed annuities. In the fourth quarter of 2021, our primary life insurance subsidiary, Jackson National Life Insurance Company and its insurance subsidiaries (“Jackson”) successfully launched Market Link ProSM and Market Link Pro AdvisorySM, its commission and advisory based suite of registered index-linked annuities ("RILA"). Also in the fourth quarter of 2021, we entered the Defined Contribution market as a carrier in the AllianceBernstein Lifetime Income Strategy ("AllianceBernstein").
We sell our products through a distribution network that includes independent broker-dealers, wirehouses, regional broker-dealers, banks, and independent registered investment advisors, third-party platforms and insurance agents. We have been the top selling retail annuity company in the United States for nine of the past ten years, according to the Life Insurance Marketing and Research Association ("LIMRA").
Our operating platform is scalable and efficient. We administer approximately 77% of our in-force policies on our in-house policy administration platform. The remainder of our business is administered through established third-party arrangements. We believe that our operating platform provides us with a competitive advantage by allowing us to grow efficiently and provide superior customer service.
We manage our business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks. We report certain activities and items that are not included in these segments, including the results of PPM Holdings, Inc., the holding company of PPM, which manages the majority of our general account investment portfolio, in Corporate and Other. See Note 3 to Condensed Consolidated Financial Statements for further information on our segments.
75
Item 2 | Management’s Discussion and Analysis | Executive Summary
There are several significant recent events involving us, including:
•Demerger from Prudential plc: We were previously a majority-owned subsidiary of Prudential plc (“Prudential”), London, England and served as the holding company for its U.S. operations. The demerger, or separation, from Prudential was completed on September 13, 2021 ("Demerger"), and we are no longer a majority-owned subsidiary of Prudential. Prudential retained an equity interest in us, which, as a result of sales subsequent to the Demerger, represents 14.3% of our outstanding Class A Common Stock as of June 30, 2022. Prudential sold additional shares of the Company’s Class A Common Stock during the third quarter of 2022 and as of August 5, 2022 Prudential retained a 9.0% remaining interest in the Company.
•Common Stock Reclassification: On September 9, 2021, Jackson Financial effected a 104,960.3836276-for-1 stock split of its Class A Common Stock and Class B Common Stock by way of a reclassification of its Class A Common Stock and Class B Common Stock. All share and earnings per share information presented in this Report have been retroactively adjusted to reflect the stock split.
•Athene Transactions: On June 18, 2020, Jackson announced that it had entered into a funds withheld coinsurance agreement (the “Athene Reinsurance Agreement”) with Athene Life Re Ltd. (“Athene”) effective June 1, 2020 to reinsure on 100% quota share basis, a block of Jackson’s in-force fixed and fixed-index annuity product liabilities in exchange for a $1.2 billion ceding commission (the “Athene Reinsurance Transaction”). As a result, we hold various investments whose economic performance accrues to Athene but is reported in our financial statements. In July 2020, Athene invested $500 million of capital into the Company for an equity interest. In August 2020, the Company contributed $500 million, as a capital contribution to Jackson. Athene has an equity interest in us, which represents an 8.9% economic interest and an 8.9% voting interest of our outstanding Class A Common Stock as of June 30, 2022.
•Elimination of Class B Common Stock: On June 9, 2022, our Second Amended and Restated Certificate of Incorporation was further amended and restated, following shareholder approval, to eliminate the Class B Common Stock.
•Common Stock Repurchases: Since the Demerger and through June 30, 2022, we have repurchased 11,083,113 shares of our Class A Common Stock for an aggregate consideration of $417 million. After giving effect to those repurchases and issuances for our share based compensation, we had 9,608,399 of treasury stock and 84,864,727 shares of Class A Common Stock outstanding at June 30, 2022.
•As discussed in Note 2 of Notes to Condensed Consolidated Financial Statements in this Report, we will be adopting ASU 2018-12, “Targeted Improvements to the Accounting for Long-Duration Contracts,” (“LDTI”) for our fiscal year beginning January 1, 2023, with a transition date of January 1, 2021. Based upon the elected transition methods, the Company currently estimates the adoption of the standard will result in a decrease of between approximately $2 billion and $4 billion in the Company’s total equity at the transition date of January 1, 2021. Market changes since the transition date, primarily higher interest rates, have significantly reduced the estimated negative impact to the Company’s total equity as of June 30, 2022. See further discussion in Note 2 for the significant changes for this future change in accounting principle.
Our GAAP results are affected by the potential variability associated with our amortization of deferred acquisition costs and the fact that our use of derivatives does not qualify for GAAP deferral, meaning that the derivatives are marked to market each reporting period. See “Summary of Critical Accounting Estimates” below for more information.
Also, an understanding of several key operating measures, including sales, account value, net flows, benefit base and AUM, is helpful to evaluating our results. See “Key Operating Measures” below. Finally, we are affected by various economic, industry and regulatory trends, which are described below under “Macroeconomic, Industry and Regulatory Trends.”
76
Item 2 | Management’s Discussion and Analysis | Non-GAAP Financial Measures
Non-GAAP Financial Measures
In addition to presenting our results of operations and financial condition in accordance with U.S. GAAP, we use and report, selected non-GAAP financial measures. Management believes that the use of these non-GAAP financial measures, together with relevant U.S. GAAP financial measures, provides a better understanding of our results of operations, financial condition and the underlying performance drivers of our business. These non-GAAP financial measures should be considered supplementary to our results of operations and financial condition that are presented in accordance with U.S. GAAP and should not be viewed as a substitute for the U.S. GAAP financial measures. Other companies may use similarly titled non-GAAP financial measures that are calculated differently from the way we calculate such measures. Consequently, our non-GAAP financial measures may not be comparable to similar measures used by other companies. These non-GAAP financial measures should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with U.S. GAAP.
Adjusted Operating Earnings
Adjusted Operating Earnings is an after-tax non-GAAP financial measure, which we believe should be used to evaluate our financial performance on a consolidated basis by excluding certain items that may be highly variable from period to period due to accounting treatment under U.S. GAAP or that are non-recurring in nature, as well as certain other revenues and expenses that we do not view as driving our underlying performance. Adjusted Operating Earnings should not be used as a substitute for net income as calculated in accordance with U.S. GAAP. However, we believe the adjustments to net income are useful for gaining an understanding of our overall results of operations.
Adjusted Operating Earnings equals our net income adjusted to eliminate the impact of the following items:
1.Guaranteed Benefits and Hedging Results: the fees attributed to guaranteed benefits, the associated movements in optional guaranteed benefit liabilities and related claims and benefit payments are excluded from Adjusted Operating Earnings, as we believe this approach appropriately removes the impact to both revenue and related expenses associated with the guaranteed benefit features that are offered for certain of our variable annuities and fixed index annuities and gives investors a better picture of what is driving our underlying performance. This adjustment includes the following components:
•Fees Attributable to Guarantee Benefits: fees earned in conjunction with guaranteed benefit features offered for certain of our variable annuities and fixed index annuities are set at a level intended to mitigate the cost of hedging and funding the liabilities associated with such guaranteed benefit features. The full amount of the fees attributable to guaranteed benefit features have been excluded from Adjusted Operating Earnings as the related net movements in freestanding derivatives and net reserve and embedded derivative movements, as described below, have been excluded from Adjusted Operating Earnings. This adjusted presentation of our earnings is intended to directly align revenue and related expenses associated with the guaranteed benefit features;
•Net Movement in Freestanding Derivatives, except earned income (periodic settlements and changes in settlement accruals) on derivatives that are hedges of investments, but do not qualify for hedge accounting treatment: changes in the fair value of our freestanding derivatives used to manage the risk associated with our life and annuity reserves, including those arising from the guaranteed benefit features offered for certain of our variable annuities and fixed index annuities. Net movements in freestanding derivatives have been excluded from Adjusted Operating Earnings as the market value of these derivatives may vary significantly from period to period as a result of near-term market conditions and therefore are not directly comparable or reflective of the underlying performance of our business;
77
Item 2 | Management’s Discussion and Analysis | Non-GAAP Financial Measures
•Net Reserve and Embedded Derivative Movements: changes in the valuation of certain life and annuity reserves, a portion of which are accounted for as embedded derivative instruments, and which are primarily composed of variable and fixed index annuity reserves, including those arising from the guaranteed benefit features offered for certain of our variable annuities. Net reserve and embedded derivative movements have been excluded from Adjusted Operating Earnings as the carrying values of these derivatives may vary significantly from period to period as the result of near-term market conditions and policyholder behavior-related inputs and therefore are not directly comparable or reflective of the underlying performance of our business. Movements in reserves attributable to the current period claims and benefit payments in excess of a customer’s account value on these policies are also excluded from Adjusted Operating Earnings as these benefit payments are affected by near-term market conditions and policyholder behavior-related inputs and therefore may vary significantly from period to period;
•DAC and Deferred Sales Inducements ("DSI") Impact: amortization of deferred acquisition costs and deferred sales inducements associated with the items excluded from Adjusted Operating Earnings;
•Assumption changes: the impact on the valuation of Net Derivative and Reserve Movements, including amortization on DAC, arising from changes in underlying actuarial assumptions on an annual basis;
2.Net Realized Investment Gains and Losses including change in fair value of funds withheld embedded derivative: Realized investment gains and losses associated with the periodic sales or disposals of securities, excluding those held within our trading portfolio, as well as impairments of securities, after adjustment for the non-credit component of the impairment charges and change in fair value of funds withheld embedded derivative related to the Athene Reinsurance Transaction;
3.Loss on Athene Reinsurance Transaction: includes contractual ceding commission, cost of reinsurance write-off and DAC and DSI write-off related to the Athene Reinsurance Transaction;
4.Net investment income on funds withheld assets: includes net investment income on funds withheld assets related to funds withheld reinsurance transactions;
5.Other items: one-time or other non-recurring items, such as costs relating to the Demerger and our separation from Prudential, the impact of discontinued operations and investments that are consolidated on our financial statements due to U.S. GAAP accounting requirements, such as our investments in CLOs, but for which the consolidation effects are not aligned with our economic interest or exposure to those entities.
Operating income taxes are calculated using the prevailing corporate federal income tax rate of 21% while taking into account any items recognized differently in our financial statements and federal income tax returns, including the dividends received deduction and other tax credits. For interim reporting periods, the company uses an estimated annual effective tax rate (“ETR”) in computing its tax provision including consideration of discrete items.
78
Item 2 | Management’s Discussion and Analysis | Non-GAAP Financial Measures
The following is a reconciliation of Adjusted Operating Earnings to net income (loss) attributable to Jackson Financial Inc., the most comparable U.S. GAAP measure.
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Net income (loss) attributable to Jackson Financial, Inc. | $ | 2,903 | $ | (540) | $ | 4,928 | $ | 2,392 | ||||||||||||||||||
Income tax expense (benefit) | 717 | (54) | 1,047 | 531 | ||||||||||||||||||||||
Pretax income (loss) attributable to Jackson Financial Inc | 3,620 | (594) | 5,975 | 2,923 | ||||||||||||||||||||||
Non-operating adjustments (income) loss: | ||||||||||||||||||||||||||
Guaranteed benefits and hedging results: | ||||||||||||||||||||||||||
Fees attributable to guarantee benefit reserves | (765) | (701) | (1,529) | (1,373) | ||||||||||||||||||||||
Net movement in freestanding derivatives | (2,847) | 442 | (1,371) | 3,473 | ||||||||||||||||||||||
Net reserve and embedded derivative movements | 772 | 1,374 | (1,067) | (3,219) | ||||||||||||||||||||||
DAC and DSI impact | 845 | (243) | 1,190 | 453 | ||||||||||||||||||||||
Assumption changes | — | — | — | — | ||||||||||||||||||||||
Total guaranteed benefits and hedging results | (1,995) | 872 | (2,777) | (666) | ||||||||||||||||||||||
Net realized investment (gains) losses including change in fair value of funds withheld embedded derivative | (1,082) | 752 | (1,980) | (298) | ||||||||||||||||||||||
Net investment income on funds withheld assets | (364) | (294) | (624) | (585) | ||||||||||||||||||||||
Other items | 64 | 25 | 67 | 20 | ||||||||||||||||||||||
Total non-operating adjustments | (3,377) | 1,355 | (5,314) | (1,529) | ||||||||||||||||||||||
Pretax Adjusted Operating Earnings | 243 | 761 | 661 | 1,394 | ||||||||||||||||||||||
Operating income taxes | 18 | 125 | 82 | 189 | ||||||||||||||||||||||
Adjusted Operating Earnings | $ | 225 | $ | 636 | $ | 579 | $ | 1,205 |
79
Item 2 | Management’s Discussion and Analysis | Non-GAAP Financial Measures
Adjusted Book Value and Adjusted Operating ROE
We use Adjusted Operating Return on Equity ("ROE") to manage our business and evaluate our financial performance. Adjusted Operating ROE excludes items that vary from period to period due to accounting treatment under U.S. GAAP or that are non-recurring in nature, as such items may distort the underlying performance of our business. We calculate Adjusted Operating ROE by dividing our Adjusted Operating Earnings by average Adjusted Book Value. Adjusted Book Value excludes Accumulated Other Comprehensive Income (Loss) ("AOCI") attributable to Jackson Financial Inc. AOCI attributable to Jackson Financial Inc. does not include AOCI arising from investments held within the funds withheld account related to the Athene Reinsurance Transaction. We exclude AOCI attributable to Jackson Financial Inc. from Adjusted Book Value because our invested assets are generally invested to closely match the duration of our liabilities, which are longer duration in nature, and therefore we believe period-to-period fair market value fluctuations in AOCI to be inconsistent with this objective. We believe excluding AOCI attributable to Jackson Financial Inc. is more useful to investors in analyzing trends in our business. Changes in AOCI within the funds withheld account related to the Athene Reinsurance Transaction offset the related non-operating earnings from the Athene Reinsurance Transaction resulting in a minimal net impact on Adjusted Book Value of Jackson Financial Inc.
Adjusted Book Value and Adjusted Operating ROE should not be used as substitutes for total shareholders’ equity and ROE as calculated using annualized net income and average equity in accordance with U.S. GAAP. However, we believe the adjustments to equity and earnings are useful to gaining an understanding of our overall results of operations.
The following is a reconciliation of Adjusted Book Value to total shareholders’ equity and a comparison of Adjusted Operating ROE to ROE, the most comparable U.S. GAAP measure:
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Net income (loss) attributable to Jackson Financial, Inc. | $ | 2,903 | $ | (540) | $ | 4,928 | $ | 2,392 | ||||||||||||||||||
Adjusted Operating Earnings | $ | 225 | 636 | 579 | 1,205 | |||||||||||||||||||||
Total shareholders' equity | $ | 9,563 | $ | 10,391 | $ | 9,563 | $ | 10,391 | ||||||||||||||||||
Adjustments to total shareholders’ equity: | ||||||||||||||||||||||||||
Exclude accumulated other comprehensive income (loss) attributable to Jackson Financial Inc. (1) | 2,045 | (1,758) | 2,045 | (1,758) | ||||||||||||||||||||||
Adjusted Book Value | $ | 11,608 | $ | 8,633 | $ | 11,608 | $ | 8,633 | ||||||||||||||||||
ROE | 121.4 | % | (21.2) | % | 100.1 | % | 48.3 | % | ||||||||||||||||||
Adjusted Operating ROE on average equity | 8.4 | % | 29.2 | % | 11.4 | % | 31.2 | % | ||||||||||||||||||
(1) Excludes $(1,677) million and $632 million related to the investments held within the funds withheld account related to the Athene Reinsurance Transaction as of June 30, 2022 and 2021, respectively. |
80
Item 2 | Management’s Discussion and Analysis | Key Operating Measures
Key Operating Measures
We use a number of operating measures that management believes provide useful information about our businesses and the operational factors underlying our financial performance.
Sales
Sales of annuities and institutional products include all money deposited by customers into new and existing contracts. We believe sales statistics are useful to gaining an understanding of, among other things, the attractiveness of our products, how we can best meet our customers’ needs, evolving industry product trends and the performance of our business from period to period.
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Sales | ||||||||||||||||||||||||||
Variable annuities | $ | 3,633 | $ | 4,821 | $ | 8,208 | $ | 9,495 | ||||||||||||||||||
RILA | 490 | — | 689 | — | ||||||||||||||||||||||
Fixed Index Annuities | 13 | 32 | 32 | 72 | ||||||||||||||||||||||
Fixed Annuities | 6 | 6 | 10 | 16 | ||||||||||||||||||||||
Total Retail Annuity Sales | 4,142 | 4,859 | 8,939 | 9,583 | ||||||||||||||||||||||
Total Institutional Product Sales | 201 | — | 1,176 | — | ||||||||||||||||||||||
Total Sales | $ | 4,343 | $ | 4,859 | $ | 10,115 | $ | 9,583 |
For the three and six months ended June 30, 2022, total sales decreased by $516 million and increased by $532 million compared to the three and six months ended June 30, 2021, respectively. Lower retail sales were primarily due to decreased sales of our variable annuities with lifetime living benefits, partially offset by sales of our lifetime income solutions offering in the defined contribution market and our new RILA product, that were both launched in the fourth quarter of 2021. In addition, sales of our institutional products were higher by $201 million and $1,176 million, compared to the three and six months ended June 30, 2021, respectively. Sales of fixed index and fixed annuities remained at historically low levels although higher rates in 2022 have enabled more frequent pricing actions.
81
Item 2 | Management’s Discussion and Analysis | Key Operating Measures
Account Value
Account value generally equals the account value of our variable annuities, RILA, fixed index annuities, fixed annuities, and institutional products. It reflects the total amount of customer invested assets that have accumulated within a respective product and equals cumulative customer contributions, which includes gross deposits or premiums, plus accrued credited interest plus or minus the impact of market movements, as applicable, less withdrawals and various fees. We believe account value is a useful metric in providing an understanding of, among other things, the sources of potential fee income generation, potential benefit obligations and risk management priorities.
June 30, 2022 | December 31, 2021 | ||||||||||
(in millions) | |||||||||||
Account Value | |||||||||||
GMWB For Life | $ | 149,730 | $ | 188,078 | |||||||
GMWB | 5,778 | 7,318 | |||||||||
Other Guarantees - Living Benefits | 1,401 | 1,808 | |||||||||
No Living Benefits | 49,390 | 60,719 | |||||||||
Total Variable Annuity Account Value | 206,299 | 257,923 | |||||||||
RILA | 735 | 110 | |||||||||
Fixed Index Annuity (1) | 321 | 291 | |||||||||
Fixed Annuity (1) | 1,102 | 1,099 | |||||||||
Total Fixed & Fixed Index Annuity Account Value | 1,423 | 1,390 | |||||||||
Total Retail Annuities Account Value | $ | 208,457 | $ | 259,423 | |||||||
Total Institutional Products Account Value | $ | 8,483 | $ | 8,830 | |||||||
Total Closed Life and Annuity Blocks Account Value (2) | $ | 8,568 | $ | 8,778 | |||||||
(1) Net of reinsurance to Athene. | |||||||||||
(2) Excludes payout annuities and traditional life insurance without account value. |
82
Item 2 | Management’s Discussion and Analysis | Key Operating Measures
Net Flows
Net flows represent the net change in customer account balances during a period, including gross premiums, surrenders, withdrawals and benefits. Net flows exclude investment performance, interest credited to customer accounts, transfers between fixed and variable benefits for variable annuities and policy charges. We believe net flows is a useful metric in providing an understanding of, among other things, sales, ongoing premiums and deposits, the changes in account value from period to period, sources of potential fee income and policyholder behavior.
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Net Flows: | ||||||||||||||||||||||||||
Variable Annuity | $ | (300) | $ | (325) | $ | (298) | $ | (565) | ||||||||||||||||||
RILA | 489 | — | 687 | — | ||||||||||||||||||||||
Fixed Index Annuity (1) | 18 | 27 | 33 | 62 | ||||||||||||||||||||||
Fixed Annuity (1) | (8) | 13 | (13) | 3 | ||||||||||||||||||||||
Total Retail Annuities Net Flows, Net of Reinsurance | 199 | (285) | 409 | (500) | ||||||||||||||||||||||
Net flows ceded to Athene | $ | (585) | $ | (599) | $ | (1,188) | $ | (1,252) | ||||||||||||||||||
Total Retail Annuities net flows, Gross of Reinsurance | $ | (386) | $ | (884) | $ | (779) | $ | (1,752) | ||||||||||||||||||
Total Institutional Products Net Flows | $ | (667) | $ | (1,735) | $ | (351) | $ | (2,281) | ||||||||||||||||||
Total Closed Life and Annuity Blocks Net Flows (2) | $ | (72) | $ | (61) | $ | (159) | $ | (145) | ||||||||||||||||||
(1) Net of reinsurance to Athene. | ||||||||||||||||||||||||||
(2) Excludes payout annuities and traditional life insurance without account value. |
Net flows improved for the three and six months ended June 30, 2022, compared to the three and six months ended June 30, 2021, due primarily to increased sales of both RILA and institutional products which has a positive effect on net flows.
83
Item 2 | Management’s Discussion and Analysis | Key Operating Measures
Benefit Base
Benefit base refers to a notional amount that represents the value of a customer’s guaranteed benefit, and therefore may be a different value from the invested assets in a customer’s account value. The benefit base may be used to calculate the fees for a customer’s guaranteed benefits within an annuity contract. The guaranteed death benefit and guaranteed living benefit within the same contract may not have the same benefit base. We believe benefit base is a useful metric for our variable annuity policies in providing an understanding of, among other things, fee income generation, potential optional guarantee benefit obligations and risk management priorities. The following table shows variable annuity account value and benefit base as of June 30, 2022 and December 31, 2021:
June 30, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||
Account Value | Benefit Base | Account Value | Benefit Base | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
No Living Benefits | $ | 49,390 | N/A | $ | 60,719 | N/A | |||||||||||||||||||||||
By Guaranteed Living Benefits: | |||||||||||||||||||||||||||||
GMWB for Life | 149,730 | 187,862 | 188,078 | 183,626 | |||||||||||||||||||||||||
GMWB | 5,778 | 5,792 | 7,318 | 5,860 | |||||||||||||||||||||||||
GMIB (1) | 1,401 | 1,977 | 1,808 | 2,059 | |||||||||||||||||||||||||
Total | $ | 206,299 | $ | 195,631 | $ | 257,923 | $ | 191,545 | |||||||||||||||||||||
By Guaranteed Death Benefit: | |||||||||||||||||||||||||||||
Return of AV (No GMDB) | $ | 25,114 | N/A | $ | 30,337 | N/A | |||||||||||||||||||||||
Return of Premium | 157,491 | 137,498 | 197,544 | 135,034 | |||||||||||||||||||||||||
Highest Anniversary Value | 12,242 | 14,552 | 15,599 | 14,767 | |||||||||||||||||||||||||
Rollup | 3,334 | 4,785 | 4,188 | 4,850 | |||||||||||||||||||||||||
Combination HAV/Rollup | 8,118 | 10,373 | 10,255 | 10,402 | |||||||||||||||||||||||||
Total | $ | 206,299 | $ | 167,208 | $ | 257,923 | $ | 165,053 | |||||||||||||||||||||
(1) Substantially all of our GMIB benefits are reinsured. |
Assets Under Management
AUM, or assets under management, refers to investment assets that are managed by one of our subsidiaries and includes: (i) the assets in our investment portfolio managed by PPM, which excludes assets held in funds withheld accounts for reinsurance transactions, (ii) third-party assets managed by PPM, including those for Prudential and its affiliates or third parties, and (iii) the separate account assets of our Retail Annuities segment that Jackson National Asset Management ("JNAM") manages and administers. Total AUM reflects exclusions between segments to avoid double counting. We believe AUM is a useful metric for understanding of, among other things, the sources of our earnings, net investment income and performance of our invested assets, customer directed investments and risk management priorities.
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Jackson Invested Assets | $ | 46,267 | $ | 47,224 | |||||||
Third Party Invested Assets (including CLOs) | 26,751 | 31,980 | |||||||||
Total PPM AUM | 73,018 | 79,204 | |||||||||
Total JNAM AUM | 221,634 | 280,250 | |||||||||
Total AUM | $ | 294,652 | $ | 359,454 |
PPM manages the majority of our investment portfolio and provides investment management services to Prudential affiliates in Asia, former affiliates in the United Kingdom, and other third parties across markets, including public fixed income, private equity, private debt and commercial real estate.
84
Item 2 | Management’s Discussion and Analysis | Macroeconomic, Industry and Regulatory Trends
Macroeconomic, Industry and Regulatory Trends
We discuss a number of trends and uncertainties below that we believe could materially affect our future business performance, including our results of operations, our investments, our cash flows, and our capital and liquidity position.
Macroeconomic and Financial Market Conditions
Our business and results of operations are affected by macroeconomic factors. The level of interest rates and shape of the yield curve, credit and equity market performance (including market paths, equity volatility and other factors), regulation, tax policy, the level of U.S. employment, inflation and the overall economic growth rate can affect both our short and long-term profitability. Monetary and fiscal policy in the United States, or similar actions in foreign nations, could result in increased volatility in financial markets, including interest rates, currencies and equity markets, and could impact our business in both the short-term and medium-term. Political events, including the imposition of stay-at-home orders and business shutdowns or other effects arising as a result of the COVID-19 pandemic, civil unrest, tariffs or other barriers to international trade, and the effects that these or other political events could have on levels of economic activity, could also impact our business through impacts on consumers’ behavior or impact on financial markets.
In the short- to medium-term, the potential for increased volatility could pressure sales and reduce demand for our products as consumers consider purchasing alternative products to meet their objectives, especially while prevailing interest rates remain below historical averages. In addition, low interest rate environments can make it difficult to consistently develop products that are attractive to customers while rising interest rates may make certain product features more attractive. Our financial performance can be adversely affected by market volatility and equity market declines if fees assessed on the account value of our annuities fluctuate, hedging costs increase and revenues decline due to reduced sales and increased outflows.
Equity Market Environment
Our financial performance is impacted by the performance of equity markets. For example, our variable annuities earn fees based on the account value, which changes with equity market levels. After a very volatile 2020, U.S. equity markets performed well in 2021 with the S&P 500 generally at or near all-time highs throughout the year. Through the first half of 2022 equity markets declined and equity volatility increased, resulting in higher hedging costs. The financial performance of our hedging program could be impacted by large directional market movements or periods of high volatility. In particular, our hedges could be less effective in periods of large directional movements or we could experience more frequent or more costly rebalancing in periods of high volatility, which would lead to adverse performance versus our hedge targets and increased hedging costs. Further, we are also exposed to basis risk, which results from our inability to purchase or sell hedge assets whose performance is perfectly correlated to the performance of the funds into which customers allocate their assets. We make funds available to customers where we believe we can transact in sufficiently correlated hedge assets, and we anticipate some variance in the performance of our hedge assets and customer funds. This variance may result in our hedge assets outperforming or underperforming the customer assets they are intended to match. This variance may be exacerbated during periods of high volatility, leading to a mismatch in our hedge results relative to our hedge targets and GAAP results.
85
Item 2 | Management’s Discussion and Analysis | Macroeconomic, Industry and Regulatory Trends
Interest Rate Environment
The interest rate environment has affected, and will continue to affect our business and financial performance in the future for the following reasons:
•To the extent interest rates continue to increase, consistent with the Federal Reserve’s signals about upcoming interest rate decisions, the effects of low interest rates discussed below will diminish over time. However, both nominal and real interest rates remain low by historical standards and may continue to be so even after additional rounds of interest rate increases by the Federal Reserve.
During periods of sharp rises in interest rates, the results of our variable annuity business, statutory capital and RBC ratio may be impacted both positively and negatively. While rising rates result in hedging losses immediately due to reductions in the market value of interest rate hedges, we would expect lower hedging costs and reduced levels of hedging going forward in a higher interest rate environment. Further, we expect near-term hedging losses from rising rates may be more than offset by changes in the fair value of the related guaranteed benefit liabilities as was the case in the first half of 2022. Our statutory capital and RBC ratio may be negatively impacted by rising rates due to minimum required reserving levels (i.e., cash surrender value floor) when reserve releases are limited and unable to offset interest rate hedging losses.
•For the past several years, we have operated in a low interest rate environment. A prolonged low interest rate environment subjects us to increased hedging costs or an increase in the amount of statutory reserves that our insurance subsidiaries are required to hold for optional guaranteed benefits, decreasing statutory surplus, which would adversely affect their ability to pay dividends. Certain inputs to the statutory models rely on prescribed interest rates, which are, in turn, determined using a historical interest rate perspective with a mean reversion path over the longer term. At low interest rate levels these prescribed rates could decline further as the NAIC updates the calculations each year, which would adversely impact our statutory capital. In addition, low interest rates could also increase the perceived value of optional guaranteed benefit features to our customers, which in turn could lead to a higher utilization of withdrawal or annuitization features of annuity policies and higher persistency of those products over time. Finally, low interest rates would continue to cause an acceleration of DAC amortization or reserve increase due to loss recognition for annuities and interest-sensitive life insurance.
A gradual rise in interest rates would have benefits that are offsetting to a low interest rate environment previously described. Those potential benefits of rising interest rates include increased new money investment yields, a reduction in hedging requirements and more attractive product features.
•Some of our annuities have a guaranteed minimum interest crediting rate. These guaranteed minimum interest crediting rates may not be lowered, even if earnings on our investment portfolio decline, resulting in net investment spread compression that negatively impacts earnings. In addition, we expect more customers to hold policies with comparatively high guaranteed minimum interest crediting rates longer in a low interest rate environment, resulting in lower than previously expected lapse rates. Conversely, a rise in the average yield on our investment portfolio should positively impact earnings. Similarly, we expect customers would be less likely to hold policies if existing guaranteed minimum interest crediting rates are perceived to have less value as interest rates rise, resulting in higher than previously expected lapse rates.
86
Item 2 | Management’s Discussion and Analysis | Macroeconomic, Industry and Regulatory Trends
Credit Market Environment
Our financial performance is impacted by conditions in fixed income markets. After tightening in 2021, credit spreads widened in the first half of 2022. As credit spreads widen, the fair value of our existing investment portfolio generally decreases, although we generally expect the widening spreads to increase the yield on new fixed income investments. Conversely, as credit spreads tighten, the fair value of our existing investment portfolio generally increases, and the yield available on new investment purchases decreases. While changing credit spreads impact the fair value of our investment portfolio, this revaluation is generally reflected in our Accumulated Other Comprehensive Income. The revaluation will impact net income for realized gains or losses from the sale of securities, the change in fair value of trading securities or securities carried at fair value under the fair value election, or potential changes in the allowance for credit loss ("ACL"). Shifts in the credit quality of the assets underlying our investment portfolio may also impact the level of regulatory required statutory capital for our insurance company subsidiaries. As such, significant credit rating downgrades or payment defaults could negatively impact our RBC ratio.
COVID-19
We continue to closely monitor developments related to the COVID-19 pandemic. The COVID-19 pandemic has caused significant economic and financial turmoil both in the United States and around the world. While there has been a gradual resumption of activity, COVID-19 and its variants continue to affect activity, and those effects could worsen in the future. At this time, it is not possible to estimate the long-term effectiveness of any therapeutic treatments and vaccines for COVID-19, or their efficacy with respect to current or future variants or mutations of COVID-19, or the longer-term effects that the COVID-19 pandemic could have on our business. The extent to which the COVID-19 pandemic impacts our business, results of operations, financial condition and cash flows will depend on future developments which are highly uncertain and cannot be predicted, including the availability and efficacy of vaccines against COVID-19 and against variant strains of the virus. Federal and state authorities’ actions could include restrictions of movements. We are not able to predict the duration and effectiveness of governmental and regulatory actions taken to contain or address the COVID-19 pandemic or the impact of future laws, regulations or restrictions on our business.
Consumer Behavior
We believe that many retirees have begun to look to tax-efficient savings products as a tool for addressing their unmet need for retirement planning. We believe our products are well positioned to meet this increasing consumer demand. However, consumer behavior may be impacted by increased economic uncertainty, increased unemployment rates, declining equity markets, lower interest rates and increased volatility of financial markets. In recent years, we have introduced new products to better address changes in consumer demand and targeted distribution channels which meet changes in consumer preferences.
Demographics
We expect demographic trends in the U.S. population, in particular the increase in the number of retirement age individuals, to generate significant demand for our products. In addition, the potential risk to government social safety net programs and shifting of responsibility for retirement planning and financial security from employers and other institutions to employees, highlights the need for individuals to plan for their long-term financial security and will create additional opportunities to generate sustained demand for our products. We believe we are well positioned to capture the increased demand generated by these demographic trends.
Regulatory Policy
We operate in a highly regulated industry. Our insurance company subsidiaries are regulated primarily at the state level, with some policies and products also subject to federal regulation. As such, regulations recently approved or currently under review at both the U.S. federal and state level could impact our business model, including statutory reserve and capital requirements. We anticipate that our ability to respond to changes in regulation and other legislative activity will be critical to our long-term financial performance. In particular, the following could materially impact our business:
87
Item 2 | Management’s Discussion and Analysis | Macroeconomic, Industry and Regulatory Trends
Department of Labor Fiduciary Advice Rule
The Department of Labor (“DOL”) has issued a new regulatory action (the “Fiduciary Advice Rule”) effective February 16, 2021, that reinstates the text of the DOL’s 1975 investment advice regulation defining what constitutes fiduciary “investment advice” to Employee Retirement Income Security Act ("ERISA") Plans and Individual Retirement Accounts ("IRAs") and provides guidance interpreting such regulation. The guidance provided by the DOL broadens the circumstances under which financial institutions, including insurance companies, could be considered fiduciaries under ERISA or the Tax Code. In particular, the DOL states that a recommendation to “roll over” assets from a qualified retirement plan to an IRA, or from an IRA to another IRA, can be considered fiduciary investment advice if provided by someone with an existing relationship with the ERISA Plan or an IRA owner (or in anticipation of establishing such a relationship). This guidance reverses an earlier DOL interpretation suggesting that roll over advice did not constitute investment advice giving rise to a fiduciary relationship. Because we do not engage in direct distribution of annuities, including IRA products and annuities sold to ERISA plan participants and to IRA owners, we believe that we will have limited exposure to the new Fiduciary Advice Rule. Unlike the DOL’s previous fiduciary rule issued in 2016, compliance with the Fiduciary Advice Rule will not require us or our distributors to provide the disclosures required for exemptive relief under the previous rule. However, we continue to analyze the impact of the Fiduciary Advice Rule, and, while we cannot predict the rule’s impact, it could have an adverse effect on sales of annuities through our distribution partners. The Fiduciary Advice Rule may also lead to changes to our compensation practices and product offerings and increased litigation risk, which could adversely affect our results of operations and financial condition. We may also need to take certain additional actions in order to comply with or assist our distributors in their compliance with the Fiduciary Advice Rule.
Legislative Reforms
Congress approved the Setting Every Community Up for Retirement Enhancement Act of 2019 (the "SECURE Act") on December 20, 2019. The SECURE Act provides individuals with greater access to retirement products. Namely, it makes it easier for 401(k) programs to offer annuities as an investment option by, among other things, creating a statutory safe harbor in ERISA for a retirement plan’s selection of an annuity provider. The SECURE Act represents the largest overhaul to retirement plans in over a decade. We view these reforms as beneficial to our business model and expect growth opportunities will arise from the new law.
Tax Laws
All of our annuities offer investors the opportunity to benefit from tax deferral. If U.S. tax laws were to change, such that our annuities no longer offer tax-deferred advantages, demand for our products could materially decrease.
88
Item 2 | Management’s Discussion and Analysis | Consolidated Results of Operations
Consolidated Results of Operations
The following table sets forth, for the periods presented, certain data from our Condensed Consolidated Income Statements. The information contained in the table below should be read in conjunction with our Condensed Consolidated Financial Statements and the related notes elsewhere in this Report:
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||
Fee income | $ | 1,852 | $ | 1,896 | $ | 3,774 | $ | 3,712 | ||||||||||||||||||
Premiums | 32 | 31 | 66 | 65 | ||||||||||||||||||||||
Net investment income | 747 | 796 | 1,467 | 1,724 | ||||||||||||||||||||||
Net gains (losses) on derivatives and investments | 3,867 | (2,521) | 5,472 | 185 | ||||||||||||||||||||||
Other income | 21 | 30 | 41 | 53 | ||||||||||||||||||||||
Total revenues | 6,519 | 232 | 10,820 | 5,739 | ||||||||||||||||||||||
Benefits and Expenses | ||||||||||||||||||||||||||
Death, other policy benefits and change in policy reserves, net of deferrals | 912 | 210 | 1,479 | 493 | ||||||||||||||||||||||
Interest credited on other contract holder funds, net of deferrals | 217 | 217 | 423 | 440 | ||||||||||||||||||||||
Interest expense | 24 | 7 | 44 | 13 | ||||||||||||||||||||||
Operating costs and other expenses, net of deferrals | 517 | 600 | 1,124 | 1,198 | ||||||||||||||||||||||
Amortization of deferred acquisition and sales inducement costs | 1,198 | (264) | 1,713 | 548 | ||||||||||||||||||||||
Total benefits and expenses | 2,868 | 770 | 4,783 | 2,692 | ||||||||||||||||||||||
Pretax income (loss) | 3,651 | (538) | 6,037 | 3,047 | ||||||||||||||||||||||
Income tax expense (benefit) | 717 | (54) | 1,047 | 531 | ||||||||||||||||||||||
Net income (loss) | 2,934 | (484) | 4,990 | 2,516 | ||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 31 | 56 | 62 | 124 | ||||||||||||||||||||||
Net income (loss) attributable to Jackson Financial Inc. | $ | 2,903 | $ | (540) | $ | 4,928 | $ | 2,392 | ||||||||||||||||||
Adjusted Operating Earnings | ||||||||||||||||||||||||||
Net income (loss) attributable to Jackson Financial, Inc. | $ | 2,903 | $ | (540) | $ | 4,928 | $ | 2,392 | ||||||||||||||||||
Income tax expense (benefit) | 717 | (54) | 1,047 | 531 | ||||||||||||||||||||||
Pretax income (loss) attributable to Jackson Financial Inc | 3,620 | (594) | 5,975 | 2,923 | ||||||||||||||||||||||
Non-operating adjustments (income) loss: | ||||||||||||||||||||||||||
Guaranteed benefits and hedging results: | ||||||||||||||||||||||||||
Fees attributable to guarantee benefit reserves | (765) | (701) | (1,529) | (1,373) | ||||||||||||||||||||||
Net movement in freestanding derivatives | (2,847) | 442 | (1,371) | 3,473 | ||||||||||||||||||||||
Net reserve and embedded derivative movements | 772 | 1,374 | (1,067) | (3,219) | ||||||||||||||||||||||
DAC and DSI impact | 845 | (243) | 1,190 | 453 | ||||||||||||||||||||||
Assumption changes | — | — | — | — | ||||||||||||||||||||||
Total guaranteed benefits and hedging results | (1,995) | 872 | (2,777) | (666) | ||||||||||||||||||||||
Net realized investment (gains) losses including change in fair value of funds withheld embedded derivative | (1,082) | 752 | (1,980) | (298) | ||||||||||||||||||||||
Net investment income on funds withheld assets | (364) | (294) | (624) | (585) | ||||||||||||||||||||||
Other items | 64 | 25 | 67 | 20 | ||||||||||||||||||||||
Total non-operating adjustments | (3,377) | 1,355 | (5,314) | (1,529) | ||||||||||||||||||||||
Pretax Adjusted Operating Earnings | 243 | 761 | 661 | 1,394 | ||||||||||||||||||||||
Operating income taxes | 18 | 125 | 82 | 189 | ||||||||||||||||||||||
Adjusted Operating Earnings | $ | 225 | $ | 636 | $ | 579 | $ | 1,205 |
89
Item 2 | Management’s Discussion and Analysis | Consolidated Results of Operations
Three Months Ended June 30, 2022 compared to Three Months Ended June 30, 2021
Pretax Income (Loss)
Our pretax income (loss) increased by $4,189 million to a pretax income of $3,651 million for the three months ended June 30, 2022, from a pretax loss of $538 million for the three months ended June 30, 2021 primarily due to:
•$6,388 million increase in total net gains (losses) on derivatives and investments as shown in the table below and driven by:
Three Months Ended June 30, | ||||||||||||||||||||
2022 | 2021 | Variance | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Net gains (losses) excluding derivatives and funds withheld assets | $ | 5 | $ | 15 | $ | (10) | ||||||||||||||
Net gains (losses) on freestanding derivatives | 2,862 | (401) | 3,263 | |||||||||||||||||
Net gains (losses) on embedded derivatives (excluding funds withheld reinsurance) | (77) | (1,367) | 1,290 | |||||||||||||||||
Net gains (losses) on derivative instruments | 2,785 | (1,768) | 4,553 | |||||||||||||||||
Net gains (losses) on funds withheld reinsurance | 1,077 | (768) | 1,845 | |||||||||||||||||
Total net gains (losses) on derivatives and investments | $ | 3,867 | $ | (2,521) | $ | 6,388 |
◦Higher freestanding derivative gains as a result of gains on our equity derivatives primarily driven by significant market decreases in 2022, compared to market increases in the prior year, partially offset by losses within our interest rate related hedge instruments, reflecting increases in interest rates, compared to the prior year;
◦Higher benefit recognized on funds withheld reinsurance compared to prior year; and
◦Lower unfavorable movements in reserves for guaranteed benefits, primarily driven by more favorable movements in interest rates, partially offset by unfavorable equity and equity volatility movements compared to prior year.
•$83 million decrease in operating costs and other expenses, net of deferrals, primarily due to lower incentive compensation expenses in 2022, higher separation costs in 2021, and lower asset-based commissions, which are non-deferrable and the result of lower account values during the three months ended June 30, 2022.
This increase was partially offset by:
•$1,462 million increase in amortization of deferred acquisition costs and deferred sales inducement costs driven by higher net freestanding and embedded derivative gains in 2022, leading to higher current period gross profits and, therefore, higher current period amortization.
•$702 million increase in death, other policy benefits and change in policy reserves primarily due to changes in reserves on variable annuity guarantees accounted for as insurance liabilities driven by unfavorable equity movements during the three months ended June 30, 2022 compared to favorable movements during the three months ended June 30, 2021;
•$49 million decrease in net investment income as a result of lower income on limited partnership investments, which are recorded on a one quarter lag;
•$44 million decrease in fee income primarily due to decrease in average variable annuity account values stemming from unfavorable separate account performance in 2022; and
•$17 million higher interest expense incurred in the current year primarily related to our senior notes.
90
Item 2 | Management’s Discussion and Analysis | Consolidated Results of Operations
Income Taxes
Income tax expense increased $771 million to an expense of $717 million for the three months ended June 30, 2022, from a benefit of $54 million for the three months ended June 30, 2021. The provision for income tax in the current period led to an effective income tax rate of 20% for the three months ended June 30, 2022 compared to the 2021 effective income tax rate of 9%. Our ETR differs from the statutory rate of 21% primarily due to the dividends received deduction and utilization of tax credits. See Note 13 of Notes to Consolidated Financial Statements in our 2021 Annual Report for more information.
Six Months Ended June 30, 2022 compared to Six Months Ended June 30, 2021
Pretax Income (Loss)
Our pretax income (loss) increased by $2,990 million to a pretax income of $6,037 million for the six months ended June 30, 2022, from a pretax income of $3,047 million for the six months ended June 30, 2021 primarily due to:
•$5,287 million increase in total net gains (losses) on derivatives and investments as shown in the table below and driven by:
Six Months Ended June 30, | ||||||||||||||||||||
2022 | 2021 | Variance | ||||||||||||||||||
(in millions) | ||||||||||||||||||||
Net gains (losses) excluding derivatives and funds withheld assets | $ | (125) | $ | 168 | $ | (293) | ||||||||||||||
Net gains (losses) on freestanding derivatives | 1,421 | (3,394) | 4,815 | |||||||||||||||||
Net gains (losses) on embedded derivatives (excluding funds withheld reinsurance) | 2,071 | 3,281 | (1,210) | |||||||||||||||||
Net gains (losses) on derivative instruments | 3,492 | (113) | 3,605 | |||||||||||||||||
Net gains (losses) on funds withheld reinsurance | 2,105 | 130 | 1,975 | |||||||||||||||||
Total net gains (losses) on derivatives and investments | $ | 5,472 | $ | 185 | $ | 5,287 |
◦Higher freestanding derivative gains on our equity derivatives primarily driven by significant market decreases in 2022, compared to market increases in the prior year. These gains were partially offset by losses within our interest rate related hedge instruments, reflecting increases in interest rates, as compared to the prior year; and
◦Higher benefit recognized on funds withheld reinsurance compared to prior year;
Primarily offset by:
◦Less favorable movements in reserves for guaranteed benefits, primarily driven by unfavorable equity and equity volatility movements, partially offset by more favorable movements in interest rates, compared to prior year; and
◦Losses on sales of securities recognized on gains (losses) excluding derivatives and funds withheld assets, compared to prior year gains.
•$74 million decrease in operating costs and other expenses, net of deferrals, primarily due to lower asset-based commissions, which are non-deferrable and the result of lower account values during the six months ended June 30, 2022, and higher separation costs in 2021. These favorable variances were partially offset by higher incentive compensation in 2022.
•$62 million increase in fee income primarily due to increases in benefit based guarantee fee income compared to prior year, partially offset by decreases in variable fee income.
91
Item 2 | Management’s Discussion and Analysis | Consolidated Results of Operations
This increase was partially offset by:
•$1,165 million increase in amortization of deferred acquisition costs and deferred sales inducement costs driven by higher net freestanding derivative gains in 2022, leading to higher current period gross profits and, therefore, higher current period amortization;
•$986 million increase in death, other policy benefits and change in policy reserves primarily due changes in reserves on variable annuity guarantees accounted for as insurance liabilities driven by unfavorable equity movements in 2022 compared to favorable movements in 2021;
•$257 million decrease in net investment income as a result of lower income on limited partnership investments, which are recorded on a one quarter lag; and
•$31 million higher interest expense incurred in the current year primarily related to our senior notes.
Income Taxes
Income tax expense increased $516 million to an expense of $1,047 million for the six months ended June 30, 2022, from an expense of $531 million for the six months ended June 30, 2021. The provision for income tax in the current period led to an effective income tax rate of 18% for the six months ended June 30, 2022 compared to the 2021 effective income tax rate of 18%. Our ETR differs from the statutory rate of 21% primarily due to the dividends received deduction and utilization of tax credits. See Note 13 of Notes to Consolidated Financial Statements in our 2021 Annual Report for more information.
92
Item 2 | Management’s Discussion and Analysis | Segment Results of Operations
Segment Results of Operations
We manage our business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks. We report certain activities and items that are not included in these segments, including the results of PPM Holdings, Inc., the holding company of PPM, within Corporate and Other. The following tables and discussion represent an overall view of our results of operations for each segment.
Pretax Adjusted Operating Earnings by Segment
The following table summarizes pretax adjusted operating earnings (non-GAAP) from the Company's business segment operations and also provides a reconciliation of the segment measure to net income on a consolidated GAAP basis. Also, see Note 3 to Condensed Consolidated Financial Statements for further information regarding the calculation of pretax adjusted operating earnings:
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Pretax Adjusted Operating Earnings by Segment: | ||||||||||||||||||||||||||
Retail Annuities | $ | 218 | $ | 683 | $ | 624 | $ | 1,252 | ||||||||||||||||||
Institutional Products | 19 | 6 | 42 | 16 | ||||||||||||||||||||||
Closed Life and Annuity Blocks | 6 | 56 | (2) | 135 | ||||||||||||||||||||||
Corporate and Other | — | 16 | (3) | (9) | ||||||||||||||||||||||
Pretax Adjusted Operating Earnings | 243 | 761 | 661 | 1,394 | ||||||||||||||||||||||
Pre-tax reconciling items from adjusted operating income to net income (loss) attributable to Jackson Financial, Inc.: | ||||||||||||||||||||||||||
Guaranteed benefits and hedging results: | ||||||||||||||||||||||||||
Fees attributable to guarantee benefit reserves | 765 | 701 | 1,529 | 1,373 | ||||||||||||||||||||||
Net movement in freestanding derivatives | 2,847 | (442) | 1,371 | (3,473) | ||||||||||||||||||||||
Net reserve and embedded derivative movements | (772) | (1,374) | 1,067 | 3,219 | ||||||||||||||||||||||
DAC and DSI impact | (845) | 243 | (1,190) | (453) | ||||||||||||||||||||||
Assumption changes | — | — | — | — | ||||||||||||||||||||||
Total guaranteed benefits and hedging results | 1,995 | (872) | 2,777 | 666 | ||||||||||||||||||||||
Net realized investment (gains) losses including change in fair value of funds withheld embedded derivative | 1,082 | (752) | 1,980 | 298 | ||||||||||||||||||||||
Net investment income on funds withheld assets | 364 | 294 | 624 | 585 | ||||||||||||||||||||||
Other items | (64) | (25) | (67) | (20) | ||||||||||||||||||||||
Total pre-tax reconciling items | 3,377 | (1,355) | 5,314 | 1,529 | ||||||||||||||||||||||
Pretax income (loss) attributable to Jackson Financial Inc. | 3,620 | (594) | 5,975 | 2,923 | ||||||||||||||||||||||
Income tax expense (benefit) | 717 | (54) | 1,047 | 531 | ||||||||||||||||||||||
Net income (loss) attributable to Jackson Financial Inc. | $ | 2,903 | $ | (540) | $ | 4,928 | $ | 2,392 |
93
Item 2 | Management’s Discussion and Analysis | Segment Results of Operations
Retail Annuities
The following table sets forth, for the periods presented, certain data underlying the results for our Retail Annuities segment. The information contained in the table below should be read in conjunction with our Condensed Consolidated Financial Statements and the related notes appearing elsewhere in this Report:
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Retail Annuities: | ||||||||||||||||||||||||||
Operating Revenues | ||||||||||||||||||||||||||
Fee income | $ | 949 | $ | 1,050 | $ | 1,965 | $ | 2,046 | ||||||||||||||||||
Net investment income | 124 | 144 | 242 | 349 | ||||||||||||||||||||||
Income (loss) on operating derivatives | 7 | 15 | 18 | 29 | ||||||||||||||||||||||
Other income | 11 | 11 | 22 | 23 | ||||||||||||||||||||||
Total Operating Revenues | 1,091 | 1,220 | 2,247 | 2,447 | ||||||||||||||||||||||
Operating Benefits and Expenses | ||||||||||||||||||||||||||
Death, other policy benefits and change in policy reserves | 9 | 11 | 25 | 17 | ||||||||||||||||||||||
Interest credited on other contract holder funds | 71 | 66 | 139 | 133 | ||||||||||||||||||||||
Interest expense | 6 | 6 | 11 | 11 | ||||||||||||||||||||||
Operating costs and other expenses, net of deferrals | 441 | 485 | 945 | 961 | ||||||||||||||||||||||
Amortization of deferred acquisition costs and deferred sales inducement costs | 346 | (31) | 503 | 73 | ||||||||||||||||||||||
Total Operating Benefits and Expenses | 873 | 537 | 1,623 | 1,195 | ||||||||||||||||||||||
Pretax Adjusted Operating Earnings | $ | 218 | $ | 683 | $ | 624 | $ | 1,252 |
The following table summarizes a roll forward of activity affecting account value for our Retail Annuities segment for the periods indicated:
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Retail Annuities Account Value: | ||||||||||||||||||||||||||
Balance as of beginning of period | $ | 266,647 | $ | 264,111 | $ | 284,379 | $ | 256,741 | ||||||||||||||||||
Premiums and deposits | 4,179 | 4,903 | 9,021 | 9,675 | ||||||||||||||||||||||
Surrenders, withdrawals, and benefits | (4,565) | (5,787) | (9,800) | (11,427) | ||||||||||||||||||||||
Net flows | (386) | (884) | (779) | (1,752) | ||||||||||||||||||||||
Credited Interest/Investment performance | (33,319) | 13,632 | (49,932) | 22,511 | ||||||||||||||||||||||
Policy Charges and other | (723) | (674) | (1,449) | (1,315) | ||||||||||||||||||||||
Balance as of end of period | 232,219 | 276,185 | 232,219 | 276,185 | ||||||||||||||||||||||
Ceded reinsurance | (23,762) | (25,920) | (23,762) | (25,920) | ||||||||||||||||||||||
Balance as of end of period, net of ceded reinsurance | $ | 208,457 | $ | 250,265 | $ | 208,457 | $ | 250,265 |
94
Item 2 | Management’s Discussion and Analysis | Segment Results of Operations
Three Months Ended June 30, 2022 compared to Three Months Ended June 30, 2021
Pretax Adjusted Operating Earnings
Pretax Adjusted Operating Earnings decreased $465 million to $218 million for the three months ended June 30, 2022 from $683 million for the three months ended June 30, 2021 primarily due to:
•$377 million increase in amortization of deferred acquisition costs and deferred sales inducement costs primarily due to lower separate account returns, which led to decreased expected future gross profits, and therefore higher current period amortization during 2022;
•$101 million decrease in fee income primarily due to a decrease in average variable annuity account values stemming from unfavorable separate account performance in 2022; and
•$20 million decrease in net investment income primarily due to lower levels of investment income on private equity and other limited partnership investments, when compared to the same period in 2021.
These decreases were partially offset by:
•$44 million decrease in operating costs and other expenses, net of deferrals, primarily due to lower asset-based commissions, which are non-deferrable and the result of lower account values during the three months ended June 30, 2022, and lower incentive compensation expenses in 2022.
Six Months Ended June 30, 2022 compared to Six Months Ended June 30, 2021
Pretax Adjusted Operating Earnings
Pretax Adjusted Operating Earnings decreased $628 million to $624 million for the six months ended June 30, 2022 from $1,252 million for the six months ended June 30, 2021 primarily due to:
•$430 million increase in amortization of deferred acquisition costs and deferred sales inducement costs primarily due to lower separate account returns, which led to decreased expected future gross profits, and therefore higher current period amortization during 2022;
•$107 million decrease in net investment income primarily due to lower levels of investment income on private equity and other limited partnership investments, when compared to the same period in 2021; and
•$81 million decrease in fee income primarily due to a decrease in average variable annuity account values stemming from unfavorable separate account performance in 2022.
These decreases were partially offset by:
•$16 million decrease in operating costs and other expenses, net of deferrals, primarily due to lower asset-based commissions, which are non-deferrable and the result of lower account values during 2022. This favorable variance was partially offset by higher incentive compensation in 2022.
Account Value
Retail annuities account value, gross of reinsurance, decreased $44 billion between periods primarily due to negative variable annuity separate account growth driven by unfavorable market performance in 2022, as well as negative net flows over the period, primarily from our reinsured fixed and fixed index annuity block.
95
Item 2 | Management’s Discussion and Analysis | Segment Results of Operations
Institutional Products
The following table sets forth, for the periods presented, certain data underlying the results for our Institutional Products segment. The information contained in the table below should be read in conjunction with our Condensed Consolidated Financial Statements and the related notes appearing elsewhere in this Report.
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Institutional Products: | ||||||||||||||||||||||||||
Operating Revenues | ||||||||||||||||||||||||||
Net investment income | $ | 72 | $ | 57 | $ | 136 | $ | 120 | ||||||||||||||||||
Income (loss) on operating derivatives | (4) | — | (5) | — | ||||||||||||||||||||||
Total Operating Revenues | 68 | 57 | 131 | 120 | ||||||||||||||||||||||
Operating Benefits and Expenses | ||||||||||||||||||||||||||
Interest credited on other contract holder funds | 47 | 48 | 86 | 100 | ||||||||||||||||||||||
Interest expense | — | 1 | — | 2 | ||||||||||||||||||||||
Operating costs and other expenses, net of deferrals | 2 | 2 | 3 | 2 | ||||||||||||||||||||||
Total Operating Benefits and Expenses | 49 | 51 | 89 | 104 | ||||||||||||||||||||||
Pretax Adjusted Operating Earnings | $ | 19 | $ | 6 | $ | 42 | $ | 16 |
The following table summarizes a roll forward of activity affecting account value for our Institutional Products segment for the periods indicated:
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Institutional Products: | ||||||||||||||||||||||||||
Balance as of beginning of period | $ | 9,173 | $ | 10,579 | $ | 8,830 | $ | 11,138 | ||||||||||||||||||
Premiums and deposits | 201 | — | 1,176 | — | ||||||||||||||||||||||
Surrenders, withdrawals, and benefits | (868) | (1,735) | (1,527) | (2,281) | ||||||||||||||||||||||
Net flows | (667) | (1,735) | (351) | (2,281) | ||||||||||||||||||||||
Credited Interest | 47 | 49 | 86 | 102 | ||||||||||||||||||||||
Policy Charges and other | (70) | 17 | (82) | (49) | ||||||||||||||||||||||
Balance as of end of period | $ | 8,483 | $ | 8,910 | $ | 8,483 | $ | 8,910 |
Three Months Ended June 30, 2022 compared to Three Months Ended June 30, 2021
Pretax Adjusted Operating Earnings
Pretax Adjusted Operating Earnings increased $13 million to $19 million for the three months ended June 30, 2022 from $6 million for the three months ended June 30, 2021 primarily due to increased investment income compared to prior year.
Six Months Ended June 30, 2022 compared to Six Months Ended June 30, 2021
Pretax Adjusted Operating Earnings
Pretax Adjusted Operating Earnings increased $26 million to $42 million for the six months ended June 30, 2022 from $16 million for the six months ended June 30, 2021 primarily due to increased investment income and a decrease in interest credited compared to prior year.
96
Item 2 | Management’s Discussion and Analysis | Segment Results of Operations
Account Value
Institutional product account value decreased from $8,910 million at June 30, 2021 to $8,483 million at June 30, 2022. The decline in account value was driven by continued maturities of the existing contracts and funding agreements, partially offset by new issuances in 2022.
Closed Life and Annuity Blocks
The following table sets forth, for the periods presented, certain data underlying the results for our Closed Life and Annuity Blocks segment. The information contained in the table below should be read in conjunction with our Condensed Consolidated Financial Statements and the related notes appearing elsewhere in this Report.
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Closed Life and Annuity Blocks: | ||||||||||||||||||||||||||
Operating Revenues | ||||||||||||||||||||||||||
Fee income | $ | 119 | $ | 123 | $ | 240 | $ | 248 | ||||||||||||||||||
Premiums | 35 | 34 | 72 | 71 | ||||||||||||||||||||||
Net investment income | 185 | 205 | 381 | 461 | ||||||||||||||||||||||
Income (loss) on operating derivatives | 13 | 17 | 28 | 38 | ||||||||||||||||||||||
Other income | 9 | 12 | 17 | 22 | ||||||||||||||||||||||
Total Operating Revenues | 361 | 391 | 738 | 840 | ||||||||||||||||||||||
Operating Benefits and Expenses | ||||||||||||||||||||||||||
Death, other policy benefits and change in policy reserves | 217 | 192 | 459 | 413 | ||||||||||||||||||||||
Interest credited on other contract holder funds | 99 | 103 | 198 | 207 | ||||||||||||||||||||||
Operating costs and other expenses, net of deferrals | 39 | 38 | 79 | 78 | ||||||||||||||||||||||
Amortization of deferred acquisition costs and deferred sales inducement costs | — | 2 | 4 | 7 | ||||||||||||||||||||||
Total Operating Benefits and Expenses | 355 | 335 | 740 | 705 | ||||||||||||||||||||||
Pretax Adjusted Operating Earnings | $ | 6 | $ | 56 | $ | (2) | $ | 135 |
Three Months Ended June 30, 2022 compared to Three Months Ended June 30, 2021
Pretax Adjusted Operating Earnings
Pretax Adjusted Operating Earnings decreased $50 million to $6 million for the three months ended June 30, 2022 from $56 million for the three months ended June 30, 2021 primarily due to:
•$20 million decrease in net investment income primarily due to lower levels of investment income on private equity and other limited partnership investments, when compared to the same period in 2021; and
•$25 million increase in death, other policy benefit and change in policy reserves as a result of higher death claims and less favorable reserve movements in 2022 compared to 2021.
Six Months Ended June 30, 2022 compared to Six Months Ended June 30, 2021
Pretax Adjusted Operating Earnings
Pretax Adjusted Operating Earnings decreased $137 million to $(2) million for the six months ended June 30, 2022 from $135 million for the six months ended June 30, 2021 primarily due to:
•$80 million decrease in net investment income primarily due to lower levels of investment income on private equity and other limited partnership investments, when compared to the same period in 2021; and
•$46 million increase in death, other policy benefit and change in policy reserves as a result of higher death claims and less favorable reserve movements in 2022 compared to 2021.
97
Item 2 | Management’s Discussion and Analysis | Segment Results of Operations
Corporate and Other
Corporate and Other includes the operations of PPM Holdings, Inc., the holding company of PPM, and unallocated corporate revenue and expenses, as well as certain eliminations and consolidation adjustments. The following table sets forth, for the periods presented, certain data underlying the results for Corporate and Other. The information contained in the table below should be read in conjunction with our Condensed Consolidated Financial Statements and the related notes appearing elsewhere in this Report.
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||
Corporate and Other: | ||||||||||||||||||||||||||
Operating Revenues | ||||||||||||||||||||||||||
Fee income | $ | 17 | $ | 19 | $ | 35 | $ | 39 | ||||||||||||||||||
Net investment income | 35 | 39 | 88 | 54 | ||||||||||||||||||||||
Income (loss) on operating derivatives | 8 | 8 | 18 | 12 | ||||||||||||||||||||||
Other income | 1 | 7 | 2 | 8 | ||||||||||||||||||||||
Total Operating Revenues | 61 | 73 | 143 | 113 | ||||||||||||||||||||||
Operating Benefits and Expenses | ||||||||||||||||||||||||||
Interest expense | 18 | — | 33 | — | ||||||||||||||||||||||
Operating costs and other expenses, net of deferrals | 35 | 49 | 96 | 107 | ||||||||||||||||||||||
Amortization of deferred acquisition costs and deferred sales inducement costs | 8 | 8 | 17 | 15 | ||||||||||||||||||||||
Total Operating Benefits and Expenses | 61 | 57 | 146 | 122 | ||||||||||||||||||||||
Pretax Adjusted Operating Earnings | $ | — | $ | 16 | $ | (3) | $ | (9) |
Three Months Ended June 30, 2022 compared to Three Months Ended June 30, 2021
Pretax Adjusted Operating Earnings
Pretax adjusted operating earnings decreased $16 million to nil for the three months ended June 30, 2022 from $16 million for the three months ended June 30, 2021 primarily due to the following:
•$18 million higher interest expense incurred in the current year primarily related to our senior notes; and
this decrease was partially offset by:
•$14 million decrease in operating costs and other expenses, net of deferrals, primarily due to lower incentive compensation expenses in 2022.
Six Months Ended June 30, 2022 compared to Six Months Ended June 30, 2021
Pretax Adjusted Operating Earnings
Pretax adjusted operating earnings increased $6 million to $(3) million for the six months ended June 30, 2022 from $(9) million for the six months ended June 30, 2021 primarily due to the following:
•$34 million increase in net investment income primarily due to higher net investment income resulting from an increased excess capital position, as the investment income on that excess capital remains in the Corporate and Other segment; and
•$11 million decrease in operating costs and other expenses, net of deferrals, primarily due to lower compensation expenses in 2022.
This increase was partially offset by:
•$33 million higher interest expense incurred in the current year primarily related to our senior notes.
98
Item 2 | Management’s Discussion and Analysis | Investments
Investments
Our investment portfolio primarily consists of fixed-income securities and loans, primarily publicly-traded corporate and government bonds, private securities and loans, asset-backed securities and mortgage loans. Asset-backed securities include mortgage-backed and other structured securities. The fair value of these and our other invested assets fluctuates depending on market and other general economic conditions and the interest rate environment and could be adversely impacted by other economic factors.
Investment Strategy
Our overall investment strategy is to maintain a diversified and largely investment grade fixed income portfolio that is capital efficient, achieves risk-adjusted returns that support competitive pricing for our products, generates profitable growth of our business and maintains adequate liquidity to support our obligations. The investments within our investment portfolio are primarily managed by PPM, our wholly-owned registered investment advisor. Our investment strategy benefits from PPM’s ability to originate investments directly, as well as participate in transactions originated by banks, investment banks, commercial finance companies and other intermediaries. Certain investments held in funds withheld accounts for reinsurance transactions are managed by Apollo Insurance Solutions Group LP ("Apollo"), an Athene affiliate, see Note 8 of Condensed Consolidated Financial Statements for further details. We may also use other third-party investment managers for certain niche asset classes. As of June 30, 2022, Apollo managed $22 billion of cash and investments and other third-party investment managers represented approximately $185 million of investments.
Our investment program seeks to generate a competitive rate of return on our invested assets to support the profitable growth of our business, while maintaining investment portfolio allocations within the company’s risk tolerance. This means seeking to maximize risk-adjusted return within the context of a largely fixed income portfolio while also managing exposure to downside risk in a stressed environment, regulatory and rating agency capital models, overall portfolio yield, diversification and correlation with other investments and company exposures.
Our Investment Committee has specified a target strategic asset allocation (“SAA”) that is designed to deliver the highest expected return within a defined risk tolerance while meeting other important objectives such as those mentioned in the prior paragraph. The fixed income portion of the SAA is assessed relative to a customized index of public corporate bonds that represents a close approximation of the maturity profile of our liabilities and a credit quality mix that is consistent with our risk tolerance. PPM’s objective is to outperform this index on a number of measures including portfolio yield, total return and capital loss due to downgrades and defaults. While PPM has access to a broad universe of potential investments, we believe grounding the investment program with a customized public corporate index that can be easily tracked and monitored helps guide PPM in meeting the risk and return expectations and assists with performance evaluation.
Recognizing the trade-offs between the level of risk, required capital, liquidity and investment return, the largest allocation within our investment portfolio is to investment grade fixed income securities. As previously mentioned, our investment manager accesses a broad universe of potential investments to construct the investment portfolio and takes into account the benefits of diversification across various sectors, collateral types and asset classes. To this end, our SAA and investment portfolio includes allocations to public and private corporate bonds (both investment grade and high yield), mortgage loans, structured securities, private equity and U.S. Treasury securities. These U.S. Treasury securities, while lower yielding than other alternatives, provide a higher level of liquidity and play a role in managing our interest rate exposure.
As of June 30, 2022 and December 31, 2021, we had total investments of $67.1 billion and $74.2 billion, respectively.
99
Item 2 | Management’s Discussion and Analysis | Investments
Portfolio Composition
The following table summarizes the carrying values of our investments:
June 30, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||
Investments excluding Funds Withheld | Funds Withheld | Total | Investments excluding Funds Withheld | Funds Withheld | Total | ||||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||||||||
Debt Securities, available-for-sale, net of allowance for credit losses | $ | 28,027 | $ | 15,451 | $ | 43,478 | $ | 32,453 | $ | 19,094 | $ | 51,547 | |||||||||||||||||||||||
Debt Securities, at fair value under fair value option | 1,848 | 157 | 2,005 | 1,547 | 164 | 1,711 | |||||||||||||||||||||||||||||
Debt securities, trading, at fair value | 103 | — | 103 | 117 | — | 117 | |||||||||||||||||||||||||||||
Equity securities, at fair value | 172 | 88 | 260 | 163 | 116 | 279 | |||||||||||||||||||||||||||||
Mortgage loans, net of allowance for credit losses | 6,935 | 4,639 | 11,574 | 6,743 | 4,739 | 11,482 | |||||||||||||||||||||||||||||
Mortgage loans, at fair value under fair value option | — | 357 | 357 | — | — | — | |||||||||||||||||||||||||||||
Policy loans | 959 | 3,500 | 4,459 | 992 | 3,483 | 4,475 | |||||||||||||||||||||||||||||
Freestanding derivative instruments | 1,149 | 94 | 1,243 | 1,375 | 42 | 1,417 | |||||||||||||||||||||||||||||
Other invested assets | 2,759 | 889 | 3,648 | 2,484 | 715 | 3,199 | |||||||||||||||||||||||||||||
Total investments | $ | 41,952 | $ | 25,175 | $ | 67,127 | $ | 45,874 | $ | 28,353 | $ | 74,227 |
Available-for-sale debt securities decreased to $43,478 million at June 30, 2022 from $51,547 million at December 31, 2021, primarily due to a decrease in net unrealized gain and sales, consistent with the decrease in underlying policy liabilities. The amortized cost of debt securities, available-for-sale, decreased from $51,206 million as of December 31, 2021 to $50,331 million as of June 30, 2022. Further, net unrealized gains on these assets decreased from a net unrealized gain of $2,178 million as of December 31, 2021 to a net unrealized loss of $4,702 million as of June 30, 2022.
Other Invested Assets
In June 2021, we entered into an arrangement to sell $420 million of limited partnership investments, of which $236 million and $168 million were sold in the second and third quarter of 2021, respectively, and the remainder was sold in January 2022. We expect to reinvest in new LPs as attractive opportunities become available. The increase in Other Invested Assets from December 31, 2021 to June 30, 2022 primarily resulted from the increased valuations of limited partnership investments.
100
Item 2 | Management’s Discussion and Analysis | Investments
Debt Securities
At June 30, 2022 and December 31, 2021, the amortized cost, allowance for credit loss, gross unrealized gains and losses, and fair value of debt securities, including trading securities and securities carried at fair value under the fair value option, were as follows (in millions):
June 30, 2022 | Amortized Cost | Allowance for Credit Loss | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||||||||||||||||
U.S. government securities | $ | 3,733 | $ | — | $ | — | $ | 745 | $ | 2,988 | ||||||||||||||||||||||
Other government securities | 1,659 | 6 | 3 | 155 | 1,501 | |||||||||||||||||||||||||||
Corporate securities | ||||||||||||||||||||||||||||||||
Utilities | 5,927 | 1 | 57 | 465 | 5,518 | |||||||||||||||||||||||||||
Energy | 3,100 | 24 | 13 | 329 | 2,760 | |||||||||||||||||||||||||||
Banking | 2,041 | — | 3 | 191 | 1,853 | |||||||||||||||||||||||||||
Healthcare | 3,135 | — | 14 | 349 | 2,800 | |||||||||||||||||||||||||||
Finance/Insurance | 4,590 | 6 | 6 | 499 | 4,091 | |||||||||||||||||||||||||||
Technology/Telecom | 2,467 | — | 4 | 245 | 2,226 | |||||||||||||||||||||||||||
Consumer goods | 2,470 | — | 4 | 326 | 2,148 | |||||||||||||||||||||||||||
Industrial | 1,848 | — | 12 | 149 | 1,711 | |||||||||||||||||||||||||||
Capital goods | 2,245 | — | 3 | 176 | 2,072 | |||||||||||||||||||||||||||
Real estate | 1,753 | — | 1 | 166 | 1,588 | |||||||||||||||||||||||||||
Media | 1,318 | — | 5 | 137 | 1,186 | |||||||||||||||||||||||||||
Transportation | 1,604 | — | 4 | 156 | 1,452 | |||||||||||||||||||||||||||
Retail | 1,345 | — | 11 | 143 | 1,213 | |||||||||||||||||||||||||||
Other (1) | 2,229 | — | 4 | 142 | 2,091 | |||||||||||||||||||||||||||
Total Corporate Securities | 36,072 | 31 | 141 | 3,473 | 32,709 | |||||||||||||||||||||||||||
Residential mortgage-backed | 479 | 6 | 26 | 29 | 470 | |||||||||||||||||||||||||||
Commercial mortgage-backed | 1,769 | — | — | 111 | 1,658 | |||||||||||||||||||||||||||
Other asset-backed securities | 6,619 | — | 14 | 373 | 6,260 | |||||||||||||||||||||||||||
Total Debt Securities | $ | 50,331 | $ | 43 | $ | 184 | $ | 4,886 | $ | 45,586 | ||||||||||||||||||||||
(1) No single remaining industry exceeds 3% of the portfolio. |
101
Item 2 | Management’s Discussion and Analysis | Investments
December 31, 2021 | Amortized Cost | Allowance for Credit Loss | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | |||||||||||||||||||||||||||
U.S. government securities | $ | 4,525 | $ | — | $ | 97 | $ | 301 | $ | 4,321 | ||||||||||||||||||||||
Other government securities | 1,489 | — | 147 | 17 | 1,619 | |||||||||||||||||||||||||||
Corporate securities | ||||||||||||||||||||||||||||||||
Utilities | 6,069 | — | 671 | 25 | 6,715 | |||||||||||||||||||||||||||
Energy | 2,872 | — | 222 | 16 | 3,078 | |||||||||||||||||||||||||||
Banking | 1,944 | — | 79 | 10 | 2,013 | |||||||||||||||||||||||||||
Healthcare | 3,196 | — | 175 | 21 | 3,350 | |||||||||||||||||||||||||||
Finance/Insurance | 4,299 | — | 228 | 47 | 4,480 | |||||||||||||||||||||||||||
Technology/Telecom | 2,376 | — | 123 | 26 | 2,473 | |||||||||||||||||||||||||||
Consumer goods | 2,525 | — | 123 | 38 | 2,610 | |||||||||||||||||||||||||||
Industrial | 1,996 | — | 118 | 10 | 2,104 | |||||||||||||||||||||||||||
Capital goods | 2,206 | — | 134 | 8 | 2,332 | |||||||||||||||||||||||||||
Real estate | 1,805 | — | 82 | 11 | 1,876 | |||||||||||||||||||||||||||
Media | 1,187 | — | 84 | 19 | 1,252 | |||||||||||||||||||||||||||
Transportation | 1,789 | — | 105 | 13 | 1,881 | |||||||||||||||||||||||||||
Retail | 1,289 | — | 75 | 13 | 1,351 | |||||||||||||||||||||||||||
Other (1) | 2,217 | — | 134 | 5 | 2,346 | |||||||||||||||||||||||||||
Total Corporate Securities | 35,770 | — | 2,353 | 262 | 37,861 | |||||||||||||||||||||||||||
Residential mortgage-backed | 528 | 2 | 46 | 3 | 569 | |||||||||||||||||||||||||||
Commercial mortgage-backed | 1,968 | — | 76 | 6 | 2,038 | |||||||||||||||||||||||||||
Other asset-backed securities | 6,926 | 7 | 71 | 23 | 6,967 | |||||||||||||||||||||||||||
Total Debt Securities | $ | 51,206 | $ | 9 | $ | 2,790 | $ | 612 | $ | 53,375 | ||||||||||||||||||||||
(1) No single remaining industry exceeds 3% of the portfolio. |
Debt Securities Credit Quality
The following tables set forth the composition of the fair value of debt securities, including both those held as available-for-sale and for trading, as classified by rating categories as assigned by nationally recognized statistical rating organizations (“NRSRO”), the NAIC or, if not rated by such organizations, our consolidated investment advisor, PPM. The Company uses the second lowest rating by an NRSRO when NRSRO ratings are not equivalent and, for purposes of the table, if not otherwise rated by a NRSRO, the NAIC rating of a security is converted to an equivalent NRSRO-style rating.
Percent of Total Debt Securities Carrying Value | ||||||||||||||
June 30, | December 31, | |||||||||||||
Investment Rating | 2022 | 2021 | ||||||||||||
AAA | 12.4 | % | 14.5 | % | ||||||||||
AA | 9.2 | % | 9.6 | % | ||||||||||
A | 30.4 | % | 28.5 | % | ||||||||||
BBB | 40.3 | % | 40.9 | % | ||||||||||
Investment grade | 92.3 | % | 93.5 | % | ||||||||||
BB | 4.0 | % | 3.6 | % | ||||||||||
B and below | 3.7 | % | 2.9 | % | ||||||||||
Below investment grade | 7.7 | % | 6.5 | % | ||||||||||
Total debt securities | 100.0 | % | 100.0 | % |
102
Item 2 | Management’s Discussion and Analysis | Investments
Unrealized Losses
The following tables summarize the amount of gross unrealized losses, fair value and the number of securities aggregated by investment category and length of time that individual debt securities have been in a continuous loss position (dollars in millions):
June 30, 2022 | December 31, 2021 | |||||||||||||||||||||||||||||||||||||
Less than 12 months | Less than 12 months | |||||||||||||||||||||||||||||||||||||
Gross | Fair Value | Gross | Fair Value | |||||||||||||||||||||||||||||||||||
Unrealized | # of | Unrealized | # of | |||||||||||||||||||||||||||||||||||
Losses | securities | Losses | securities | |||||||||||||||||||||||||||||||||||
U.S. government securities | $ | 172 | $ | 1,013 | 29 | $ | 2 | $ | 107 | 16 | ||||||||||||||||||||||||||||
Other government securities | 154 | 1,282 | 153 | 17 | 252 | 23 | ||||||||||||||||||||||||||||||||
Public utilities | 398 | 4,453 | 508 | 17 | 721 | 93 | ||||||||||||||||||||||||||||||||
Corporate securities | 2,426 | 20,501 | 2,585 | 180 | 6,343 | 728 | ||||||||||||||||||||||||||||||||
Residential mortgage-backed | 26 | 288 | 205 | 3 | 174 | 109 | ||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 97 | 1,567 | 203 | 5 | 314 | 37 | ||||||||||||||||||||||||||||||||
Other asset-backed securities | 360 | 5,081 | 625 | 22 | 3,224 | 338 | ||||||||||||||||||||||||||||||||
Total temporarily impaired securities | $ | 3,633 | $ | 34,185 | 4,308 | $ | 246 | $ | 11,135 | 1,344 | ||||||||||||||||||||||||||||
12 months or longer | 12 months or longer | |||||||||||||||||||||||||||||||||||||
Gross | Fair Value | Gross | Fair Value | |||||||||||||||||||||||||||||||||||
Unrealized | # of | Unrealized | # of | |||||||||||||||||||||||||||||||||||
Losses | securities | Losses | securities | |||||||||||||||||||||||||||||||||||
U.S. government securities | $ | 573 | $ | 1,801 | 8 | $ | 299 | $ | 3,190 | 7 | ||||||||||||||||||||||||||||
Other government securities | 1 | 10 | 5 | — | 4 | 2 | ||||||||||||||||||||||||||||||||
Public utilities | 67 | 171 | 29 | 7 | 99 | 8 | ||||||||||||||||||||||||||||||||
Corporate securities | 582 | 1,729 | 217 | 58 | 661 | 69 | ||||||||||||||||||||||||||||||||
Residential mortgage-backed | 3 | 45 | 47 | — | 11 | 12 | ||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 14 | 72 | 6 | 1 | 30 | 3 | ||||||||||||||||||||||||||||||||
Other asset-backed securities | 13 | 119 | 20 | 1 | 11 | 3 | ||||||||||||||||||||||||||||||||
Total temporarily impaired securities | $ | 1,253 | $ | 3,947 | 332 | $ | 366 | $ | 4,006 | 104 | ||||||||||||||||||||||||||||
Total | Total | |||||||||||||||||||||||||||||||||||||
Gross | Fair Value | Gross | Fair Value | |||||||||||||||||||||||||||||||||||
Unrealized | # of | Unrealized | # of | |||||||||||||||||||||||||||||||||||
Losses | securities | Losses | securities | |||||||||||||||||||||||||||||||||||
U.S. government securities | $ | 745 | $ | 2,814 | 33 | $ | 301 | $ | 3,297 | 23 | ||||||||||||||||||||||||||||
Other government securities | 155 | 1,292 | 157 | 17 | 256 | 25 | ||||||||||||||||||||||||||||||||
Public utilities | 465 | 4,624 | 530 | 24 | 820 | 101 | ||||||||||||||||||||||||||||||||
Corporate securities (1) | 3,008 | 22,230 | 2,728 | 238 | 7,004 | 797 | ||||||||||||||||||||||||||||||||
Residential mortgage-backed | 29 | 333 | 252 | 3 | 185 | 121 | ||||||||||||||||||||||||||||||||
Commercial mortgage-backed | 111 | 1,639 | 208 | 6 | 344 | 40 | ||||||||||||||||||||||||||||||||
Other asset-backed securities | 373 | 5,200 | 637 | 23 | 3,235 | 341 | ||||||||||||||||||||||||||||||||
Total temporarily impaired securities | $ | 4,886 | $ | 38,132 | 4,545 | $ | 612 | $ | 15,141 | 1,448 |
(1) Certain corporate securities contain multiple lots and fit the criteria of both aging groups.
The increase in rates on U.S. Treasury securities and the widening credit spreads of investment grade corporate securities resulted in the reduction in fair values and increase in unrealized losses during the six months ended June 30, 2022. Of the $4,274 million total increase in unrealized losses and the $22,991 million additional fair value on securities with an associated unrealized loss, $1,999 million and $5,773 million, respectively, are associated with assets subject to funds withheld agreements.
103
Item 2 | Management’s Discussion and Analysis | Investments
Evaluation of Available-For-Sale Debt Securities
See Note 4 to Condensed Consolidated Financial Statements for information about how we evaluate our available-for-sale debt securities for credit loss.
The following table summarizes net gains (losses) on derivatives and investments (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Available-for-sale securities | ||||||||||||||||||||||||||
Realized gains on sale | $ | 5 | $ | 96 | $ | 29 | $ | 121 | ||||||||||||||||||
Realized losses on sale | (63) | (52) | (241) | (58) | ||||||||||||||||||||||
Credit loss income (expense) | 1 | (1) | 1 | 7 | ||||||||||||||||||||||
Credit loss income (expense) on mortgage loans | (9) | (10) | 3 | 48 | ||||||||||||||||||||||
Other (1) | 71 | (18) | 83 | 50 | ||||||||||||||||||||||
Net gains (losses) excluding derivatives and funds withheld assets | 5 | 15 | (125) | 168 | ||||||||||||||||||||||
Net gains (losses) on derivative instruments | 2,785 | (1,768) | 3,492 | (113) | ||||||||||||||||||||||
Net gains (losses) on funds withheld reinsurance treaties | 1,077 | (768) | 2,105 | 130 | ||||||||||||||||||||||
Total net gains (losses) on derivatives and investments | $ | 3,867 | $ | (2,521) | $ | 5,472 | $ | 185 | ||||||||||||||||||
(1) Includes the foreign currency gain or loss related to foreign denominated mortgage loans and trust instruments supporting funding agreements. |
Equity Securities
Equity securities consist of investments in common and preferred stock holdings and mutual fund investments. Common and preferred stock investments generally arise out of previous private equity investments or other settlements rather than as direct investments. Mutual fund investments typically represent investments made in our own mutual funds to seed those structures for external issuance at a later date. The following table summarizes our holdings:
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Common Stock | $ | 89 | $ | 78 | |||||||
Preferred Stock | 143 | 168 | |||||||||
Mutual Funds | 28 | 33 | |||||||||
Total | $ | 260 | $ | 279 |
Mortgage Loans
Commercial mortgage loans of $10.8 billion and $10.5 billion at June 30, 2022 and December 31, 2021, respectively, are reported net of an allowance for credit losses of $77 million and $85 million at each date, respectively. At June 30, 2022, commercial mortgage loans were collateralized by properties located in 38 states, the District of Columbia, and Europe. Residential mortgage loans of $1,170 million and $939 million at June 30, 2022 and December 31, 2021, respectively, are reported net of an allowance for credit losses of $3 million and $9 million at each date, respectively. Loans were collateralized by properties located in 50 states, the District of Columbia, Mexico, and Europe.
104
Item 2 | Management’s Discussion and Analysis | Investments
The table below presents the carrying value, net of allowance of credit loss, of our mortgage loans by property type:
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Commercial: | |||||||||||
Apartment | $ | 3,920 | $ | 3,755 | |||||||
Hotel | 1,067 | 1,054 | |||||||||
Office | 1,894 | 1,889 | |||||||||
Retail | 2,134 | 2,104 | |||||||||
Warehouse | 1,746 | 1,741 | |||||||||
Total Commercial | $ | 10,761 | $ | 10,543 | |||||||
Residential | 1,170 | 939 | |||||||||
Total | $ | 11,931 | $ | 11,482 |
The table below presents the carrying value, net of allowance for credit loss, of our mortgage loans by region:
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
United States: | |||||||||||
East North Central | $ | 1,210 | $ | 1,184 | |||||||
East South Central | 534 | 491 | |||||||||
Middle Atlantic | 1,651 | 1,558 | |||||||||
Mountain | 651 | 688 | |||||||||
New England | 464 | 452 | |||||||||
Pacific | 3,063 | 2,897 | |||||||||
South Atlantic | 2,276 | 2,295 | |||||||||
West North Central | 569 | 552 | |||||||||
West South Central | 960 | 829 | |||||||||
Total United States | 11,378 | 10,946 | |||||||||
Foreign | 553 | 536 | |||||||||
Total | $ | 11,931 | $ | 11,482 |
105
Item 2 | Management’s Discussion and Analysis | Investments
The following table provides information about the credit quality of our mortgage loans:
June 30, | December 31, | ||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Commercial mortgage loans | |||||||||||
Loan to value ratios: | |||||||||||
Less than 70% | $ | 10,025 | $ | 9,819 | |||||||
70% - 80% | 683 | 670 | |||||||||
80% - 100% | 43 | 44 | |||||||||
Greater than 100% | 10 | 10 | |||||||||
Total | 10,761 | 10,543 | |||||||||
Residential mortgage loans | |||||||||||
Performing | 1,091 | 727 | |||||||||
Nonperforming (1) | 79 | 212 | |||||||||
Total | 1,170 | 939 | |||||||||
Total mortgage loans | $ | 11,931 | $ | 11,482 |
(1) As of June 30, 2022 and December 31, 2021, includes $56 million and $202 million of loans purchased when the loans were greater than 90 days delinquent and $15 million and $5 million of loans in process of foreclosure, respectively, and are supported with insurance or other guarantees provided by various governmental programs.
The following table provides a summary of the allowance for credit losses related to our mortgage loans:
June 30, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Balance at beginning of period | $ | 94 | $ | 179 | |||||||
Provision (release) | (14) | (43) | |||||||||
Balance at end of period | $ | 80 | $ | 136 |
The Company’s mortgage loans that are current and in good standing are accruing interest. Interest is not accrued on loans greater than 90 days delinquent and in process of foreclosure, when deemed uncollectible. Delinquency status is determined from the date of the first missed contractual payment.
At June 30, 2022, there was $18 million of recorded investment, $19 million of unpaid principal balance, no related loan allowance, $12 million of average recorded investment, and no investment income recognized on impaired residential mortgage loans.
At December 31, 2021, there was $6 million of recorded investment, $7 million of unpaid principal balance, no related loan allowance, $2 million of average recorded investment, and no investment income recognized on impaired residential mortgage loans.
106
Item 2 | Management’s Discussion and Analysis | Investments
Derivative Instruments
The following table presents the aggregate contractual or notional amounts and the fair values of our freestanding and embedded derivatives instruments (in millions):
June 30, 2022 | |||||||||||||||||||||||
Contractual/ | Assets | Liabilities | Net | ||||||||||||||||||||
Notional | Fair | Fair | Fair Value | ||||||||||||||||||||
Amount (1) | Value | Value | Asset (Liability) | ||||||||||||||||||||
Freestanding derivatives | |||||||||||||||||||||||
Cross-currency swaps | $ | 1,802 | $ | 48 | $ | 108 | $ | (60) | |||||||||||||||
Equity index call options | 24,000 | 13 | — | 13 | |||||||||||||||||||
Equity index futures (2) | 25,272 | — | — | — | |||||||||||||||||||
Equity index put options | 32,500 | 1,030 | — | 1,030 | |||||||||||||||||||
Interest rate swaps | 7,728 | 30 | 60 | (30) | |||||||||||||||||||
Interest rate swaps - cleared (2) | 1,500 | — | — | — | |||||||||||||||||||
Put-swaptions | 22,000 | — | 1,029 | (1,029) | |||||||||||||||||||
Treasury futures (2) | 14 | — | — | — | |||||||||||||||||||
Total return swaps | 700 | 12 | 4 | 8 | |||||||||||||||||||
Total freestanding derivatives | 115,516 | 1,133 | 1,201 | (68) | |||||||||||||||||||
Embedded derivatives | |||||||||||||||||||||||
Variable annuity embedded derivatives (3) | N/A | — | 601 | (601) | |||||||||||||||||||
Fixed index annuity embedded derivatives (4) | N/A | — | 1,087 | (1,087) | |||||||||||||||||||
Registered index linked annuity embedded derivatives (4) | N/A | — | 4 | (4) | |||||||||||||||||||
Total embedded derivatives | N/A | — | 1,692 | (1,692) | |||||||||||||||||||
Derivatives related to funds withheld under reinsurance treaties | |||||||||||||||||||||||
Cross-currency swaps | 158 | 24 | 1 | 23 | |||||||||||||||||||
Cross-currency forwards | 1,190 | 86 | 15 | 71 | |||||||||||||||||||
Funds withheld embedded derivative (5) | N/A | 2,508 | — | 2,508 | |||||||||||||||||||
Total derivatives related to funds withheld under reinsurance treaties | 1,348 | 2,618 | 16 | 2,602 | |||||||||||||||||||
Total | $ | 116,864 | $ | 3,751 | $ | 2,909 | $ | 842 |
(1) The notional amount for swaps and swaptions represents the stated principal balance used as a basis for calculating payments. The contractual amount for futures and options represents the market exposure of open positions. | ||||||||||||||
(2) Variation margin is considered settlement resulting in the netting of cash received/paid for variation margin against the fair value of the trades. | ||||||||||||||
(3) Included within reserves for future policy benefits and claims payable on the Condensed Consolidated Balance Sheets. The nonperformance risk adjustment is included in the balance above. | ||||||||||||||
(4) Included within other contract holder funds on the Condensed Consolidated Balance Sheets. The nonperformance risk adjustment is included in the balance above. | ||||||||||||||
(5) Included within funds withheld payable under reinsurance treaties on the Condensed Consolidated Balance Sheets. |
107
Item 2 | Management’s Discussion and Analysis | Investments
December 31, 2021 | |||||||||||||||||||||||
Contractual/ | Assets | Liabilities | Net | ||||||||||||||||||||
Notional | Fair | Fair | Fair Value | ||||||||||||||||||||
Amount (1) | Value | Value | Asset (Liability) | ||||||||||||||||||||
Freestanding derivatives | |||||||||||||||||||||||
Cross-currency swaps | $ | 1,767 | $ | 55 | $ | 35 | $ | 20 | |||||||||||||||
Equity index call options | 21,000 | 606 | — | 606 | |||||||||||||||||||
Equity index futures (2) | 18,258 | — | — | — | |||||||||||||||||||
Equity index put options | 27,500 | 150 | — | 150 | |||||||||||||||||||
Interest rate swaps | 7,728 | 430 | — | 430 | |||||||||||||||||||
Interest rate swaps - cleared (2) | 1,500 | — | — | — | |||||||||||||||||||
Put-swaptions | 19,000 | 133 | — | 133 | |||||||||||||||||||
Treasury futures (2) | 912 | — | — | — | |||||||||||||||||||
Total return swaps | — | — | — | — | |||||||||||||||||||
Total freestanding derivatives | 97,665 | 1,374 | 35 | 1,339 | |||||||||||||||||||
Embedded derivatives | |||||||||||||||||||||||
Variable annuity embedded derivatives (3) | N/A | — | 2,626 | (2,626) | |||||||||||||||||||
Fixed index annuity embedded derivatives (4) | N/A | — | 1,439 | (1,439) | |||||||||||||||||||
Registered index linked annuity embedded derivatives (4) | N/A | — | 6 | (6) | |||||||||||||||||||
Total embedded derivatives | N/A | — | 4,071 | (4,071) | |||||||||||||||||||
Derivatives related to funds withheld under reinsurance treaties | |||||||||||||||||||||||
Cross-currency swaps | 158 | 10 | 1 | 9 | |||||||||||||||||||
Cross-currency forwards | 1,119 | 33 | 5 | 28 | |||||||||||||||||||
Funds withheld embedded derivative (5) | N/A | — | 120 | (120) | |||||||||||||||||||
Total derivatives related to funds withheld under reinsurance treaties | 1,277 | 43 | 126 | (83) | |||||||||||||||||||
Total | $ | 98,942 | $ | 1,417 | $ | 4,232 | $ | (2,815) |
(1) The notional amount for swaps and swaptions represents the stated principal balance used as a basis for calculating payments. The contractual amount for futures and options represents the market exposure of open positions. | ||||||||||||||
(2) Variation margin is considered settlement resulting in the netting of cash received/paid for variation margin against the fair value of the trades. | ||||||||||||||
(3) Included within reserves for future policy benefits and claims payable on the Condensed Consolidated Balance Sheets. The nonperformance risk adjustment is included in the balance above. | ||||||||||||||
(4) Included within other contract holder funds on the Condensed Consolidated Balance Sheets. The nonperformance risk adjustment is included in the balance above. | ||||||||||||||
(5) Included within funds withheld payable under reinsurance treaties on the Condensed Consolidated Balance Sheets. |
108
Item 2 | Management’s Discussion and Analysis | Investments
Investment Income
Our sources of net investment income are as follows (in millions):
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||
Debt securities (1) | $ | 213 | $ | 277 | $ | 486 | $ | 601 | ||||||||||||||||||
Equity securities | 6 | 7 | 7 | 7 | ||||||||||||||||||||||
Mortgage loans | 68 | 80 | 141 | 162 | ||||||||||||||||||||||
Policy loans | 17 | 17 | 34 | 36 | ||||||||||||||||||||||
Limited partnerships | 50 | 150 | 158 | 393 | ||||||||||||||||||||||
Other investment income | 10 | 5 | 11 | 8 | ||||||||||||||||||||||
Total investment income excluding funds withheld assets | 364 | 536 | 837 | 1,207 | ||||||||||||||||||||||
Net investment income on funds withheld assets | 364 | 294 | 624 | 585 | ||||||||||||||||||||||
Investment expenses: | ||||||||||||||||||||||||||
Derivative trading commission | (1) | (1) | (2) | (1) | ||||||||||||||||||||||
Depreciation on real estate | (3) | (2) | (6) | (5) | ||||||||||||||||||||||
Expenses related to consolidated entities (2) | (15) | (9) | (36) | (17) | ||||||||||||||||||||||
Other investment income (expense) (3) | 38 | (22) | 50 | (45) | ||||||||||||||||||||||
Total investment expenses | 19 | (34) | 6 | (68) | ||||||||||||||||||||||
Net investment income | $ | 747 | $ | 796 | $ | 1,467 | $ | 1,724 | ||||||||||||||||||
(1) Includes unrealized gains and losses on trading securities and includes $(95) million and $(85) million as of June 30, 2022 and 2021, respectively, related to the change in fair value for securities carried under the fair value option.
(2) Includes management fees, administrative fees, legal fees, and other expenses related to the consolidation of certain investments.
(3) Includes interest expense and market appreciation on deferred compensation, investment software expense, custodial fees, and other bank fees; institutional product issuance related expenses; and other expenses.
Evaluation of Invested Assets
We perform regular evaluations of our invested assets. On a monthly basis, management identifies those investments that may require additional monitoring and carefully reviews the carrying value of such investments to determine whether specific investments should be placed on a non-accrual status and to determine if an allowance for credit loss is required. In making these reviews, management principally considers the adequacy of any collateral, compliance with contractual covenants, the borrower’s recent financial performance, news reports and other externally generated information concerning the issuer’s affairs. In the case of publicly traded bonds, management also considers market value quotations, where available. For mortgage loans, management generally considers information concerning the mortgaged property and, among other things, factors impacting the current and expected payment status of the loan and, if available, the current fair value of the underlying collateral. For investments in partnerships, management reviews the financial statements and other information provided by the general partners.
In determination of an allowance for credit loss, we consider a security’s forecasted cash flows as well as the severity of depressed fair values. Investment income is not accrued on securities in default and otherwise where the collection is uncertain. Subsequent receipts of interest on such securities are generally used to reduce the cost basis of the securities. The provisions for impairment on mortgage loans are based on losses expected by management to be realized on transfers of mortgage loans to real estate, on the disposition and settlement of mortgage loans and on mortgage loans that management believes may not be collectible in full. Accrual of interest on mortgage loans is generally suspended when principal or interest payments on mortgage loans are past due more than 90 days. Interest is then accounted for on a cash basis.
109
Item 2 | Management’s Discussion and Analysis | Policy and Contract Liabilities
Policy and Contract Liabilities
We establish, and carry as liabilities, actuarially determined amounts that are calculated to meet policy obligations or to provide for future annuity payments. Amounts for actuarial liabilities are computed and reported on the Condensed Consolidated Financial Statements in conformity with GAAP. For more details on Policyholder Liabilities, see "Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Estimates” included in our 2021 Annual Report.
As an insurance company, a substantial portion of our profits are derived from fee income and the invested assets backing our policy and contract liabilities, which includes separate account liabilities, reserves for future policy benefits and claims payable and other contract holder funds. As of June 30, 2022, 88% of our policy and contract liabilities were in our Retail Annuities segment, 3% were in our Institutional Products segment and 9% were in our Closed Life and Annuity Blocks segment.
The table below represents a breakdown of our policy and contract liabilities:
June 30, 2022 | Separate Accounts | Reserves for future policy benefits | Other contract holder funds | Total | |||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Variable Annuities | $ | 196,114 | $ | 3,165 | $ | 11,060 | $ | 210,339 | |||||||||||||||
Registered Index Linked Annuities | — | — | 735 | 735 | |||||||||||||||||||
Fixed Annuities | — | 2 | 12,715 | 12,717 | |||||||||||||||||||
Fixed Index Annuities | — | — | 12,458 | 12,458 | |||||||||||||||||||
Payout Annuities | — | — | 1,382 | 1,382 | |||||||||||||||||||
Total Retail Annuities | 196,114 | 3,167 | 38,350 | 237,631 | |||||||||||||||||||
Total Institutional Products | — | — | 8,483 | 8,483 | |||||||||||||||||||
Traditional Life | — | 4,638 | 4,107 | 8,745 | |||||||||||||||||||
Interest-sensitive Life | 70 | 1,675 | 7,258 | 9,003 | |||||||||||||||||||
Group Payout Annuities | — | 4,734 | — | 4,734 | |||||||||||||||||||
Other Annuities | — | — | 1,378 | 1,378 | |||||||||||||||||||
Total Closed Life and Annuity Blocks | 70 | 11,047 | 12,743 | 23,860 | |||||||||||||||||||
Total Policy and Contract Liabilities | 196,184 | 14,214 | 59,576 | 269,974 | |||||||||||||||||||
Claims payable and other | — | 1,839 | — | 1,839 | |||||||||||||||||||
Total | $ | 196,184 | $ | 16,053 | $ | 59,576 | $ | 271,813 |
110
Item 2 | Management’s Discussion and Analysis | Policy and Contract Liabilities
December 31, 2021 | Separate Accounts | Reserves for future policy benefits | Other contract holder funds | Total | |||||||||||||||||||
(in millions) | |||||||||||||||||||||||
Variable Annuities | $ | 248,859 | 4,330 | 10,030 | 263,219 | ||||||||||||||||||
Registered Index Linked Annuities | — | — | 110 | 110 | |||||||||||||||||||
Fixed Annuities | — | 2 | 13,172 | 13,174 | |||||||||||||||||||
Fixed Index Annuities | — | 50 | 13,161 | 13,211 | |||||||||||||||||||
Payout Annuities | — | — | 1,399 | 1,399 | |||||||||||||||||||
Total Retail Annuities | 248,859 | 4,382 | 37,872 | 291,113 | |||||||||||||||||||
Total Institutional Products | — | — | 8,830 | 8,830 | |||||||||||||||||||
Traditional Life | — | 4,762 | 4,161 | 8,923 | |||||||||||||||||||
Interest-sensitive Life | 90 | 1,722 | 7,410 | 9,222 | |||||||||||||||||||
Group Payout Annuities | — | 4,895 | — | 4,895 | |||||||||||||||||||
Other Annuities | — | — | 1,416 | 1,416 | |||||||||||||||||||
Total Closed Life and Annuity Blocks | 90 | 11,379 | 12,987 | 24,456 | |||||||||||||||||||
Total Policy and Contract Liabilities | 248,949 | 15,761 | 59,689 | 324,399 | |||||||||||||||||||
Claims payable and other | — | 1,868 | — | 1,868 | |||||||||||||||||||
Total | $ | 248,949 | $ | 17,629 | $ | 59,689 | $ | 326,267 |
As of June 30, 2022, $196.2 billion or 73% of our policy and contract liabilities were backed by separate accounts assets. These separate account assets backed reserves primarily related to our variable annuities. Separate account liabilities are fully funded by cash flows from the customer’s corresponding separate account assets and are set equal to the fair value of such invested assets. We generate revenue on our separate account liabilities primarily from asset-based fee income. Separate account assets and associated liabilities are subject to variability driven by the performance of the underlying investments, which are exposed to fluctuations in equity markets and bond fund valuations. As a result, revenue derived from asset-based fee income is similarly subject to variability in line with the variability of the underlying separate account assets.
As of June 30, 2022, $49.8 billion or 18% of our policy and contract liabilities were backed by our investment portfolio and $24.0 billion reinsured by Athene, were backed by funds withheld assets. Our variable annuity fixed account option, variable annuity guaranteed benefit and other reserves, our RILA and fixed annuities and fixed index annuities reserves, not reinsured, our Institutional Products segment reserves, as well as our Closed Life and Annuity Blocks segment reserves, were primarily backed by our investment portfolio. As of June 30, 2022, our general account policy and contract liabilities, net of those ceded to Athene, were composed of 1% for registered index linked annuities, 5% for fixed index annuities and fixed deferred and payout annuities, 17% for Institutional Products segment, 21% for fixed account option variable annuities, 8% for guaranteed benefit and other variable annuity reserves, and a 48% Closed Life and Annuity Block segment reserves. As of June 30, 2022, 39% of our fixed annuity and fixed index annuity policy and contract liabilities were subject to surrender charges of at least 5% or at market value in the event of discretionary withdrawal by customers. As of June 30, 2022, 100% of our RILA policy and contract liabilities were subject to surrender charges of at least 5% or at market value in the event of discretionary withdrawal by customers. We have the discretion, subject to contractual limitations and minimums, to reset the crediting terms on the majority of our fixed index annuities and fixed annuities. As of June 30, 2022, 92% of fixed annuity, fixed-indexed annuity, and the fixed accounts of RILA and variable annuity correspond to crediting rates that are at the guaranteed minimum crediting rate.
Liabilities for other contract holder funds are policy account balances on interest-sensitive life insurance, fixed annuities, fixed index annuities, RILA and variable annuity or variable life insurance contract allocations to fixed fund options. These account balance liabilities are equal to the sum of deposits, plus interest credited, less charges and withdrawals.
111
Item 2 | Management’s Discussion and Analysis | Policy and Contract Liabilities
We establish reserves for future policy benefits and claims payable under insurance policies using methodologies consistent with U.S. GAAP. Reserves for insurance policies are generally equal to the present value of future expected benefits to be paid, reduced by the present value of future expected revenue. The assumptions used in establishing reserves are generally based on our experience, industry benchmarking or other factors, as applicable. Annually, or as circumstances warrant, we conduct a comprehensive review of our actuarial assumptions, and update those assumptions when appropriate. The principal assumptions used in the establishment of reserves for future policy benefits are policy lapse, mortality, benefit utilization and withdrawals, investment returns, and expenses. Generally, we do not expect trends that impact our assumptions to change significantly in the short-term and, to the extent these trends may change, we expect such changes to be gradual over the long-term.
For non–life-contingent components of Guaranteed Minimum Withdrawal Benefits ("GMWB") features available in our variable annuities, the guaranteed benefits are accounted for as embedded derivatives, with fair values calculated as the present value of expected future guaranteed benefit payments to contract holders less the present value of assessed rider fees attributable to the embedded derivative feature. In accordance with U.S. GAAP, the fair values of these guaranteed benefit features are based on assumptions a market participant would use in valuing these embedded derivatives. Changes in the fair value of the embedded derivatives are recorded through a benefit or charge to current period earnings. Movements in the fair value of the embedded derivatives are typically in the opposite direction relative to primary market risks. Specifically, downward movements in equity market levels reduce contract holder account value and typically correlate with an increased likelihood that outstanding guaranteed benefits will result in a claim, increasing the fair value liability. Similarly, downward movements in interest rates lower the assumed future market growth and typically correlate with an increased likelihood that outstanding guaranteed benefits will result in a claim, increasing the fair value liability. Downward movements in interest rates also lower the discount rates used in the calculation of the fair value liability associated with higher projected future guaranteed benefit payments, which increases the fair value liability.
For reserves related to the life-contingent components of guaranteed benefit features available in our variable annuities, fixed index annuities and RILA, we calculate the change in reserves by applying a “benefit ratio” to total assessments received in the period. The benefit ratio is determined by dividing the present value of total expected benefit payments by the present value of total expected assessments, primarily fees based on account value or benefit base, over the life of the contract. The level and direction of the change in reserves will vary over time based on the benefit ratio and the level of assessments associated with the variable annuity, fixed index annuity, or RILA. These reserves typically move in the opposite direction relative to primary market risks. Specifically, downward movements in equity market levels will reduce contract holder account value and typically correlate with an increased likelihood that outstanding guaranteed benefits will result in a claim, which increases the reserve.
For traditional life insurance and payout annuities, reserves for future policy benefits are measured using assumptions determined as of the issuance date or acquisition date with provisions for the risk of adverse deviation, as appropriate. These assumptions are not unlocked unless a premium deficiency exists. At least annually, we perform premium deficiency tests using best estimate assumptions as of the testing date without provision for adverse deviation. If the liabilities determined based on these best estimate assumptions are greater than the net reserves (i.e., U.S. GAAP reserves net of any DAC or reinsurance), the existing net reserves are adjusted by first reducing the DAC or DSI by the amount of the deficiency (or to zero) through a charge to current period earnings. If the deficiency is more than these asset balances, we increase the reserves by the excess through a charge to current period earnings. If a premium deficiency is recognized, the assumptions as of the premium deficiency test date are locked in and used in subsequent reserve measurements, and the net reserves continue to be subject to premium deficiency testing. In a sustained low interest rate environment, there is generally an increased likelihood that the liabilities determined based on best estimate assumptions will be greater than the net reserves.
112
Item 2 | Management’s Discussion and Analysis | Liquidity and Capital Resources
Liquidity and Capital Resources
Liquidity is our ability to generate sufficient cash flows to meet the cash requirements of operating, investing and financing activities. Capital refers to our long-term financial resources available to support the business operations and contribute to future growth. Our ability to generate and maintain sufficient liquidity and capital depends on the profitability of the businesses, timing of cash flows on investments and products, general economic conditions and access to the capital markets and the alternate sources of liquidity and capital described herein.
The discussion below describes our liquidity and capital resources for the six months ended June 30, 2022 and 2021.
Cash Flows
The following table presents a summary of our cash flow activity for the periods set forth below:
Six Months Ended June 30, | |||||||||||
2022 | 2021 | ||||||||||
(in millions) | |||||||||||
Net cash provided by (used in) operating activities | $ | 2,096 | $ | 2,148 | |||||||
Net cash provided by (used in) investing activities | 2,615 | 580 | |||||||||
Net cash provided by (used in) financing activities | (2,076) | (3,211) | |||||||||
Net increase (decrease) in cash, cash equivalents, and restricted cash | 2,635 | (483) | |||||||||
Cash, cash equivalents, and restricted cash at beginning of period | 2,631 | 2,019 | |||||||||
Total cash, cash equivalents, and restricted cash at end of period | $ | 5,266 | $ | 1,536 |
Cash flows provided by Operating Activities
The principal operating cash inflows from our insurance activities come from insurance premiums, fees charged on our products and net investment income. The principal operating cash outflows are the result of annuity and life insurance benefits, interest credited on other contract holder funds, operating expenses and income tax, as well as interest expense. The primary liquidity concern with respect to these cash flows is the risk of early contract holder and policyholder benefit payments.
Cash flows provided by (used in) operating activities of $2,096 million for the six months ended June 30, 2022 were relatively flat compared to the $2,148 million for the six months ended June 30, 2021.
Cash flows provided by (used in) Investing Activities
The principal cash inflows from our investment activities come from repayments of principal, proceeds from maturities and sales of investments, as well as settlements of freestanding derivatives. The principal cash outflows relate to purchases of investments and settlements of freestanding derivatives. It is not unusual to have a net cash outflow from investing activities because cash inflows from insurance operations are typically reinvested to fund insurance liabilities. We closely monitor and manage these risks through our comprehensive investment risk management process. The primary liquidity concerns with respect to these cash flows are the risk of default by debtors or market disruptions that might impact the timing of investment related cash flows as well as derivative collateral needs.
Cash flows provided by (used in) investing activities increased $2,035 million to $2,615 million during the six months ended June 30, 2022 from $580 million during the six months ended June 30, 2021. This increase was primarily due to inflows related to derivative settlements in 2022 compared to outflows in 2021, partially offset by lower sales of funds withheld assets in 2022, as compared to 2021.
113
Item 2 | Management’s Discussion and Analysis | Liquidity and Capital Resources
Cash flows provided by (used in) Financing Activities
The principal cash inflows from our financing activities come from deposits of funds associated with policyholder account balances, issuance of debt, and lending of securities. The principal cash outflows come from withdrawals associated with policyholder account balances, repayment of debt, and the return of securities on loan. The primary liquidity concerns with respect to these cash flows are market disruption and the risk of early policyholder withdrawal.
Cash flows provided by (used in) financing activities increased $1,135 million to $(2,076) million during the six months ended June 30, 2022 from $(3,211) million during the six months ended June 30, 2021. This increase was primarily due to decreased withdrawals of policyholders' account balances during 2022 compared to 2021, partially offset by outflows related to the settlement of our repurchase agreements, compared to inflows in the prior year.
Statutory Capital
Our insurance company subsidiaries have statutory surplus above the level needed to meet current regulatory requirements. RBC requirements are used as minimum capital requirements by the NAIC and the state insurance departments to identify companies that merit regulatory action. RBC is based on a formula that incorporates both factor-based components (applied to various asset, premium, claim, expense and statutory reserve items) and model-based components. The formula takes into account the risk characteristics of the insurer, including asset risk, insurance risk, interest rate risk, market risk and business risk and is calculated on an annual basis. The formula is used as an early warning regulatory tool to identify possible inadequately capitalized insurers for purposes of initiating regulatory action, and not as a means to rank insurers generally. As of June 30, 2022, our insurance companies were well in excess of the minimum required capital levels. Jackson is also subject to risk-based capital guidelines that provide a method to measure the adjusted capital that a life insurance company should have for regulatory purposes, taking into account the risk characteristics of Jackson’s investments and products.
Holding Company Liquidity
As a holding company with no business operations of its own, Jackson Financial primarily derives cash flows from dividends and interest payments from its insurance subsidiaries. These principal sources of liquidity are expected to be supplemented by cash and short-term investments held by Jackson Financial and access to bank lines of credit and the capital markets. We intend to maintain a minimum amount of cash and highly liquid securities at Jackson Financial adequate to fund two years of holding company fixed expenses which is currently targeted at $250 million. The main uses of liquidity for Jackson Financial are interest payments and debt repayment, holding company operating expenses, payment of dividends and other distributions to shareholders, which may include stock repurchases, and capital contributions, if needed, to our insurance company subsidiaries. Our principal sources of liquidity and our anticipated capital position are described in the following paragraphs.
Distributions from our Insurance Company Subsidiaries
The ability of our insurance company subsidiaries to pay dividends is limited by applicable laws and regulations of the jurisdictions where such subsidiaries are domiciled as well as agreements entered into with regulators. These laws and regulations require, among other things, our insurance company subsidiaries to maintain minimum solvency requirements and limit the amount of dividends these subsidiaries can pay.
114
Item 2 | Management’s Discussion and Analysis | Liquidity and Capital Resources
Subject to these limitations, our insurance company subsidiaries are permitted to pay ordinary dividends based on calculations specified under insurance laws of the relevant state of domicile, subject to prior notification to the appropriate regulatory agency. Any distributions above the amount permitted by statute in any twelve-month period are considered to be extraordinary dividends, and the approval of the appropriate regulator is required prior to payment. In Michigan, the Director of the Michigan Department of Insurance and Financial Services (the Michigan Director of Insurance) may limit, or not permit, the payment of dividends from either Jackson or Brooke Life, Jackson's direct parent company, if it determines that the surplus of either these subsidiaries is not reasonable in relation to their outstanding liabilities and is not adequate to meet their financial needs, as required by Michigan insurance law. Unless otherwise approved by the Michigan Director of Insurance, dividends may only be paid from earned surplus. Also, surplus note arrangements and interest payments must be approved by the Michigan Director of Insurance and such interest payments to related parties reduce the otherwise calculated ordinary dividend capacity for that period. In New York, all dividends require approval from the New York State Department of Financial Services.
For 2022, Jackson and Brooke Life have total ordinary dividend capacity, based on 2021 statutory capital and surplus and statutory net gain from operations, subject to the availability of earned surplus, of $608 million and $514 million, respectively. Brooke Life, as the sole owner of our other insurance company subsidiaries, including Jackson and Jackson National Life NY, is the direct recipient of any dividend payments from those subsidiaries and must make dividend payments to its ultimate parent company, Jackson Financial, in order for any funds from our insurance company subsidiaries to reach Jackson Financial. As such, Jackson Financial’s ability to receive dividend payments from our insurance company subsidiaries is effectively limited by Brooke Life’s ability to make dividend payments to Jackson Financial.
On March 1, 2022, Jackson remitted a $600 million return of capital to its parent company, Brooke Life. Brooke Life subsequently paid a $510 million ordinary dividend to its ultimate parent, Jackson Financial. In addition, Brooke Life also paid $45 million of interest associated with the $2 billion surplus note between Brooke Life and Jackson Finance, LLC ("Jackson Finance"), a subsidiary of Jackson Financial.
The maximum distribution permitted by law or contract is not necessarily indicative of an insurer’s actual ability to pay such distributions, which may be constrained by business and other considerations, such as imposition of withholding tax, the impact of such distributions on surplus, which could affect the insurer’s ratings or competitive position, the ability to generate new annuity sales and the ability to pay future dividends or make other distributions. Further, state insurance laws and regulations require that the statutory surplus of our insurance subsidiaries following any dividend or distribution must be reasonable in relation to their outstanding liabilities and adequate for the insurance subsidiaries’ financial needs. Along with solvency regulations, another primary consideration in determining the amount of capital used for dividends is the level of capital needed to maintain desired financial strength ratings from rating agencies, including A.M. Best, S&P, Moody’s and Fitch. Given recent economic events that have affected the insurance industry, both regulators and rating agencies could become more conservative in their methodology and criteria, including increasing capital requirements for insurance company subsidiaries. We believe our insurance company subsidiaries have sufficient statutory capital and surplus to maintain their desired financial strength rating.
Insurance Company Subsidiaries’ Liquidity
The liquidity requirements for our insurance company subsidiaries primarily relate to the liabilities associated with their insurance and reinsurance activities, operating expenses and income taxes. Liabilities arising from insurance and reinsurance activities include the payment of policyholder benefits when due, cash payments in connection with policy surrenders and withdrawals and policy loans.
115
Item 2 | Management’s Discussion and Analysis | Liquidity and Capital Resources
Liquidity requirements are principally for purchases of new investments, management of derivative related margin requirements, repayment of principal and interest on debt, payments of interest on surplus notes, funding of insurance product liabilities including payments for policy benefits, surrenders, maturities and new policy loans, funding of expenses including payment of commissions, operating expenses and taxes. As of June 30, 2022, Jackson’s outstanding surplus notes and bank debt included $63 million of bank loans from the Federal Home Loan Bank of Indianapolis ("FHLBI"), collateralized by mortgage-related securities and mortgage loans and $250 million of surplus notes maturing in 2027. Significant increases in interest rates could create sudden increases in surrender and withdrawal requests by customers and contract holders, and result in increased liquidity requirements at our insurance company subsidiaries. Significant increases in interest rates or equity markets may also result in higher margin and collateral requirements on our derivative portfolio.
Other factors that are not directly related to interest rates can also give rise to an increase in liquidity requirements, including, changes in ratings from rating agencies, general policyholder concerns relating to the life insurance industry (e.g., the unexpected default of a large, unrelated life insurer) and competition from other products, including non-insurance products such as mutual funds, certificates of deposit and newly developed investment products. Most of the life insurance and annuity products Jackson offers permit the policyholder or contract holder to withdraw or borrow funds or surrender cash values. As of June 30, 2022, approximately half of Jackson’s general account reserves are either not surrenderable, included surrender charges greater than 5%, or market value adjustments to discourage early withdrawal of policy and contract funds.
The liquidity sources for our insurance company subsidiaries are their cash, short-term investments, sales of publicly traded bonds, insurance premiums, fees charged on our products, sales of annuities and institutional products, investment income, commercial repurchase agreements and utilization of a short-term borrowing facility with the FHLBI.
Jackson uses a variety of asset liability management techniques to provide for the orderly provision of cash flow from investments and other sources as policies and contracts mature in accordance with their normal terms. Jackson’s principal sources of liquidity to meet unexpected cash outflows associated with sudden and severe increases in surrenders and withdrawals or benefit payments are its portfolio of liquid assets and its net operating cash flows. As of June 30, 2022, the portfolio of cash, short-term investments and privately and publicly traded securities and equities, which are unencumbered and unrestricted to sale, amounted to $24.4 billion.
Our Indebtedness
Senior Notes
On June 8, 2022, the Company issued $750 million aggregate principal amount of its senior unsecured notes, consisting of $400 million aggregate principal amount of 5.170% Senior Notes due June 8, 2027 (the “2027 Notes”) and $350 million aggregate principal amount of 5.670% Senior Notes due June 8, 2032 (the “2032 Notes”). The net proceeds of the 2027 Notes and 2032 Notes were used, together with cash on hand, to repay the Company’s $750 million aggregate principal amount term loan due February 2023.
On November 23, 2021, the Company issued $1.6 billion aggregate principal amount of its senior unsecured notes consisting of $600 million aggregate principal amount of 1.1% Senior Notes due November 22, 2023 (the “2023 Senior Notes”), $500 million aggregate principal amount of 3.1% Senior Notes due November 23, 2031 (the “2031 Senior Notes”) and $500 million aggregate principal amount of 4.0% Senior Notes due November 23, 2051 (the “2051 Senior Notes” and, together with the 2023 Senior Notes and the 2031 Senior Notes, the “Senior Notes”). The proceeds of the Senior Notes were used, together with cash on hand, to repay the Company’s $1.6 billion aggregate principal amount term loan that was due May 2022.
116
Item 2 | Management’s Discussion and Analysis | Liquidity and Capital Resources
Revolving Credit Agreement
The Company is party to a Revolving Facility providing for borrowings for working capital and other general corporate purposes under aggregate commitments of $1.0 billion, with a sub-limit of $500 million available for letters of credit. The Revolving Facility further provides for the ability to request, subject to customary terms and conditions, an increase in commitments thereunder by up to an additional $500 million. Commitments under the Revolving Facility terminate on February 22, 2024.
The credit agreement contains a number of customary representations and warranties, affirmative and negative covenants and events of default (including a change of control provision). Such covenants, among other things, restrict, subject to certain exceptions, our ability to pay dividends and distributions or repurchase common shares if a default or event of default has occurred and is continuing (with such negative covenant dropping away if our long term unsecured senior, non-credit enhanced, debt ratings are either (x) BBB+ or better from S&P or (y) Baa1 or better from Moody’s), incur additional indebtedness, create liens on our or our subsidiaries’ assets and make fundamental changes. The credit agreement contains financial maintenance covenants, including a minimum adjusted consolidated net worth test of no less than 70% of our adjusted consolidated net worth as of the date of the Demerger (taking into account 50% of the proceeds of any additional equity issuances) and a maximum consolidated indebtedness to total capitalization ratio test not to exceed 35%. We were in compliance with these covenants at June 30, 2022.
Surplus Notes
On March 15, 1997, our subsidiary, Jackson, issued 8.2% surplus notes in the principal amount of $250 million due March 15, 2027. These surplus notes were issued pursuant to Rule 144A under the Securities Act of 1933, as amended, and are unsecured and subordinated to all present and future indebtedness, policy claims and other creditor claims and may not be redeemed at the option of the Company or any holder prior to maturity. Interest is payable semi-annually on March 15th and September 15th of each year. Interest expense on the notes was $5 million and $10 million for both the three and six months ended June 30, 2022 and 2021, respectively.
Under Michigan Insurance Law, for statutory reporting purposes, the surplus notes are not part of the legal liabilities of the Company and are considered surplus funds. Payments of interest or principal may only be made with the prior approval of the Michigan Director of Insurance and only out of surplus earnings which the director determines to be available for such payments under Michigan Insurance Law.
Federal Home Loan Bank
Jackson is a member of the regional FHLBI primarily for the purpose of participating in its collateralized loan advance program with funding facilities. Membership requires us to purchase and hold a minimum amount of FHLBI capital stock, plus additional stock based on outstanding advances. Advances are in the form of either notes or funding agreements issued to FHLBI. As of June 30, 2022 and December 31, 2021, Jackson held a bank loan with an outstanding balance of $63 million and $67 million, respectively.
Dividend and Stock Repurchase
Consistent with our goals to manage risk and capital and optimize our financial leverage, we generally intend to target return of capital to our shareholders, which may take the form of cash dividends and/or stock repurchases, on an annual basis of approximately 40-60% of the annual change in our excess capital, adjusted for any contributions and distributions, subject to market conditions and approval by our Board of Directors. For purposes of this analysis, we define excess capital as total adjusted capital less 400% of company action level required capital. Consistent with statutory accounting requirements, total adjusted capital is defined as Jackson’s statutory capital and surplus, plus asset valuation reserve and 50% of policyholder dividends of Jackson and its subsidiaries. Company action level required capital is the minimum amount of capital necessary for Jackson to avoid submitting a corrective action plan to its regulator.
117
Item 2 | Management’s Discussion and Analysis | Liquidity and Capital Resources
Any declaration of cash dividends or stock repurchases will be at the discretion of JFI’s Board of Directors and will depend on our financial condition, earnings, liquidity and capital requirements, regulatory constraints, level of indebtedness, contractual restrictions with respect to paying cash dividends or repurchasing stock, restrictions imposed by Delaware law, general business conditions and any other factors that JFI’s Board of Directors deems relevant in making any such determination. Therefore, there can be no assurance that we will pay any cash dividends to holders of our common stock or approve any increase in the existing, or any new, stock repurchase program, or as to the amount of any such cash dividends or stock repurchases.
Delaware law requires that dividends be paid and stock repurchases made only out of “surplus,” which is defined as the fair market value of our net assets, minus our stated capital; or out of the current or the immediately preceding year’s earnings. JFI is a holding company and has no direct operations. All of our business operations are conducted through our subsidiaries. Any dividends we pay or stock repurchases we make will depend upon the funds legally available for distribution, including dividends or distributions from our subsidiaries to us. The states in which our insurance subsidiaries are domiciled impose certain restrictions on our insurance subsidiaries’ ability to pay dividends to their parent companies. These restrictions are based in part on the prior year’s statutory income and surplus, as well as earned surplus. Such restrictions, or any future restrictions adopted by the states in which our insurance subsidiaries are domiciled, could have the effect, under certain circumstances, of significantly reducing dividends or other amounts payable by our subsidiaries without affirmative approval of state regulatory authorities. See “Holding Company Liquidity – Distributions from our Insurance Company Subsidiaries” above, and “Part I, Item 1A. Risk Factors—As a holding company, JFI depends on the ability of its subsidiaries to meet its obligations and liquidity needs, including dividends and stock repurchases” in our 2021 Annual Report.
Dividends to Shareholders and Share Repurchases
During the second quarter of 2022, we paid a cash dividend of $0.55 per share on JFI's Class A Common Stock totaling $50 million. On August 8, 2022, our Board of Directors approved a third quarter cash dividend on JFI's Common Stock of $0.55 per share, payable on September 15, 2022 to shareholders of record on September 1, 2022.
We repurchased a total of 1,870,854 shares and a total of 5,304,464 shares of Class A Common Stock for an aggregate purchase price of $66 million and $206 million in the three and six months ended June 30, 2022, respectively, which were funded with cash on hand.
See Note 18 to Condensed Consolidated Financial Statements in this Report for further information on dividends to shareholders and share repurchases.
Financial Strength Ratings
Our access to funding and our related cost of borrowing, the attractiveness of certain of our subsidiaries’ products to customers, our attractiveness as a reinsurer to potential ceding companies and requirements for derivatives collateral posting are affected by our credit ratings and financial strength ratings, which are periodically reviewed by the rating agencies. Financial strength ratings and credit ratings are important factors affecting consumer confidence in an insurer and its competitive position in marketing products as well as critical factors considered by ceding companies in selecting a reinsurer.
Our principal insurance company subsidiaries are rated by A.M. Best, S&P, Moody’s and Fitch. Financial strength ratings represent the opinions of rating agencies regarding the financial ability of an insurer or reinsurer to meet its obligations under an insurance policy or reinsurance arrangement and generally involve quantitative and qualitative evaluations by rating agencies of a company’s financial condition and operating performance. Generally, rating agencies base their financial strength ratings upon information furnished to them by the company and upon their own investigations, studies and assumptions. Financial strength ratings are based upon factors of concern to customers, distribution partners and ceding companies and are not directed toward the protection of investors. Financial strength ratings are not recommendations to buy, sell or hold securities and they may be revised or revoked at any time at the sole discretion of the rating organization.
118
Item 2 | Management’s Discussion and Analysis | Liquidity and Capital Resources
As of August 5, 2022, the financial strength ratings of our principal insurance subsidiaries were as follows:
Company | A.M. Best | Fitch | Moody’s | S&P | ||||||||||||||||||||||
Jackson National Life Insurance Company | ||||||||||||||||||||||||||
Rating | A | A | A2 | A | ||||||||||||||||||||||
Outlook | stable | stable | negative | stable | ||||||||||||||||||||||
Jackson National Life Insurance Company of New York | ||||||||||||||||||||||||||
Rating | A | A | A2 | A | ||||||||||||||||||||||
Outlook | stable | stable | negative | stable | ||||||||||||||||||||||
Brooke Life Insurance Company | ||||||||||||||||||||||||||
Rating | A | |||||||||||||||||||||||||
Outlook | stable |
In evaluating a company’s financial strength, the rating agencies evaluate a variety of factors including our strategy, market positioning and track record, our mix of business, profitability, leverage and liquidity, the adequacy and soundness of our reinsurance, the quality and estimated market value of our assets, the adequacy of our surplus, our capital structure, and the experience and competence of our management.
In addition to the financial strength ratings, rating agencies use an outlook statement to indicate a short- or medium-term trend which, if continued, may lead to a rating change. A positive outlook indicates a rating may be raised and a negative outlook indicates a rating may be lowered. A stable outlook is assigned when ratings are not likely to be changed. Outlooks should not be confused with expected stability of the issuer’s financial or economic performance. A stable outlook does not preclude a rating agency from changing a rating at any time without notice.
A.M. Best, S&P, Moody’s and Fitch review their ratings of insurance companies from time to time. There can be no assurance that any particular rating will continue for any given period of time or that it will not be changed or withdrawn entirely if, in their judgment, circumstances so warrant. While the degree to which ratings adjustments will affect sales of our annuities and institutional products, and persistency is unknown, if our ratings are negatively adjusted for any reason, we believe we could experience a material decline in the sales in our individual channel, origination in our institutional channel, and the persistency of our existing business.
119
Item 2 | Management’s Discussion and Analysis | Summary of Critical Accounting Estimates
Summary of Critical Accounting Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported in our Condensed Consolidated Financial Statements included elsewhere in this Report. The most critical estimates include those used in determining:
• deferred acquisition costs
• reserves for future policy benefits and claims payable and other contract holder funds
• income taxes and the ability to realize certain deferred tax benefits
• accounting for reinsurance
• valuation and impairment of investments, including estimates related to expectations of credit losses on certain financial assets
• valuation of freestanding derivative instruments
• valuation of embedded derivatives
• net investment income
• contingent liabilities
• consolidation of variable interest entities
In applying our accounting policies, we make subjective and complex judgments that frequently require estimates about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries while others are specific to our business and operations. Since future events and their effects cannot be determined with precision, actual results could differ from these estimates.
The above critical accounting estimates are described in “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Estimates” and Notes 1 and 2 of the Notes to the Consolidated Financial Statements included in our 2021 Annual Report.
Off–Balance Sheet Arrangements
We do not have any off–balance sheet arrangements as of June 30, 2022.
120
Item 3 | Quantitative and Qualitative Disclosures about Market Risk
Item 3. Quantitative and Qualitative Disclosures about Market Risk
There have been no material changes to the quantitative and qualitative disclosures about market risk described in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Quantitative and Qualitative Disclosures About Market Risk” previously disclosed in our 2021 Annual Report.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We maintain disclosure controls and procedures, which are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. During the period covered by this Report, we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act).
We describe in the Company's Form 10, Note 2—Restatement of Previously Issued Financial Statements to our audited financial statements, the background to the restatement of our previously-issued audited financial statements for the year ended December 31, 2020. Our management has concluded that the restatement resulted from a material weakness in our internal control over financial reporting as of December 31, 2020. Due to this material weakness in our disclosure controls and procedures and internal control over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were not effective as of June 30, 2022.
Although the Company has taken significant steps in our remediation plan, the Company continues to implement, document, and communicate policies, procedures, and internal controls. As a result of the material weakness, our management has identified the need for stronger controls when assessing the accounting for significant and unusual transactions that involve a high degree of judgment and complexity, along with the need for additional technical U.S. GAAP accounting expertise. Our management has implemented and enhanced controls when assessing the accounting for significant and unusual transactions in the third quarter of 2021 as well as made some key hires for additional technical U.S. GAAP accounting expertise. The Company believes that these actions will remediate the material weakness. However, the material weakness will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. We expect that the remediation of this material weakness will be completed by year-end 2022.
Changes in Internal Control Over Financial Reporting
As described above, the Company has taken steps to remediate the material weakness in its internal control over financial reporting and is implementing additional controls to remediate the material weakness. Other than these additional controls, there was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended June 30, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
121
Part II - Other Information
Item 1. Legal Proceedings.
For a discussion of legal proceedings, see Note 14 to Condensed Consolidated Financial Statements included elsewhere in this Report.
Item 1A. Risk Factors.
We discuss in this Report, in our 2021 Annual Report and in our other filings with the SEC, various risks that may materially affect our business. In addition, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Forward-Looking Statements - Cautionary Language” included herein. There have been no material changes to our risk factors from the risk factors previously disclosed in our 2021 Annual Report.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Recent Sales of Unregistered Securities.
None.
Repurchase of Equity by the Company.
Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of Publicly Announced Program (2) | Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (in millions) (2) | ||||||||||
April 1, 2022 - April 30, 2022 (1) | ||||||||||||||
Share repurchase program | 349,357 | $ | 43.40 | 349,357 | $ | 234 | ||||||||
Employee transactions (3) | 784,727 | 43.21 | N/A | N/A | ||||||||||
May 1, 2022 - May 31, 2022 | ||||||||||||||
Share repurchase program | 1,046,497 | 35.29 | 1,046,497 | 197 | ||||||||||
Employee transactions (3) | N/A | N/A | N/A | N/A | ||||||||||
June 1, 2022 - June 30, 2022 | ||||||||||||||
Share repurchase program | 475,000 | 28.75 | 475,000 | 183 | ||||||||||
Employee transactions (3) | N/A | N/A | N/A | N/A | ||||||||||
Totals | ||||||||||||||
Share repurchase program | 1,870,854 | 1,870,854 | ||||||||||||
Employee transactions (3) | 784,727 | N/A | ||||||||||||
2,655,581 | 1,870,854 |
(1) Includes repurchases of shares under Class A Common Stock repurchase agreements with Athene.
(2) On February 28, 2022, our Board of Directors authorized an increase of $300 million to the existing share repurchase authorization. For more information on common stock repurchases, see Note 18 to Condensed Consolidated Financial Statements included elsewhere in this Report.
(3) Includes shares withheld pursuant to the terms of awards under the Company's 2021 Omnibus Incentive Plan to offset tax withholding obligations that occur upon vesting and release of shares, which are treated as share repurchases. The value of the shares withheld is the closing price of common stock of Jackson Financial, Inc. on the date the relevant transaction occurs.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
None.
122
Item 6. Exhibits.
The following documents are filed as exhibits hereto:
Number | Description | ||||
3.1 | |||||
4.2 | |||||
4.3 | |||||
10.1*† | |||||
10.2*† | |||||
10.3*† | |||||
10.4*† | |||||
31.1* | |||||
31.2* | |||||
32.1* | |||||
32.2* | |||||
101.INS* | Inline XBRL Instance Document – The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document | ||||
101.SCH* | Inline XBRL Taxonomy Extension Schema Document | ||||
101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
* Filed herewith.
† Identifies each management contract or compensatory plan or arrangement.
123
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
JACKSON FINANCIAL INC. | |||||||||||
(Registrant) | |||||||||||
Date: August 10, 2022 | By: | /s/ Marcia Wadsten | |||||||||
Marcia Wadsten | |||||||||||
Executive Vice President and Chief Financial Officer | |||||||||||
(Principal Financial Officer) |
124